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ABSTRACT
Improvements in the production of recombinant therapeutic proteins from in vitro
mammalian cell cultures depend on the extension of viable proliferation. The
emergence of cell death within a few days of inoculation of a fed-batch process occurs
for unknown reasons, and despite the optimal control of culture parameters such as
temperature, pH, osmolarity, dissolved oxygen, nutrient levels, and growth factor
requirements. Given that the death observed is that of genetically controlled apoptosis
(a phenomenon necessary for biological systems under other circumstances), changes
in cellular physiology were investigated along the emergence of apoptosis. In this
regard, environmental factors such as insulin and rapamycin were studied for their
effects on metabolism, cell cycle progression, and apoptosis.
The apoptotic cell death of a hybridoma cell line was studied in steady state
chemostat cultures grown in reduced glutamine, serum-free, hydrolysate-free IMDM
medium. Five steady states were characterized at dilution rates of 0.04 hr-, 0.03 hr-,
0.02 hr 1, 0.01 hr 1, and 0.04 hr-1 again in turn. The steady states spanned a range of
cultures with higher viability and faster growth rate down to lower viability and slower
growth rate. The physiology of the hybridoma culture for each steady state was
measured in terms of cell density and viability, growth and death rates, extent of
apoptotic cell death, cell cycle distribution, metabolite uptake and production rates, and
the production of MAb product. Furthermore, intracellular metabolite fluxes and ATP
production were calculated based on a model for central carbon metabolism.
From this series of steady states it was observed that culture metabolism shifts
towards more complete oxidation of glucose and increased TCA cycle activity for steady
states under more severe nutrient limitation at lower dilution rates. Even though growth
rate is inhibited and cell death emerges, the shift in metabolism is interpreted as a
robust cellular response to the less optimal environmental conditions. The shift in
metabolism is one that generates more intracellular energy per given nutrients, and is
presumably required to meet increased maintenance energy demands resulting from
environmental stresses. Upon increasing the dilution rate back to the same initial high
setting, the culture whose metabolism had been shifted by exposure to leaner nutritional
environment actually outperforms the high dilution rate steady state obtained initially. As
a result of the increase in metabolic efficiency, the observed multiple steady state
exhibited a viable cell density twice that of the first steady state. Culture physiology is
thus characterized to depend not only on the imposed environment (i.e. the dilution rate
setting) but also on the internal metabolism of the cells.
Despite metabolic effects, the amount of apoptotic cell death for a steady state
culture still correlated inversely with dilution rate. Interestingly, even though there was a
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reduction in growth rate and death emerges, cell cycle distribution did not shift towards
an arrest in the G1 phase of the cell cycle (the gap following cell division and preceding
DNA synthesis). Rather, cells accumulated within the S-phase (DNA synthesis). This
lack of cell cycle arrest in the G1 phase for cells under nutritional limitation points to a
defect in cell cycle control. In this regard, it was further shown that the hybridoma cells
express high levels of c-myc, a proto-oncogene associated with cell cycle entry. Hence,
unbridled entry to the cell cycle and the accumulation of cells in the S-phase is believed
to be associated with higher levels of apoptotic cell death than would otherwise be
observed under nutrient limiting conditions.
To address the apparent defect in control of cell cycle entry, the cell cycle
arresting agent rapamycin was identified and employed as a medium additive to inhibit
cell cycle entry of hybridoma cells during fed-batch cultures. Results demonstrate a
delay in the emergence of cell death from 48 to 72 hours in the presence of rapamycin.
Despite growth being mildly inhibited, the extension of viable proliferation results in
higher maximum viable cell densities and greater integrated viable cell densities. Over
the course of 6-day fed-batch experiments, the positive effects of rapamycin on culture
physiology yield increases of monoclonal antibody titers from 0.25 g/L up to 0.55 g/L.
Such an improvement of titer is due to the increase in viable cell density as well as an
increase in apparent specific productivity. Rapamycin's mechanism for the above
physiological changes for this hybridoma cell line, and in particular, its ability to
postpone and minimize apoptotic cell death, remains an open question. It is possible
that delay of progression through G1 allows for more timely production of intracellular
molecular factors needed for cellular function and survival during DNA synthesis and
mitosis. Yet, preliminary evidence suggests that rapamycin's effect metabolism may
also play a key role in the enhanced survival of the hybridomas.
The role of insulin for protecting hybridomas against apoptosis was investigated
by comparing culture physiology in the presence and absence of insulin in chemostat
and batch cultures. The hybridoma's dependence on insulin for growth with high viability
was demonstrated to depend on the extent of conditioning of culture medium. Under
optimal conditions, insulin is not required for viable proliferation. Yet as the environment
becomes more conditioned during fed-batch cultivation, insulin is then required to
extend viable growth beyond 24 hours to 48 hours. The emergence of cell death with or
without insulin coincides with a delay of progression through all phases of the cell cycle
and a shift in metabolism. Thus, it appears that insulin protects cells more through its
stimulation of metabolism and less as a growth factor for cell cycle progression. Insulin
stimulation of metabolism may confer protection against apoptosis by bolstering the
metabolic shift needed to counter environmental stresses that promote cell death.
Overall, rapamycin and insulin protect cells against apoptosis indirectly through
their effects on cell cycle and metabolism. Rapamycin, a newly discovered protective
factor for the hybridomas, protects cells against apoptosis through its inhibition of cell
cycle entry. Such an effect by rapamycin yields significant improvements to fed-batch
productivity. Further improvements will stem from engineering ways to alleviate the
metabolic impediment that is also associated with apoptosis.
Thesis Supervisor: Gregory N. Stephanopoulos
Title: Professor of Chemical Engineering
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1 INTRODUCTION
1.1 THE PRODUCTION OF RECOMBINANT THERAPEUTIC
PROTEINS
The overall aim for this thesis was to increase the final titer of recombinant therapeutic
proteins produced from mammalian cell culture during fed-batch processes.
Recombinant DNA technology has allowed us to use cells to produce many kinds of
proteins: enzymes, antibodies, growth factors, hormones, blood factors, neuropeptides,
etc. Today, approximately 20 years after the production and sale of the first
recombinant therapeutic protein (Genentech's recombinant insulin from bacterial
culture), the market for such products is well established and continues growing. As of
1992, the estimated worldwide sales for 14 recombinant therapeutic proteins was 4.4
billion dollars (Klausner 1993). A more recent report optimistically expresses growth for
the future, from which I excerpt a portion of its abstract:
"During the past ten years, the biopharmaceutical landscape has changed
significantly, from 5 drugs on the market in 1987 with combined sales of
less than $1 billion to more than 30 drugs for as many as 50 indications,
with sales close to $13 billion. In 1996, for the first time in history, sales of
two biopharmaceutical products-Amgen's epoetin alfa (EPO, Epogen) and
granulocyte colony stimulating factor (G CSF, Neupogen)-achieved more
than $1 billion in worldwide sales. In 1997, we anticipate that Johnson &
Johnson's Procrit, also an epoetin alfa, will join the ranks of billion dollar
pharmaceuticals. We expect worldwide sales of biopharmaceutical
products to reach $12.8 billion in 1997, an 8.6% increase over 1996 sales.
Although worldwide biopharmaceutical sales make up just 5% of world
prescription drug sales, they have grown tremendously over the past
decade."
Biopharmaceutical Sales and Forecasts to 2002
Samantha S. Cheng
Pharmaceutical Industry Dynamics
Issue #159, 12/9/97
The use of recombinant bacterial cultures for the production of therapeutic proteins is
the superior method to produce titers as high as possible during a fermentation. The
achievable product titer is a key parameter that determines whether a given process is
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economically feasible. Yet, the limitation of bacterial systems for the production of
therapeutic proteins is the inability of the bacterium to perform post-translational
modifications to the protein of interest. Producing a backbone amino acid structure by
mRNA translation is a necessary step for the formation of a protein, but, depending on
the protein of interest, it is not always sufficient for producing a more complex protein
with the desired bioactivity. Many proteins are modified post-translationally. Types of
modifications include glycosylation, sulfide bridge formation, cleavages, and assembly
of subunit proteins. Such modifications determine the actual properties of the protein,
above and beyond just the amino acid sequence.
Mammalian cells are able to perform the variety of post-translation modifications that
are needed for proteins of a more complex nature. This ability of mammalian cells
makes them an attractive system in which to produce therapeutic proteins that are
secreted in active form. As not all mammalian cell types necessarily have the same
post-translational capacities, part of the decision regarding which type of mammalian
cell to use for a particular protein depends on the nature of the post-translational
modifications required.
The downsides of using mammalian cells are the relatively lower secretion rates for the
recombinant protein, the dramatically slower growth rate of the cells, and the relatively
lower achievable maximum cell density. All these factors severely impact the economic
viability of a therapeutic protein production process. As the product titer coming from the
primary fermentation vessel is dramatically reduced, not only is the gross amount of
product less, but the costs associated with downstream processing and purification are
much higher. Unfortunately, given today's current technology and economic climate,
many drugs produced by cell culture technology are very expensive or cannot even be
produced at all.
Yet despite these obstacles, mammalian cell technology has emerged as the best way
to produce a variety of therapeutic proteins. It is possible today to culture a multitude of
different types of cells from a variety of different organisms, including humans. Indeed,
the cultivation of mammalian cells has gone far beyond just using the cells as catalysts
to produce a therapeutic protein. In vitro cultivation has become a means of cultivating
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cells for the purpose of studying human illnesses and diseases, regenerating cells taken
from a patient in need of tissue repair, or to produce cellular stocks and artificial organs
for implantation.
1.2 PROGRAMMED CELL DEATH
The in vitro cultivation of cells has in many ways been satisfactorily reduced to practice.
A researcher today can fairly simply choose from a multitude of cell lines in a given cell
bank, test a few well-established media, setup flasks or bioreactors, and culture cells for
his or her particular needs. Many of the engineering and technological challenges have
been addressed. There is plenty of information concerning the overall effects of and
methods to control many culture parameters, such as temperature, pH, osmolarity,
nutrient concentrations, serum and growth factors, and dissolved oxygen and carbon
dioxide levels. Likewise there are many alternate ways to grow cells, such as in batch,
or fed-batch, or continuous mode, or on a surface or microcarriers or within a matrix for
perfusion or within polymer bead capsules. All of these advances have given
researchers the means in which to cultivate a sufficient quantity of cells for analysis and
experiments.
The caveat to the above statements concerning the progress that has been made thus
far is that we have yet to learn how to cultivate cells at "ultra-high" cell densities. The
ultra-high cell density we desire would make the production of nearly any therapeutic
protein economically feasible. It is also of interest for the production of artificial tissues.
One of the main obstacles we encounter in growing cells at higher densities is cell
death. Cell death by necrosis occurs due to shear damage, sparging damage, and
accumulation of toxic by-products such as lactate, ammonia, and CO 2. Such type of
necrotic cell death has been adequately addressed and minimized by a combination of
engineering and biological remedies. Yet, another type of cell death, called programmed
cell death or apoptosis, also plagues cultures depending on the mode of operation of
the process and the environment.
The detrimental effect of apoptosis on the performance of a culture has been identified
as a primary limitation in a variety of animal cell culture systems over the past several
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years. Since the overall productivity of a culture process is strongly dependent on the
viable cell density integrated over the life span of the culture, the emergence of cell
death directly detracts from the overall productivity. During the investigation of
apoptosis, many stimuli of apoptosis have been identified and studied. It is known that
the emergence of apoptosis is affected by nutrient and growth factor availability, as well
as by the presence of genetic and molecular factors related to apoptosis and cell cycle
progression.
Despite the variety of advances in cell culture engineering and our better understanding
of apoptosis, apoptotic cell death still persists in continuing to limit cell culture
processes. Even despite the control of all the possible environmental parameters that
we know can stimulate apoptosis and that we can manipulate, apoptosis emerges within
the first several days of a fed-batch cultivation. The ultimate cause for apoptosis
remains unknown. The complexity of the phenomenon of such cell death is that it is
associated with several other global cellular phenomena, such as growth, cell cycle
progression, and metabolism.
1.3 THESIS ORGANIZATION
The motivation and development of my thesis objectives is first presented in Chapter 2.
Thereafter, my own investigations into the relationship between metabolism, cell cycle
progression, and apoptotic cell death are provided in Chapter 3, 4, and 5, where I look
at the effects of nutrients, rapamycin, and insulin in turn. Chapter 6 integrates my
findings in a discussion of their implication to the field of cell culture engineering. In
Chapter 7, I conclude by summarizing the major findings.
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2 BACKGROUND AND MOTIVATION
2.1 CELL CULTURE ENGINEERING TECHNOLOGY
2.1.1 Production of Recombinant Therapeutic Proteins
The ability to grow cells in vitro is a prerequisite for biochemical, biological, and
biomedical research and engineering. Today, the in vitro cultivation of cells is common
practice for a wide variety of applications. From making therapeutic proteins for human
beings, to cultivating human tissue cells for tissue repair, to investigating cellular
function, and to testing genetic therapies, a cell culture is a powerful platform in which to
investigate, elucidate, manipulate, emulate, and recreate biological phenomena for the
production of biological materials.
The accumulated experience of worldwide research has yielded a technology that
allows researchers today grow cells, handle them in a aseptic fashion, cryogenically
freeze them for preservation, partially manipulate their behavior, and use genetic
techniques to alter or enhance or clone them. With these tools comes the knowledge of
how best to grow cells in vitro. Depending on the particular application, experimental
and process objectives can be most readily achieved through the understanding and
exploitation or manipulation of cellular behavior.
One particular application of cell culture engineering is the production of recombinant
therapeutic proteins for use as human pharmaceuticals. The first such commercial cell
culture process was initiated in the 1970's (by Genentech and produced by Lilly in 1982)
for recombinant insulin using bacterial cells. The advent of recombinant technology and
its debut in the commercial production of recombinant insulin set the stage for the
myriad of other therapeutic protein drugs on the market today, 20 years later.
As the technology evolved, the desire to accommodate the production of more complex
proteins led to recombinant technology in conjunction with mammalian cells, which can
perform additional post-translation protein modifications. The benefits of using
mammalian cells to produce therapeutic proteins do not come without additional
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technical challenges. The major drawback for mammalian cell culture processes is the
lower cell densities that are obtainable and the smaller specific production rates for the
product. These drawbacks lead to processes that yield much lower product titers
relative to their bacterial counterparts for less complicated proteins. For this reason, the
production of a therapeutic protein is even more tightly dependent on overall process
economics. Unfortunately, with current technology, it is not possible to produce just any
therapeutic protein.
Many technical challenges were overcome in the development of the first cell culture
process and since then. This chapter, which serves as background for my own
contributions to the field, describes a cumulative body of work regarding the culturing of
mammalian cells in vitro, with the principle aim of increasing production capacity of cell
culture systems for recombinant therapeutic proteins. As will be evident in this review
and in my own contributions, cell death by apoptosis remains the ultimate limitation for
many cell culture processes. For this reason, the advances and challenges that I
describe for the fed-batch cultivation of cells for the production of therapeutic proteins
are cast in the light of how they impact culture longevity and cell death.
2.1.2 Proposed Milestone for Fed-batch Production
In considering the advances of cell culture towards producing therapeutic proteins from
animal cells, it is important to be aware of the best possible outcome for a proposed
process. When I began my work, the ultimate (unofficial) objective was to develop a cell
culture process that is capable of producing 10 g/L of a desired therapeutic product
within a couple weeks of fed-batch cultivation. Despite advances in the field, and taking
a step back in production potential by switching to serum-free medium, this milestone in
product titer of 10 g/L has yet to be achieved.
The following example shows that this objective would be attainable, even despite the
slower growth of animal cells and their lower specific productivity, if cell death could be
prevented altogether. Let us imagine a cell line with a constant growth rate of 0.03 hr 1
and a constant specific productivity of 1.5 x 10-9 mg/cell/hr, and that the cell line does
not succumb to cell death during the course of a batch. To reach 10 g/L in such a
system, the cells would need to grow from 2e5 cell/ml at inoculation up to 2e8 cells/ml
22
over a 10-day period. The corresponding integrated viable cell density for such a batch
run would be 6.7e9 cell-hr/ml. In this scenario, the ten-day fed-batch would yield the
desired 10 g/L of product. The final cell density achieved for such a hypothetical culture
is reasonable in regard to a calculated maximum cell density for close-packed cells of
2e9 cell/mI (assuming a cell diameter of 15 ptm and no void space). The final cell
density, though quite high, is only one-tenth that of the close-packed limit.
I use this scenario for the theoretical objective to compare improvements to fed-batch
cultures. Below I plot the cell densities, viabilities, and product titers for the objective
along with two real processes below (Figure 2.1 a b). The real processes shown are
those for hybridoma cells grown in serum-based medium (Xie and Wang 1996) and
hybridoma cells grown in serum-free medium (my own data). For the former data, I
show the first 10 days of the 23-day run (that yielded 2.4 g/L overall). For the latter data,
I extend the six-day run to ten days by calculating total and viable cell densities using
growth and death rates from the sixth day. It is obvious that the actual process data
pale in comparison to the best case for the desired objective. Maximum viable cell
densities for the actual processes are 40 to 100 times lower than that of the scenario.
Product titers (0.70 g/L and 0.35 g/L for serum and serum-free) are 15 to 30 times
smaller than the objective (Figure 2.2). From the cell density and viability plots, it is clear
that the emergence of cell death has a severe negative impact on culture productivity.
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Figure 2.1 a,b. Comparison of cell density and viability for serum- and serum-free
hybridoma fed-batch cultivations vs. a theoretical death-free culture.
Data for the serum-hybridoma truncated to 10 days from a 23-day run performed by Xie and
Wang (Xie and Wang 1996). Data for serum-free hybridomas extended from data for a 6-day
run, using growth rate and death rate of 0.011 and 0.018 hr', respectively. Theoretical data is
calculated using a constant growth rate of 0.03 hr-1 and constant viability of 95%.
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Serum-
Hybridoma
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Figure 2.2 Comparison of 10-day fed-batch titers from serum- and
hybridoma cultivations vs. a theoretical death-free culture.
serum-free
Titer for the serum-hybridoma is that for the 23-day run performed by Xie and Wang at day 10
(Xie and Wang 1996). 10-day titer for serum-free hybridomas is based on the 6-day titer of
0.25 g/L, extended using the viable cell density from Fig. 2.1 and a specific productivity of
1.5e-9 mg/cell/hr. Theoretical data is calculated using viable cell density from Fig. 2.1 and a
specific productivity of 1.5e-9 mg/cell/ml.
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There remains ample room for further improvement of today's fed-batch processes.
Even for the data shown above it is evident that the use of serum has a beneficial effect
on culture performance by supporting viable proliferation up through four days. The
switch to serum-free medium actually pushed progress backwards - cells grow viably
for just two days and yield half the product titer. Nonetheless, the improvement of
serum-free processes still depends on understanding and defeating cell death. As will
be discussed in Chapter 4, the extension of viable growth of a serum-free hybridoma
culture by one day and the increase of apparent specific productivity (by using a cell
cycle arresting agent rapamycin) results in a doubling of product titer during a six-day
serum-free cultivation of hybridomas. On the same 10-day basis described above, such
rapamycin treated cultures can rival the serum-based counterparts by yielding an
estimated titer of 0.95 g/L.
Thus, the ability to make vast improvements on culture production rests on learning how
to extend viability by reducing cell death. Two types of death can plague a cell culture
process: necrosis and apoptosis. The following sections discuss relatively recent works
that have helped minimize or understand the emergence of these types of cell death
during culture processes. The works and concepts presented comprise the knowledge
base on which I developed my own hypothesis, experiments, and results.
2.2 ADVANCES AND OPPORTUNITIES IN FED-BATCH
CULTIVATION
The following topics in cell culture engineering pertain to advances in the culturing of
cells in batches and fed-batches. The topics and references chosen place the focus of
the discussion on continuous cell lines, such as hybridoma and Chinese hamster ovary
cells. The scope is further narrowed to focus on process limitations that may possibly be
implicated in the emergence of apoptosis.
Today the field of cell culture engineering is "maturing" to a new level of analysis,
objectives, and engineering goals. The figure below represents my view of the hierarchy
for research and analysis of cells in vitro.
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4 Gene Therapy
3 Identification of
Genetic Targets
2 Cell Physiology
1 Environmental
Parameters
Figure 2.3 Hierarchy for the investigation and manipulation of cellular behavior of
mammalian cells.
Initially, cell culture research involves the study of the many various culture parameters
that affect growth, productivity, and/or survival of cells in vitro. For the culturing of
continuous cell lines for use in fed-batch processes, such investigation has been
exhausted for the current achievable cell densities. Yet, in the cultivation of new types of
cells (such as hematopoeitic and bone marrow cells) researchers find themselves
testing the effects of pH, shear, dissolved oxygen, nutrients, and growth factors on
culture physiology all over again. Establishment of the optimal culture parameters for a
given cell line is usually a necessary first step. Today, researchers finding themselves
with a new cell line or cell type to cultivate, can readily characterize it using the
knowledge base methods established over the previous 20 years.
Implicit in determining the optimal environment for the cultivation of a cell line is the
description of the overall physiology of a cell culture that is observed and that which is
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The manipulation of cellular behavior depends
on the determination of relevant genetic targets
for manipulation, which in turn relies on the
elucidation of cellular and environmental
parameters
ultimately desired. Having designed the best possible environment, the next endeavor
may be to characterize cellular phenomena such as growth, metabolism, cell cycle
control and progression, specific productivity, and/or programmed cell death. These five
phenomena are used as a basis to characterize cellular behavior. Their variation is
observed to be related to one another in vitro and can be affected by the choice of
culture parameters. Furthermore, all the phenomena are genetically controlled. The
observed relationships in these cellular phenomena can be used to determine the
genetic constraints for cellular behavior and identify potential opportunities to
manipulate it for our particular needs. The work described in this thesis falls within this
scope of determining and manipulating cellular physiology.
The determination of targets for genetic manipulation relies on information pertaining to
the cellular phenomenon of interest as well as the relevant environmental parameters
that must be maintained in vitro. Today, the choice of possible genetic targets relies on
observations of physiology coupled with established biological models from the
literature. A more rational and quantitative approach is the use of metabolic
engineering, a proven methodology for the analysis of biochemical pathways and their
control. Metabolic flux analysis is used to quantify intracellular fluxes and determine
potential ramifications of altering the flux network. Besides metabolic pathways, the
methodology is now finding its way to be used for analysis of signal transduction
pathways and the supply and fate of precursors for post-translation modification of
proteins. Yet without the genetic map for the cells or a full complement of tools with
which to study genetic modifications for mammalian cells, the identification of the best
targets remains a challenging endeavor.
The emerging fields of genomics and proteonomics promise to develop the means by
which to implement the genetic changes that are warranted from the study of cellular
physiology and proposed by metabolic engineering analysis. Manipulation of animal cell
culture behavior and productivity through genetic means has yet to be reduced to
practice. The insertion or knockout of key genes in mammalian cells is still a formidable
endeavor. Furthermore, the choice of critical genes that could have desired impacts is
not available. Advances in genomics and proteonomics will enable cell culture
researchers to more fully probe and understand the genetic "circuits" and protein
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networks that ultimately control cellular behavior. This direction of evolution for cell
culture engineering technology will ally itself with developments in gene therapy
techniques for inserting and manipulating mammalian genes. Together, the genetic
revolution, which is being fueled by biomedical applications, will exploit the in vitro
cultivation of mammalian cells in its quest to cure human illnesses. Cell culture
researchers, however, will also be able to make use of such techniques to "cure" their
own cultures of the limitations of low specific productivity and susceptibility to apoptotic
cell death during batch cultivation. These are indeed exciting times to capitalize on the
synergy between the genetic manipulations proposed by gene therapy for humans, and
the genetic manipulations needed to maximize cell culture processes. In both cases, we
seek to use genetic modifications to achieve a desire phenotype of cellular behavior.
2.2.1 Environmental Culture Parameters
2.2.1.1 Temperature
For many fed-batch processes, temperature is simply fixed near or at 370C throughout
the cultivation. Yet, as has been recently reported (Chuppa, Tsai et al. 1997), the choice
of temperature setpoint, or the variation of its setpoint during a culture process, may
have beneficial effects on viability and productivity. As reported, the lowering of the
temperature setpoint down to 340 C during perfusion culture was associated with a
variety of significant physiological changes for a recombinant hamster cell line. At
temperatures of 370, 35.50, and 340, cell density and viability remained constant at 20 x
106 cell/ml and 90%, where as growth rate decreased 20%, glucose uptake decreased
50%, lactate production decreased 30%, glutamine uptake decreased 15%, ammonia
production decreased 20%, oxygen and carbon dioxide rates decreased by 25%, and
production of the therapeutic protein was mildly enhanced and glycosylation was
comparable. Thus, it appears that the downshift in metabolism follows the downshift in
growth rate, without detriment to cell density being that it is a perfusion process.
On hindsight for the work of this thesis, the changes in metabolism and cell cycle
progression associated with temperature could be of interest in the extension of viable
proliferation of hybridoma fed-batch cultures. As is demonstrated in later chapters, the
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inhibition of G1 progression by rapamycin greatly reduces apoptotic cell death, cell
death is associated with changes in metabolic efficiency, and productivity is a function
of cell cycle progression, metabolism, and cell death. Thus, it could be of interest to
compare rapamycin's positive effects on viable proliferation to those that are reported
for a decrease in fermentor temperature. Nonetheless, given the ease of controlling
temperature, neither disturbances in culture temperature nor the choice of setpoint at
370C is implicated in the emergence of death in fed-batches.
2.2.1.2 Extracellular pH
Optimal extracellular pH for viable hybridoma cell density has been measured to be 7.1
to 7.4 (Miller, Wilke et al. 1987). Some reports for hybridomas quote the larger range of
6.8 to 7.6 where effects on growth are minor (McQueen and Bailey 1990), while other
reports indicate that there is pronounced growth inhibition for hybridomas as
extracellular pH is lowered from 7.0 to 6.7 (Cherlet and Marc 1998). Freshney quotes a
range of 7.0 to 7.4 cells for transformed cell lines as determined by Eagle (Freshney
1994).
Within a C02 incubator and using buffered medium or within a properly controlled
bioreactor with acid/CO2 and base addition, suboptimal pH is not a likely suspect for the
growth arrest and cell death that occurs in fed-batches. In my own work, chemostat
cultures were maintained within a pH range from 7.15 and 7.25. For T-flask cultures
kept in incubators, pH begins at 7.2 and is observed to fall below 7.0 (6.8-7.0 measured
by blood gas analyzer) as batches progress, but this drop coincides with or follows after
the emergence of cell death. Furthermore, bioreactor batches suffer the same fate of
cell death despite pH control. Thus, I am confident that pH is not the limiting factor for
today's fed-batches.
On hindsight to my observations concerning metabolic changes associated with cell
death, it is interesting that the metabolic symptoms associated with an extracellular pH
that is too low (around 6.7) are mild to severe growth arrest, decreases in specific
glucose consumption (higher cellular yield), and increases in specific glutamine
consumption (lower cellular yield) (McQueen and Bailey 1990; Cherlet and Marc 1998).
These metabolic shifts are attributed to higher maintenance requirements as the
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differential between intracellular and extracellular pH increases. My own observations
reveal a similar shift towards increased energy production as death emerges, but as the
result of unknown causes rather than low pH. The similarity in metabolic responses for
pH-induced stress and that of growth arrest and death in fed-batches suggests that the
unknown factor(s) that plague fed-batch processes may exercise its negative impact by
raising maintenance requirements by some as of yet undetermined mechanism.
2.2.1.3 Dissolved Oxygen
Supply of oxygen is indispensable for the cultivation of aerobic mammalian cells. This
issue is further intimately tied to the method and efficiency of stirring and sparging,
which can be detrimental to cell integrity (Gardner, Gainer et al. 1990). During agitation,
the presence of a vortex and the resultant bubble entrainment can be detrimental to cell
density. In the absence of a vortex, agitation as high as 700 rpm is not harmful (Kunas
and Papoutsakis 1990). Thus, even though the mammalian cells are more sensitive to
shear damage than bacterial cells, agitation by itself is not implicated in causing cell
death and cultures can be thoroughly agitated to ensure a well-mixed environment.
Many engineering configurations are available for the supply of oxygen. Headspace
aeration only allows for a limited cell density. Sparging can be used with ease and
successfully with the presence of pluronic F-68 and other surfactants that help minimize
cell disruption (Meier 1998). Other techniques include the use of a coiled silicone tubes,
perfluorocarbon, or an external aerator (Aunins, Croughan et al. 1986; Mano, Kimura et
al. 1990).
In addition to supplying oxygen, the dissolved oxygen concentration chosen for setpoint
can also affect culture growth and metabolism, though the optimal setpoint varies from
one report to another (Ozturk and Palsson 1990). An optimum in viability for hybridomas
was observed at the very low steady state dissolved oxygen level of 0.5% of air
saturation and is attributed to a reduction in oxidative stress (Miller, Wilke et al. 1987).
This finding is supported by the more recent study showing the ill effects of hyperoxic
conditions on viability, taken to be due to oxidative stress since anti-oxidant enzymes
are induced many-fold (Jan, Petch et al. 1997). Furthermore, the reports indicate that
DO levels between 1% and 10% are not limiting to mitochondrial respiration. Thus, for
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the fed-batch cultivation of cells, a DO setpoint which can be feasibly and reliably
implemented in the transient process must be chosen which would eliminate the
possibility of oxygen depletion without causing undue oxidative stress. As a general
guideline, a setpoint of 5-10% saturation is a safe initial range. Such a reduction in
setpoint from the typically used 40-60% DO would also allow a near doubling in
oxygenation capacity for a constant mass transfer coefficient, kLa.
My own investigations have been carried out with a setpoint of 40-50% in bioreactor
cultures and dissolved oxygen concentrations anywhere from 10-100% of air saturation
in incubator cultures. Depletion of oxygen is therefore not considered to be the cause
for cell death in fed-batches. Furthermore, the emergence of cell death that is exhibited
within my own fed-batch processes does not appear to have the same metabolic
symptoms as those reported for oxygen depletion or for hyperoxic (high oxidative
stress) conditions.
2.2.1.4 Osmolarity
Osmolarity is an important culture parameter to monitor and to maintain within a
reasonable range that does not impede cell proliferation or increase death rate (Ozturk
and Palsson 1991). Osmolarity of fresh culture medium is 260-320 mOsm. The effect of
higher starting osmolarity for batch processes reveals that culture growth is inhibited,
that cell death is increased (even during exponential growth phase), and that metabolic
rates are increased (i.e. cell yield is decreased, implying higher maintenance).
Furthermore, once the death phase commences higher osmolarity also leads to greater
death rates than controls. Thus, higher osmolarity is viewed as an environmental stress
that should be avoided in the design and control of an optimal fed-batch process.
The global symptoms of growth arrest and exacerbated cell death are similar to the
ones we observe for our current fed-batch processes, even though osmolarity is
maintained within a healthy range (Bibila, Ranucci et al. 1994; Robinson, Seamans et
al. 1994; Xie and Wang 1994). For my own work, osmolarity was infrequently measured
and assumed to be within a healthful range since were using Xie and Wang's feeding
strategy for fed-batches or running chemostats. The interesting question remains as to
what is the mechanism by which a higher osmolarity leads to slower growth and cell
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death. Investigation of this mechanism may reveal other cellular phenomena that are
possibly related to the emergence of cell death in today's fed-batches. For now,
suboptimal osmolarity is not considered to be the cause of death in fed-batches.
2.2.1.5 Toxicity of Waste Metabolites: Lactate and Ammonia
Two well-known culprits that cause cessation of culture growth and cell death are the
waste metabolites lactate and ammonia (Hassell, Gleave et al. 1991). These
compounds arise from the normal catabolism of the two major substrates glucose and
glutamine. Ammonia also further accumulates as the result of non-biological
degradation of glutamine within culture medium. Toxic lactate concentrations are
reported to range from 25 mM to 80 mM and toxic ammonia concentrations are reported
to range between 2 mM and 4 mM. Furthermore, the toxicity effects are more severe
from an initial spike of exogenous ammonia or lactate than in the gradual accumulation
throughout culture (Xie 1997).
Though the sensitivities for such substances are cell-line dependent, the response of a
culture once inhibited is growth arrest and cell death. This occurs even in the absence
of changes in pH. Furthermore, a decrease in pH from 7.8 to 6.8 reduces the effect of
ammonia inhibition in a hybridoma cell line, since it is ammonia rather than ammonium
that is the toxic species (Doyle and Butler 1990). For this reason, the presence of
lactate (hence lowering the pH) can somewhat minimize the effect of ammonia (Hassell,
Gleave et al. 1991). At the biochemical level, ammonium has been reported to elevate
the amount of intracellular UDP-GNAc, whose concentration correlates with the level of
growth inhibition in mammalian cell lines (Ryll, Valley et al. 1994). The effect of
ammonium ion has also been modeled for its effect on intracellular pH of hybridoma
cells (McQueen and Bailey 1990). Lactate toxicity on the other hand is believed to be
toxic through its effects on osmolarity and extracellular pH (Xie 1997).
Ammonia addition to continuous hybridoma cultures resulted in lower steady state cell
density due to increases in cell death, but did not affect the steady state specific growth
kinetics. Higher ammonia concentrations also were observed along with lower cell
yields for glucose, glutamine, and oxygen, hence symptoms of a loss in metabolic
efficiency (Newland, Kamal et al. 1994). The effect of a step up in ammonia
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concentration was followed by a period of adjustment in cellular metabolism. It would
have been interesting to see if the shift in metabolism would have yielded a multiple
steady state upon a downshift in ammonia concentration (which was not apparently
performed by Newland, et. al.). As will be shown in Chapter 3 for nutrient limitation, the
metabolic adaptation of hybridomas is involved in the occurrence of steady state
multiplicity.
Strategies to minimize lactate and ammonia production include proper medium design
and feeding strategies (Glacken, Fleischaker et al. 1986; Xie 1997) as well as removal
by electrical or chemical means (Chang 1994). The adjustment of metabolism through
nutrient control to minimize production of toxic by-products is the preferred method to
minimize lactate and ammonia since it can be applied at all scales.
For the hybridoma used in this study, limits for the accumulation of lactate and ammonia
were taken to be 40 mM and 4 mM, respectively. Their concentrations were measured
and shown to be below such limits during fed-batch experiments. For the moment,
lactate and ammonia concentrations can be kept just below inhibitory levels for the
viable cell densities that can presently be achieved. As advances are made towards
achieving the super-high cell density fed-batches needed to produce 10 g/L titers,
ammonia and lactate inhibition will resurface as a threat to such productivity.
2.2.1.6 Nutritional Supply - the Essence of the Fed-Batch Process
The most significant improvements in the extension of culture span in batch processes
have stemmed from the development of proper feeding strategies, and hence the
implementation of the "fed-batch" process. Culture life span has been extended well
beyond the point of depletion of nutrients from the initial batch medium by the feeding of
additional nutrients to the growing culture. Several strategies have been reported to
yield significantly increased titers over an increased culture life span (Bibila, Ranucci et
al. 1994; Bushell, Bell et al. 1994; Robinson, Seamans et al. 1994; Xie 1997). Strategies
are based on varying frameworks according to research or process development needs,
using 10 X concentrates to specifically tailored stoichiometrically-designed
supplemental media. Feeding strategies have also been coupled to on-line
measurements with more sophisticated protocols and multiple nutrient feeds with much
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success (Zhou and Hu 1994; Bibila and Robinson 1995). Thus, the supply of nutrients
has been very successful in augmenting production capacity for therapeutic proteins. As
of the early 1990s, such accomplishments in fed-batch technology had reduced the
finished price of therapeutic MAbs by 10-fold ($10k to $1k per gram) (Bibila and
Robinson 1995).
The proper feeding of fed-batch cultures can be said to have successfully eliminated
apoptotic cell death as the result of nutrient limitations. Nonetheless, apoptosis emerges
shortly (within 4 days of inoculation) after commencing a fed-batch and plagues the
culture throughout its run. The emergence of cell death not only detracts from
productivity due to the loss of viable cells, but also possibly due to physiological
changes associated with the emergence of cell death, such as shift in metabolism,
which may or may not influence specific productivity. As fed-batch development solves
one major cause for cell death in bioreactors (nutrient limitation), it leaves open the
identification of other causes for cell death. In my own work, I employ the feeding
strategy of Xie and Wang, which allows me to focus on elucidating other causes for
apoptosis besides nutrient depletion.
2.2.1.7 Serum and Serum-free Medium
The shift to serum-free medium follows from several process, research, and regulatory
pressures. For the full-scale production of therapeutic proteins, the addition of high
levels of additional proteins to the culture, though useful for cell growth, only
complicates the final isolation of the desired product. Since a large fraction of the overall
process costs are associated with downstream processing, separations, and quality
control, a lower protein burden downstream is economically desired. The savings in raw
material are roughly balanced by the cost of new supplements. From the research
perspective, the analysis of culture physiology is best achieved under as well-defined
conditions as possible. The seasonable variation in serum-products, and the unknown
identities and roles of serum components, can lead to differences in culture behavior
that are not necessarily occurring by experimental design (the same issue exists for the
use of conditioned medium, as is discussed in Chapters 5 and 6). Lastly, from the
perspective of validating a process for FDA approval, the use of serum as a raw
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material adds another uncertainty to the overall production process. For these reasons
and more, the use of animal products is becoming increasingly undesirable.
While the step-down in serum concentration initially inhibits cell growth, the long-term
cultivation of cells in low- and non-serum media results in faster growth and less
dependence on serum (Ozturk and Palsson 1991). Such adaptation is reported not to
alter culture metabolism, yet there may be a negative influence on specific productivity
that is cell line dependent. The role of serum on the emergence of cell death has been
characterized more recently (Chung, Sinskey et al. 1998). The snap-shift of cells from
5% serum to serum-free is associated with the earlier (at between 24 to 48 hours)
emergence of apoptotic cell death, in addition to a slower growth rate. Such death can
be postponed by 24 hours by the addition of insulin (as well as by the over-production of
Bcl-2, an anti-apoptotic protein.) The message of such studies is the role that
environmental factors can have on both the stimulation of growth and the emergence of
apoptosis. Serum apparently contains factors that support growth (such as insulin), but
also factors that prevent apoptosis beyond the 48 hours that insulin alone cannot.
The adaptation to serum-free media for my own hybridoma cell line was accompanied
by even lesser productivity for my fed-batch process. The emergence of cell death (in
the presence of insulin supplement) now emerged soon after 48 hours rather than at 72-
96 hours with serum, resulting in lower cell density and product titer. One of the themes
which runs throughout my work is the role of environmental factors which protect cells
against apoptosis.. To this end, insulin's effects on metabolism and cell cycle are further
investigated. Furthermore, rapamycin is identified as another environmental factor that
further delays apoptosis. Finally, new evidence is presented to support the hypothesis
that hybridoma cells produce different factors that may support viability or may stimulate
cell death.
2.2.2 Genetic and Molecular Phenomena
The analysis of cell culture at the genetic and molecular level became necessary when
it was realized that the emergence of cell death still occurred even when environmental
culture parameters were controlled to the best of our knowledge and ability. The genetic
control of cell death was an obvious choice to investigate at that time. Furthermore,
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there was emerging evidence to suggest the role of other cellular phenomena (genetic
and molecular) in the emergence of cell death. The following sections briefly describe
the works that served as the basis for my own investigations.
2.2.2.1 Apoptosis
Following the increasing interests and discoveries of the biological community regarding
programmed cell death in the late 80's and early 90's, by 1994 the cell culture
engineering community identified the phenomenon of apoptosis as a significant mode of
cell death in bioreactor cultures of continuous cell lines (Franek, Vomastek et al. 1992;
Mercille and Massie 1994; Singh, Al-Rubeai et al. 1994). This form of genetically
controlled cell death is a natural and necessary cellular function for homeostasis,
development of organisms, and the prevention of cancerous growth. Yet in the setting of
a bioreactor, such a phenomenon is essentially "genetic baggage" which amounts to a
very detrimental nuisance. Though apoptosis is related to the culture parameters and
cellular physiology, it stands alone in its genetic nature as a phenomenon worth
targeting directly for improvements in viable cell density.
Cell death in vivo or in a bioreactor can result from necrosis or apoptosis. Necrotic cell
death is that resulting from severe physical or chemical trauma and leading to the
ultimate disruption of the cell. Necrotic cell death is not involved in development and
does not require synthesis of new proteins. In vivo, the release of cellular contents as
the result of necrotic death often leads to an inflammatory response and damaging
secondary effects, (Franek, Vomastek et al. 1992; Schwartz and Osborne 1993). From
my own experience, I know that necrosis results from undue variations of pH and
osmolarity, excessive shear, damage due to sparging, and possibly the toxic effects of
ammonia and lactate.
Apoptotic cell death is an active cellular phenomenon requiring metabolic energy and
continuing protein synthesis (Fesus, Davies et al. 1991; Franek, Vomastek et al. 1992).
Apoptotic cell death is accompanied by visible morphological features such as cell
shrinkage, membrane blebbing, and chromatin condensation as the result of digestion
of DNA by an endogenous nuclease (Fesus, Davies et al. 1991; Schwartz and Osborne
1993). Apoptosis may be induced as a programmed event in developmental processes
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by biological agents, via cell surface receptors and secondary messenger molecules or
by interaction with nuclear receptors that control the expression of related genes directly
(Fesus, Davies et al. 1991). Conversely there are numerous extracellular factors that
act as survival factors by preventing apoptosis (Fesus, Davies et al. 1991). The
triggering or suppression of apoptosis by extracellular factors is dependent on signal
transduction through distinct signaling pathways or through pathways that are not solely
involved in apoptosis (Schwartz and Osborne 1993). Apoptosis also results from
suboptimal culture parameters, such as nutrient or serum limitation and oxygen
depletion. Deprivation of any amino acid can trigger apoptosis in hybridoma cells
(Simpson, Singh et al. 1998). Thus, with the many possible stimuli, both environmental
and genetic in nature, research in prevention of apoptotic cell death in bioreactors has
pushed the study of cells further onto the cellular and molecular level of analysis.
Research into the mechanism of apoptosis has revealed several genes and proteins
that are involved in the stimulation or prevention of apoptosis. In Drosophila, the reaper
gene is found to play a central role in the control of the emergence of apoptosis (White,
Grether et al. 1994), and its deletion prevents apoptosis under a variety of conditions. In
C. elegans, proteins CED-3 and CED-4 have been found necessary for cell death to
occur, whereas CED-9 is shown to protect cells against death (Chinnaiyan, O'Rourke et
al. 1997; Golstein 1997; Wu, Wallen et al. 1997). In mammalian cells, CED-3 are
homologous to the family of proteins called caspases, CED-9 corresponds to the Bcl-2
family of proteins, and the CED-4 equivalent remains unknown (Chinnaiyan, O'Rourke
et al. 1997; Golstein 1997; Wu, Wallen et al. 1997). Bcl-2 appears to be the more robust
anti-apoptotic agent since it blocks the release of cytochrome C from the mitochondrion
into the cytosol, which can activate caspases and the apoptotic pathway (Kluck, Bossy-
Wetzel et al. 1997; Yang, Xuesong et al. 1997). Overall, I believe the role of
mitochondrial proteins in apoptosis may provide a molecular mechanism with which to
better understand the possible role of metabolism and cellular energetics in the initiation
of cell death.
These findings have been applied to help minimize apoptosis in batch and fed-batch
cultures (Terada, Itoh et al. 1997; Chung, Sinskey et al. 1998; Goswami 1998; Simpson,
Singh et al. 1998; Goswami, Sinskey et al. 1999; Sanfeliu and Stephanopoulos 1999;
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Sanfeliu, Chung et al. 1999 in press). The overexpression of Bcl-2 leads to an extension
of viability under both optimal and suboptimal conditions as compared to control
cultures. The over-production of Bcl-2 is without effect on culture growth rate, yet the
impact on other parameters of culture physiology (such as metabolism and product
quality) remains unidentified. Thus, improvements to fed-batch cultures result from the
maintenance of cultures with higher viable cell density, which continue producing the
desired recombinant protein product. Titer improvements of 75% correlate well with the
increase in integrated-viable-cell-density (IVCD) for suspension CHO cells producing
gamma-interferon (Goswami 1998). Treatment of cultures with caspase inhibitors
(zVAD-fmk) has shown only mild improvements in culture viability (Goswami 1998;
Goswami, Sinskey et al. 1999). This is presumably the result that caspase activation by
cytochrome C is further downstream in the apoptotic pathway.
While the search for genetic means to block the cascade of events that occur during
apoptosis is justifiable, it is still ultimately important to ascertain the principle cause for
this detrimental cellular behavior. It is not clear whether the blocking of apoptotic cell
death will alone necessarily yield the optimal cellular behavior. The underlying causes
for cellular "unrest" leading to cellular "suicide" must be addressed as part of the total
solution.
2.2.2.2 Metabolism of Cell Culture
Metabolism of cell cultures has been widely studied for the principle aim of designing
supplemental feed media (Glacken, Huang et al. 1989; Bibila, Ranucci et al. 1994;
Bushell, Bell et al. 1994; Robinson, Seamans et al. 1994; Xie and Wang 1994; Xie and
Wang 1994; Bibila and Robinson 1995; Zhou, Rehm et al. 1995; Mollborn 1996; Xie
1997). Simply put, knowledge of cellular nutritional needs is a prerequisite for the
development of optimal feeding strategies that will supply the right mix of nutrients and
other factors to avoid limitation without over-feeding. Metabolic data is obtained from
variations of batch, fed-batch, and chemostat experiments. In each case, attention to
the effects of limiting factors on growth and death (which can influence metabolism) is
necessary to translate metabolic data to a culture intended not to have any such
limitations. Determining the optimal feeding strategy is further complicated since cell
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yields on glucose and glutamine depend on their concentrations in culture and
metabolism has also been shown to be different for different phase of the cell cycle
(Miller, Wilke et al. 1987; Miller, Wilke et al. 1989; Miller, Wilke et al. 1989; Ramirez and
Mutharasan 1990; Hiller, Aeschlimann et al. 1991; Hiller, Clark et al. 1994; Linz, Zeng et
al. 1997; Xie 1997).
In terms of a possible relationship between the emergence of apoptotic cell death and
changes in metabolism, both phenomena have been reported to occur simultaneously
during fed-batch cultures (Xie 1997; Goswami 1998). During fed-batches of hybridomas,
it was observed that metabolic rates for glucose, lactate, alanine, and glutamine change
dramatically during a fed-batch. Lactate was even reported to be consumed rather than
produced during the stationary phase. Such changes occurred even when the nutritional
environment was kept relatively constant by a proper feeding strategy. Material and
energy balances revealed that TCA cycle was more active, generating more energy
from TCA activity for cultures with lower glucose and glutamine concentrations. For
CHO fed-batch cultures, the glucose uptake rate is measured to decline rapidly just
before reaching the stationary phase. This phenomenon was investigated in terms of
other coincident changes in cell cycle progression, p53 expression and cyclin E
expression, and the possibility that insulin is depleted by degradation.
Shifts in culture metabolism have also been investigated in the course of studying other
cellular functions, such as productivity and glycosylation of recombinant proteins
(Hayter, Curling et al. 1993; Nyberg, Balcarcel et al. 1999). In glucose-limited CHO
continuous culture, Nyberg and co-workers observed a shift in metabolism at different
dilution rates. Analysis of intracellular fluxes for central carbon metabolism revealed that
metabolism shifted from glycolysis towards TCA cycle activity and oxidative
phosphorylation as the dilution rate was decreased. This metabolic shift occurred as a
result of, in conjunction with, or despite the emergence of cell death. Thus, the evidence
regarding metabolic shifts in both the hybridoma cell line and the CHO cell line were
instrumental in the development of my thesis objectives.
Another finding, occurring in parallel to my own, provided further supporting evidence to
the relationship between metabolism, cell cycle, and apoptosis (Sanfeliu and
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Stephanopoulos 1999). Sanfeliu demonstrated that growing serum-dependent
anchorage CHO cells under glutamine-limitation could minimize apoptosis following
insulin stimulation in serum-free medium. Glutamine-limited growth was accomplished
in glutamine-free medium by the addition of glutamate and the reliance of glutamine
formation on glutamine synthetase activity, which she discovered could be induced in
this cell line. The cells grown in serum-free medium (insulin(+), glutamine(+)) grew more
quickly, yet exhibited growth arrest and cell death within several days. Conversely, the
cells grown without glutamine grew more slowly and did not exhibit cell death
throughout the 12-day experiment. The growth of the glutamine-limited culture was
presumed to be limited by the rate at which glutamate was converted to glutamine by
glutamine synthetase. Thus cellular robustness against apoptosis (in the absence of
protective factors in serum) is observed to be enhanced by constraining metabolic
consumption of glutamine and the resulting slower growth rate.
A link between metabolism and apoptosis is also supported by the report that
overexpression of Bcl-2, an anti-apoptosis protein, reduces specific nutrient
consumption (Simpson, Singh et al. 1998). Such a relationship is of interest in further
elaborating Bcl-2's mechanism of protection. However, the interpretation of the effects
of Bcl-2 on cellular physiology is open to debate. Though, it is accepted today that
apoptosis, cell cycle, and metabolism are intimately related phenomena, it is very
challenging to determine the direct role of Bcl-2 on one or more of the phenomena
because its effect on one phenomenon also affects the others. Though genetic
alterations of the Bcl-2 protein can be made to alter Bcl-2's "cell cycle" function or
"apoptotic" function (Huang, Oreilly et al. 1997), I believe it still remains unclear exactly
how BcI-2 is affecting one, both, or all of the phenomena. In my own work, I came
across the similar difficulty in trying to understand how rapamycin and insulin may affect
cell cycle, apoptosis, and/or metabolism.
In this thesis, changes in metabolism are placed in the same framework as the
emergence of cell death. The quantification of shifts in metabolism is coupled with the
emergence of cell death in the hope of determining metabolic effects that either promote
or are symptomatic of cell death. The basis for the relationship between cell death and
metabolism is provided in Chapter 3, which I further build on in the discussion of the
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effects of rapamycin and insulin on viability in Chapters 4 and 5. Brian Follstad has also
pursued the relationship to investigate the role of mitochondrial potential on culture
metabolism and to design feeding strategies that result in cultures of greater metabolic
capacity and higher viable cell density (Follstad, Ph.D. Thesis, in progress).
2.2.2.3 Culture Growth and Cell Cycle
The cell cycle is a model for the progression of cells through the various phases of
division as they grow. Newborn cells, or recently induced cells, begin the cell cycle in
the G1 phase of the cell cycle, with one copy of DNA. Under the right conditions, cells
can enter the next phase, called the S-phase, where they duplicate their DNA.
Thereafter cells proceed through mitosis (M-phase) following a short preparative gap,
called G2-phase. Progression through the phases is tightly regulated by environmental
and genetic factors. Environmental factors such as nutrients and growth factors are
required for entry to the S-phase and successful completion of mitosis. Genetic factors
(in combination with environmental cues) provide checkpoints prior to cell cycle entry,
within the S-phase, and before mitosis. The checkpoints serve to control proliferation
and differentiation and prevent the propagation of errors in DNA synthesis and
chromosome separation during the cell division cycle. The checkpoints are regulated by
proteins that oscillate in concentration throughout the cell cycle (cyclins), which at peak
concentrations bind to cyclin-dependent kinases, complexes that trigger successive
molecular events necessary for cycle progression (Lodish, Baltimore et al. 1995).
Cell cycle distribution and progression can be measured and calculated for cell culture
applications in conjunction with other culture parameters and phenomena, such as
growth rate and productivity (Kromenaker and Srienc 1991; Martens, Gooijer et al.
1993). The incorporation of cell cycle phenomena is useful to better interpret culture
data. To this end, models for cell cycle progression have been combined with those for
metabolism and cell death to interpret data of hybridoma cell cultures (Suzuki and Ollis
1989; Linardos, Kalogerakis et al. 1992; Martens, Gooijer et al. 1996).
Of value for the improvement of fed-batch processes is knowledge pertaining to the
interaction between cell cycle function and apoptosis. Previous models and
observations claim that continuous cell lines such as hybridomas and CHO cells exhibit
42
increased apoptosis in conjunction with an arrest in GO/G1 and a decrease in S-phase
residence (Suzuki and Ollis 1989; Linardos, Kalogerakis et al. 1992; Martens, Gooijer et
al. 1993; Goswami 1998). Thus the inhibition of cell cycle progression (or dysfunction in
general) has been implicated in triggering apoptosis. Such phenomena served as one of
my motivations for measuring cell cycle distribution in my own experiments.
In a very thorough review, both cell cycle and apoptosis are explained as highly
regulated, genetically controlled processes which are intimately linked (Fussenegger
and Bailey 1998). The elucidation of key environmental and genetic factors continues to
yield opportunities for manipulation of either or both phenomena. In some cases,
advances can be implemented by the alteration of single genes, such as for the
moderation of c-Jun, a gene related to cell cycle entry, to viably arrest F-MEL cells in
GO-G1 or to grow them at a slower growth rate without apoptosis emerging (Kim, lida et
al. 1998). In other cases, the insertion of multiple genes is needed to achieve the
desired cellular behavior (Fussenegger, Mazur et al. 1998). Furthermore, some genes
may possibly affect both cell cycle and apoptosis simultaneously, as has been proposed
for the anti-apoptotic protein BcI-2.
In this thesis, cell cycle phenomena are investigated to help explain the decrease in
growth rate and the emergence of apoptosis that occur during fed-batch cultivation of a
hybridoma cell line. The effects of three distinct types of environmental factors are used
to probe the relationship between cell cycle progression and cell death, as well as
metabolism: glutamine limitation, insulin withdrawal, and rapamycin inhibition.
2.2.2.4 Insulin Stimulation and Protection
Insulin is a very widely studied protein that is associated with a variety of cellular
phenomena, from in vitro stimulation of cells to the regulation of glucose metabolism in
human beings. For the cultivation of cells in vitro, insulin is a commonly used
supplement for serum-free medium formulations. Its positive effects on the stimulation
of proliferation are mediated by signal transduction through the map kinase cascade,
the endpoints of which are numerous.
Insulin also plays a role in stimulating and supporting metabolic function. It has been
reported to directly support metabolism by increasing the expression of the transport
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genes, such as glut-1 for glucose (Goswami 1998), and activating phosphatase activity
of enzymes which regulate pyruvate dehydrogenase (PDH) activity (Gottschalk 1990).
Insulin also supports metabolic function by enhancing mitochondrial Kreb's cycle activity
up to 30% (Bessman and Mohan 1997). The evidence that this metabolic support is
independent of insulin receptor tyrosine kinase activity will later lend support to my
findings that insulin's protective role is likely to be more related to metabolism than to
cell cycle.
Insulin also plays a key role in regulating progression through the cell cycle. It
stimulates (via the map kinase cascade) the entry of quiescent cells into the cell cycle
by inducing the expression of c-myc, a proto-oncogene that acts early within the G1-
phase. Yet it appears that c-myc induction alone is not sufficient to ensure survival of
cells as they progress through the cell cycle. The emergence of apoptosis has also
been reported to be associated with c-myc expression. c-Myc protein "can act as a
bivalent regulator, determining either proliferation or apoptosis, depending on whether
the free movement around the cell cycle is supported (by growth factors) or is limited by
growth factor deprivation or treatment with other cycle-blocking agents. In vivo, c-myc
expression may be associated with high-turnover state in which cell proliferation and
apoptosis co-exist." (Wyllie 1993)
For anchorage dependent, serum-arrested CHO cells, c-myc was confirmed to be
inducible by insulin, reaching a peak intracellular concentration four hours after
stimulation and leading to cell cycle entry and proliferation (Sanfeliu, Chung et al. 1999
in press). Yet the expression of c-Myc and cell cycle entry that follow insulin stimulation
are associated with the emergence of cell death after several days of fast proliferation.
Presence of survival factors from serum or the over-expression of BcI-2 can minimize
the emergence of cell death resulting from c-Myc expression. From a different
perspective, overexpression of c-Myc in the hybridoma cell (which was accurately
hypothesized by Chung, and later confirmed herein) is observed to require insulin for
fast and viable proliferation up to 48-72 hours following a snap-shift to serum-free
medium (Chung, Sinskey et al. 1998). Without insulin, the cells grow slower and cell
death occurs between 24 to 48 hours. In this cell line, it appears that insulin plays more
of a role as a survival factor, given that c-myc is already induced anyway. Taking these
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findings together, it would appear that cells require additional protection against
apoptosis when proliferating (when c-myc is induced). Insulin, though also the stimulus
for c-myc expression in the CHO cell line, probably also confers some protection for
viable growth to the CHOs, but further protection is also needed from other survival
factors just as for the hybridoma cell line.
The role of insulin on metabolism and cell cycle progression is further studied in this
thesis, with the aim of better understanding its protective role for hybridoma cells, and
as a tool to probe the cause for the emergence of apoptotic cell death that it protects
against.
2.2.2.5 Specific Productivity
Specific productivity of monoclonal antibodies (and recombinant therapeutic proteins in
general), as well as product quality, can depend on many of the above mentioned
culture parameters and cellular phenomena (Al-Rubeai and Emery 1990; Ramirez and
Mutharasan 1990; Bibila and Flickinger 1991; Bushell, Bell et al. 1993; Cain and Chau
1998). Sometimes optimal conditions for productivity differ from those for culture growth,
for instance, as for the optimal osmolarity for MAb production and growth rate being 350
and 300 mOsm, respectively (Robinson, Seamans et al. 1994). Nevertheless, although
it may be beneficial on a short-term basis to sacrifice viability for productivity, the long-
term goal for improving fed-batch processes remains the increasing and maintaining of
viable cell densities, since it is the viable cells that ultimately produce the product. After
achieving optimal 'performance of the process in terms of density, further improvements
in productivity can be attempted by considering trade-offs between density and titer.
Antibody productivity has been reported to be greater for cells within the GO-G1-phase
of the cell cycle compared to other phases (Ramirez and Mutharasan 1990). In
continuous culture, specific productivity has been observed to be a function of dilution
rate, with non-growth associated behavior prevailing for hybridoma cultures (Miller,
Wilke et al. 1987; Martens, Gooijer et al. 1993). Instability of productivity has also been
documented, showing that productivity may decrease progressively over long-term
experiments (Hiller, Aeschlimann et al. 1991; Martens, Gooijer et al. 1993).
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The relatively constant specific productivity that is measured for my hybridoma cell line
for batches and fed-batches is investigated herein within chemostat cultures, along with
metabolic, cell cycle, and cell death phenomena. The preposition that higher specific
productivity is associated with environmental and nutritional stress (Miller, Wilke et al.
1987) is re-addressed here with regard to the changes in metabolism, cell cycle, and
cell death that accompany such stresses.
2.3 THESIS OBJECTIVES
The objectives of my own work in trying to understand and minimize apoptotic cell death
are listed below, and correspond to Chapters 3, 4, and 5, respectively.
1. The first objective was to characterize the physiology of a hybridoma cell line in
glutamine-limited chemostats. The physiology of cultures at high, intermediate, and
low dilution rates is analyzed for insights regarding the relationship between cell cycle
progression, metabolism, and cell death.
2. Based on the cell cycle phenomenon observed in chemostats, I hypothesize that
inhibiting entry to the cell cycle may help minimize apoptotic cell death. Thus, the
second objective was to investigate the use of cell cycle arresting agents to minimize
apoptosis.
3. The third objective was to investigate insulin's apparent protective role against
apoptotic cell death for hybridoma cells. Due to the connection of insulin to both cell
cycle progression and metabolism, I compared hybridoma physiology in the presence
and absence of insulin in order to gain further insight to the primary causes for the
emergence of cell death.
As is presented within the following pages, the analysis of hybridoma physiology in
chemostats provided quite a wealth of findings, on which my partner Brian Follstad and I
have built the rest of our theses. From the cell cycle hypothesis developed from the
chemostat runs, I crafted a significant new hypothesis for cell death of hybridomas and
was successful in using rapamycin to minimize cell death. From the observed metabolic
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steady state multiplicity in the chemostats, Brian Follstad pursued metabolic differences
between cells in culture and the role of mitochondrial potential to show that the initial
metabolic state of cells at the beginning of a batch can influence the growth and death
behavior of cultures. Finally, Brian and I, in the pursuit of additional physiological
information concerning the relationship between insulin protection, cell cycle
progression, metabolism, and apoptosis, discovered that insulin's protective role
depends on the nature and extent of conditioning of the culture environment.
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3 THE PHYSIOLOGY OF HYBRIDOMA CELLS IN
STEADY STATE CHEMOSTAT CULTURES
3.1 ABSTRACT
Apoptotic cell death of a hybridoma cell line is studied in steady state chemostat
cultures grown in reduced glutamine, serum-free, hydrolysate-free IMDM medium. Four
steady states are characterized from a single chemostat experiment in which the
dilution rate was initially set at 0.04 hr 1, then decreased to 0.03 hr', 0.02 hr' and 0.01
hr' in turn for each steady state. The steady states span a range of cultures exhibiting
physiologies from high viability and faster growth rate down to low viability and slower
growth rate. The physiology of the hybridoma culture for each steady state is described
in terms of cell density and viability, growth and death rates, extent of apoptotic cell
death, cell cycle distribution, metabolite uptake and production rates, oxygen uptake
and carbon dioxide evolution rates, and production of MAb product. Furthermore,
intracellular metabolite fluxes and ATP production are calculated based on a model for
central carbon metabolism.
Culture metabolism exhibits a robust response to increasingly lower nutrient levels at
the lower dilution rates. Measured metabolic uptake and production rates and calculated
intracellular metabolite fluxes show that central carbon metabolism shifts towards more
complete oxidation of glucose and increasing TCA cycle activity. Nonetheless, the
amount of death for a steady state culture correlates inversely with the dilution rate.
Interestingly, even though there is a reduction in growth rate and death emerges, cell
cycle distribution does not shift towards an arrest in the G1 phase of the cell cycle. This
lack of cell cycle arrest in the G1 phase for cells under nutritional limitation points to a
defect in cell cycle control. In this regard, it was further shown that the hybridoma cells
express high levels of c-myc, a proto-oncogene associated with cell cycle entry. Hence,
unbridled entry to the cell cycle is believed to be associated with higher levels of
apoptotic cell death than would otherwise be observed under nutrient limiting conditions.
The lack of G1 arrest also provides insight as to why the apparent specific production of
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MAb does not increase at lower growth rates, as has been reported for hybridomas
elsewhere.
3.2 INTRODUCTION
The detrimental effect of apoptosis (programmed cell death) on the performance of a
culture has been firmly established in a variety of cell culture systems over the past
several years (Franek, Vomastek et al. 1992; Mercille and Massie 1994; Singh, Al-
Rubeai et al. 1994). Since the overall productivity of a culture process is strongly
dependent on the viable cell density integrated over the life span of the culture, the
emergence of cell death directly detracts from the overall productivity of a culture. Thus,
a common objective for research in this field is to better understand the phenomenon of
programmed cell death in the hope of being able to minimize it or avoid it altogether
during batch and fed-batch processes.
Many stimuli of apoptosis have been studied. The emergence and extent of apoptosis is
affected by the availability of nutrients, growth factors, and genetic factors, including so-
called anti-apoptosis genes. Yet despite characterizing the effects of known inducers or
inhibitors of apoptosis, the emergence of apoptosis continues to negatively impact fed-
batch processes, even in seemingly well-maintained culture processes. Fed-batch
processes, in which nutrients and growth factors are kept in adequate supply, are still
plagued by apoptosis.
Aiming to identify the cellular and environmental components that trigger apoptotic cell
death, we turn to characterizing the "symptoms" of death that are evident during a
culture process. The emergence of apoptotic cell death during batch and fed-batch
processes occurs simultaneously with changes in culture growth rate, metabolism, cell
cycle distribution, and product synthesis. The question is which of the measured
phenomena are causes for or effects of the underlying emergence of cell death.
Whatever the cause for the physiological changes during batch cultivation, such
changes are associated with an increase in the death rate. Given the genetically
programmed nature of apoptosis, it is fitting to include this cellular phenomenon along
with the others for the description of the physiological profile for cultures. Just as growth
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and metabolism are genetically determined and have been characterized under different
conditions, so must cell death be characterized under a variety of conditions and in
conjunction with other major cellular phenomena.
Shifts in culture metabolism appear to be implicated in the cause for apoptosis. As a
fed-batch culture slows in its growth rate and death emerges, the metabolism of the
culture also changes (Xie 1997). It is reasonable that some metabolite uptake or
production rates decrease when growth slows and death emerges. Yet of more interest
is that some of the rates increase or even reverse their direction (a production becomes
an uptake, for instance). The shifts in metabolism during changes in growth and/or
death rates may be symptomatic of the underlying requirements for energy and mass
production in the culture. The cell must maintain an adequate supply of energy (ATP
and NAD(P)H) to continue carrying out cellular functions, such as DNA synthesis,
mitosis, nutrient transport, and protein production. Shifts in metabolism may therefore
provide a clue as to the underlying cause(s) that lead to culture growth arrest and
apoptotic cell death.
Cell cycle phenomena are also often implicated in the emergence of cell death
(Fussenegger and Bailey 1998; Goswami 1998; Sanfeliu, Chung et al. 1999 in press).
Data from Goswami shows a typical arrestment in the GI-phase for suspension
Chinese Hamster Ovary cells as growth declines and death emerges. Such an inability
of cells to passage through the cell cycle may be related to or indicative of the causes
for other physiological changes, including the coinciding emergence of cell death. On
the other hand, Sanfeliu shows that stimulating entry to the cell cycle in the absence of
environmental or genetic survival factors (by replacing serum with just insulin) leads to
growth accompanied by apoptosis (Sanfeliu, Chung et al. 1999 in press). Cell cycle
entry is seen as a necessary but not sufficient criterion for viable proliferation. Viable
proliferation also depends on appropriate environmental and internal genetic/protein
factors. The growth behavior for the hybridoma cell line used in this study demonstrates
a phenomenon similar to that observed for inappropriate cell cycle entry (Chung,
Sinskey et al. 1998). My own cell cycle data during batch cultivation reveal that the
majority of hybridoma cells are found within the cell cycle (in the S-phaseG2/M-phase)
as a batch progresses. Despite known limitations that can be placed on the culture
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(such as nutrient or growth factor removal), the cells continue to enter the cell cycle
without arrestment in G1 even as culture growth rate declines and death emerges. For
this cell line, it is the lack of a specific arrest within the cell cycle that may be another
symptom of the emergence of cell death. Thus, the changes in the behavior of a culture
in terms of growth, death, and (lack of) cell cycle function appear to be related.
Striving to make sense of the many changes which occur as cells die, we choose
continuous culture experiments as a tool to dissect the phenomena which are
associated with cell death. Continuous culture (chemostat) experiments are superior to
batch and fed-batch experiments in that cell physiology can be determined within a
steady state environment. Furthermore, by changing the dilution rate (or other system
parameters) different culture physiologies can be achieved. In the following study, we
vary the dilution rate in order to characterize cultures at the extremes of faster growth
and high viability versus lower growth and low viability. The different measured steady
states may be representative of the physiological states observed as a fed-batch
progresses. The fed-batch counterpart for fast viable growth in a high dilution rate
chemostat is the period of exponential growth at the beginning of the fed-batch,
whereas the fed-batch counterpart for slow growth with apoptosis in a low dilution rate
chemostat is the period of growth arrest and cell death at later times in a fed-batch.
However, the comparison of such between physiological states in chemostats and fed-
batches states is not entirely fair. The death resulting in chemostats is due to nutrient
limitation as well as unknown causes, whereas the death resulting in fed-batches,
where nutrients are kept in adequate supply, is strictly, by design, due to the unknown
causes. Nonetheless, the physiology of cell death obtained in chemostats provides very
interesting and valuable insights into the relationship between growth, death,
metabolism, and cell cycle progression.
Thus, the objectives of this chapter are to present the physiological data for a variety of
steady state conditions acquired at different dilution rates. The determination of cell
cycle progression and culture metabolism in the presence and absence of apoptosis
provide the evidence with which two novel hypotheses concerning cell physiology and
cell death have been formulated. One hypothesis, developed and pursued by Brian
Follstad and is the subject of a related paper and his own thesis, concerns metabolic
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steady state multiplicity and the role of mitochondrial potential on viable cell density,
apoptosis, and overall culture performance. The second hypothesis, which I developed,
applies knowledge gained concerning the dysfunction of cell cycle entry in the
hybridoma towards a strategy to inhibit cell cycle entry and minimize apoptosis using
cell cycle arresting agents (Chapter 4).
3.3 MATERIALS AND METHODS
3.3.1 Cell Line and Culture Medium
The cell line used is a murine hybridoma (ATCC CRL-1606) which produces and
secretes an immunoglubulin IgG against human fibronectin. The hybridomas (previously
adapted to serum-free medium) are grown in a glutamine-free IMDM basal medium
(Specialty Media, Inc., Lavallette, NJ), supplemented with 10 mg/L insulin (USB), 5
mg/L transferrin (USB), 2.44 piL/L 2-aminoethanol, 3.5 p.L/L 2-mercaptoethanol, 7.5
mg/L protease free bovine serum albumin (Sigma Chemical Co.), and 1 U/ml penicillin -
1 pg/ml streptomycin (Sigma). Glutamine is added at a concentration of 4.0 mM for
thawing and passaging inocula or at 0.8 mM for the chemostat feed medium. No serum
or hydrolysates are added. Insulin and transferrin stock solution are prepared at 2 g/L
following the method of Jenkins (Jenkins 1991) and stored at -200C.
The inoculum culture was prepared from a frozen stock of CRL 1606 hybridomas and
grown in T-flasks and spinner flasks (BelIco, Vineland, NJ) placed within a 37*C
humidified incubator (95% relative humidity) with 10% CO 2 atmosphere. The inoculum
was passaged every two days by subculturing the approximately 1.5e6 cell/ml culture
down to 2.0e5 cell/ml.
3.3.2 Bioreactor Operation
Steady state chemostat cultures were obtained using a 2-liter Applikon reactor (Foster
City, CA) at a working volume of 1.2 liters. A New Brunswick Scientific (Edison, NJ) ML
4100 controller was used to monitor the bioreactor temperature, monitor and control the
pH and dissolved oxygen, and control mixing of nitrogen, air, and oxygen for the feed
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gas via a solenoid control assembly. A heated water jacket maintained the temperature
at 37 *C and agitation was set at 200 rpm. The pH was controlled at 7.20 +/- 0.05 by
addition of 320 mM HCI or a solution of 6.2 g/I NaOH and 0.4 g/I KOH as needed. The
dissolved oxygen concentration was maintained at 40-50% of air saturation by 600
mL/min (0.5 VVM) of headspace aeration. No carbon dioxide gas was fed to the reactor
to facilitate the measurement of the carbon dioxide evolution rate. Process data (T, pH,
DO, control outputs, and %02 and PPM C02 for gas effluent) were logged through the
ML-4100 controller to a computer using the AFS software from New Brunswick
Scientific (Edison, NJ).
In a sterile manner throughout, continuous fluid flow was established using Pharmed
tubing and Alitea peristaltic pumps. Feed medium in a 5.0 L refrigerated reservoir bottle
was first pumped to a 250 mL premixer vessel (a customized water-jacketed Bellco
Spinner Flask), to equilibrate the feed with 12% CO2 at 370C. From the premixer, the
medium was pumped through a vertical, in-line 2 mL glass volumetric tube on its way to
the bioreactor, where it was delivered as a drop-wise stream from the headplate fitting
down into the culture broth. The feed flowrate was measured periodically (or in replicate
during steady states) by evacuating the contents of the in-line tube and timing the fill-up
of the tube. Such flow measurements were used to maintain the flowrate setpoint, which
over many days could drift due to tubing wear, by making minor adjustment to pump
settings. During the measurement of a steady state, the dilution rate was calculated
from duplicate or triplicate in-line flow determinations. The volume of the culture in the
reactor was maintained constant by the removal of culture broth through an Applikon
"chemostat tube" assembly. This assembly consists of two concentric tubes. The inner
tube sets the level for the reactor culture, while the outer tube serves to draw culture
medium from an intermediate culture depth, so that the effluent is drawn from the bulk
rather than the surface of the culture. The effluent flowrate is set greater than the feed
rate to ensure constant level. (The faster flow is also necessary to minimize clogging of
the downstream lines by cell debris, a situation which can lead to reactor fill up, and
possibly termination of the experiment.) The effluent is collected in 5.0 L waste
reservoirs.
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Over the course of a two to three month continuous culture, feed reservoir and waste
reservoirs are replenished and exchanged in a sterile fashion by "ethanolizing" and
"flaming" steel quick-connect fittings. Both the feed line and the waste line have a "T"
with two quick-connect outlets so that fluid flow need not be interrupted by reservoir
maintenance. Alitea pump cartridge tubing, which lasts for only about one month, is
"replaced" by switching to a fresh cartridge tubing that was connected in the feed line in
parallel and clamped off until needed. When the in-line flow measurements show
accelerated drifting, the old cartridge tubing is clamped off and the new cartridge tubing
is then calibrated in-line and used thereafter.
Culture samples, for the analysis of cells or medium, were obtained through a sampling
tube which is distinct from the effluent "chemostat" tube. The sample tube (here just a
single tube) is placed to draw culture medium from the center of the reactor. The
sampling assembly consists of the sampling tube, connected to a three-way valve,
which connects to a disposable syringe as well as a 50 ml waste reservoir, vented with
a 0.22 pLm air filter. To avoid contamination and to ensure a fresh sample, the first 4 mL
of sample are discarded to the waste reservoir (the sample line volume is about - 3
mL), after which the sample (anywhere from 1 to 100 mL) can be collected in the
syringe. The syringe is removed and immediately replaced with a fresh, sterile one,
while the sample line is clamped and the three-way is set away from the syringe port.
This method of sample proved to be very safe against contamination, as well as very
easy to use.
The reactor was inoculated with approximately 200 ml of an inoculum culture of
approximately 1.5 x 106 cell/ml (including the conditioned medium) to give a starting
density of 2.0 x 105 cell/ml. After 48 hours, the feed and waste flows were initiated at an
intermediate dilution rate, and over a period of days the feed rate was gradually
adjusted to the first desired dilution rate of 0.04 hrW. After five residence times, and
when process variables such as cell density, viability, oxygen demand, residual glucose
concentration, and lactate concentration were steady within a 10% range for 48 hours,
the system was taken to be at steady state and the physiology of the culture was
measured (Steady State A). Following the measurement of the first steady state, the
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dilution rate was reduced stepwise over three days to 0.03 hr 1. After waiting 5
residence and verifying that culture parameters were steady, the second steady state
(B) was measured. Thereafter, in a similar fashion, steady states C and D were
obtained at dilution rates of 0.02 hr 1 and 0.01 hr-. A set of physiological measurements
were made once for the first steady state (on one day), in triplicate for the second
steady state (on three consecutive days), and in duplicate for the third and fourth steady
states (on two consecutive days for each). A single measurement of a fifth steady state
(E) was made following the gradual increase of dilution rate back up to 0.04 hr' and
waiting an additional 5 residence times.
3.3.3 Analytical Methods
3.3.3.1 Cell Number, Viability, and Apoptosis
Cell number and viability were determined using cell counts on a hemacytometer with
trypan blue dye exclusion. A minimum of three slides was counted for each steady state
data set.
The extent of apoptosis was determined by cell counts on a hemacytometer using an
acridine orange / ethidium bromide (AO/EB) assay (Mercille and Massie 1994).
Apoptosis cell counts consisted of counting cells for 4 different hemacytometer
chambers for a total of 600 to 1400 cells altogether. Such cell counts were used to
calculate the observed percentage of cells that were viable, apoptotic (early and late), or
necrotic.
3.3.3.2 Metabolite Concentrations
Steady state samples taken from the reactor were centrifuged at 200*g for 8 minutes,
and the supernatant was removed and stored at -200C for future analysis. To
deproteinate the thawed samples, 100 pL of 20% m/v trichloroacetic acid was added to
340 pL of sample. After microcentrifugation at 7000*g for 10 minutes, 200 mL of the
deproteinated sample was neutralized with 50 tL of 25% m/v potassium bicarbonate.
The deproteinated samples were used in performing the glucose (Sigma protocol 16-
UV), lactate (Sigma protocol 826-UV), and ammonia (Sigma protocol 171-UV) assays,
with a Becton-Dickonsen uv/vis spectrophotometer.
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Samples for amino acid analysis were thawed and diluted between 1.5 and 3.5 times to
ensure that the maximum expected amino acid concentration was less than 1 mM (the
upper calibration limit). The internal standards norvaline and sarcosine were added
during the dilution, so that they were both present at a final concentration of 0.5 mM.
Samples were then deproteinated using Ultrafree-MC 5,000 MW cutoff ulrafilters
microcentrifuged at 40C for 70 minutes at 4000*g (Millipore, Bedford, MA). The amino
acids were analyzed using the AminoQuant protocol on an HP 1090 HPLC (Hewlett
Packard, Palo Alto, CA). This protocol uses pre-column derivitization with ortho-
phthalaldehyde (OPA) for detection of primary amino acids and 9-fluorenylmethyl
chloroformate (FMOC) for detection of secondary amino acids (AminoQuant Series 11
Operator's Handbook, Hewlett Packard part #01090-90025). Separation was achieved
on a C18 reverse-phase column (Hewlett Packard, Palo Alto, CA).
3.3.3.3 MAb Antibody Concentration
Antibody concentrations were determined using a standard ELISA procedure. First, 100
pL of a solution containing the capture antibody (Sigma M8770) diluted to 5 [Ig/mL in a
capture antibody solution (Sigma C3041) containing 0.1% (w/v) sodium azide was
added to each well on a 96 well plate and incubated overnight at 40C. Then, 200 pL of
a blocking solution (SuperBlockTM, Pierce 37515) was added and removed from each
well three times in succession. Next, 100 p.L of either samples or standards (Sigma
M9269), diluted 400-900 times in a solution of 1 part blocking solution to 9 parts
washing solution (PBS with 0.05% (w/v) Tween 20), was added and incubated for 1
hour at room temperature. Then, 100 ptL of a detection antibody solution (diluent
solution with 40 pg/ml detection antibody, Sigma A2304) was added and incubated for 1
hour at room temperature. After each of the previous steps, the plate was washed three
times in washing solution. Finally, 200 pL of a substrate solution (SigmaFAST T M OPD,
Sigma P9187) was added and incubated for 30 minutes in the dark. The reaction was
stopped with 3 M HCI and the absorbance was read at 492 nm on a microplate reader
(Molecular Devices, Palo Alto, CA). MAb antibody concentrations for the unknowns
were calculated from the linear portion of an OD vs. Standard concentration plot.
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3.3.3.4 Calculation of Growth and Death Rate and Specific Uptake and Production
Rates
The culture growth rate, p, and death rate, kd, were determined from total and viable
densities, nt and n,, obtained by Trypan blue counts, using cell balances around the
bioreactor:
d =pn,-DnT (3-1)
dt
dnv
d -nv - kdnv -Dnv (3-2)dt
where D is the dilution rate and t is the time. At steady state, these balances yield the
following expressions for culture growth and death rates:
p=D nT (3-3)
n,
kd= p-D (3-4)
Specific metabolite production or uptake rates, q, were determined by a species
balance over the liquid phase of the reactor:
dCR-C-
CR = DCF -DCR -qnv (3-5)
dt
where CR and CF are the concentration of a particular metabolite within the reactor or
the feed, respectively. At steady state, a specific rate is thus given as:
q=D(CF CR) (3-6)
n,
3.3.3.5 Oxygen Uptake Rate
The oxygen uptake rate (OUR) was obtained from the mass balance for oxygen in the
liquid phase of the reactor at steady state:
OUR = kLa(C* CR )+D(CF CR) (3-7)
where kLa = liquid phase mass transfer coefficient for oxygen; C* - liquid phase
concentration of oxygen at equilibrium with the gas phase; CR =concentration of oxygen
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in the liquid phase of the reactor; D = dilution rate; and CF =concentration of oxygen in
the liquid feed.
The first term on the right-hand side represents oxygen transport across the gas-liquid
interface. The second term accounts for the net inflow of oxygen with the liquid streams.
Liquid concentrations of oxygen in the reactor and the feed were measured with a blood
gas analyzer (Ciba Corning, Medfield, MA). The equilibrium concentration, C*, was
calculated based on the gas-phase oxygen concentration of the effluent reactor gas
stream, which was determined with a gas analyzer containing a paramagnetic oxygen
sensor (Columbus Instruments, Columbus, OH). The partial pressures of oxygen,
obtained from either the blood gas analyzer or the gas analyzer, were converted to
liquid concentrations using Henry's Law (C02 = Po21H 0 2). The Henry's constant for our
serum-free medium at 37 0C was estimated as Ho2 = 9.99 x 107 Pa*L/mol based on
correlations from literature (Schumpe, Quicker et al. 1982), which allow for the
correction of gas solubilities to account for medium composition.
3.3.3.6 Carbon Dioxide Evolution Rate
The carbon dioxide evolution rate (CER) was determined from a mass balancing
approach similar to that of Bonarius (Bonarius, Gooijer et al. 1995), except that liquid-
phase carbon dioxide levels were measured rather than calculated. A mass balance for
carbon dioxide over the entire reactor at steady state yields:
-CER = - (yR C F02 )+ D(C -- CF) (3-8)
VR
Where flg molar gas flowrate to the reactor; VR=- liquid volume of the reactor; YCO,
F
mole fraction of CO 2 in the reactor headspace; YCo, = mole fraction of CO 2 in the feed
gas; D dilution rate; CR concentration of CO 2 and bicarbonate in the liquid phase
of the reactor; CA concentration of CO 2 and bicarbonate in the liquid feed.
The first term on the right hand-side represents the net inflow of CO 2 between the
entering and exiting gas streams. The mole fractions of CO 2 in gas streams were
measured with a gas analyzer containing an IR C02 sensor with a maximum span of
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1% (10,000 PPM) for C02 (Columbus Instruments, Columbus, OH). To allow for more
accurate determination of Yco, C02 was omitted from the feed gas (Y, < 10 ppm).
The second term on the right-hand side of equation (3-8) represents the net inflow of
C02 with the liquid streams. A 250-mL pre-mixing vessel was used to equilibrate the
feed liquid with air containing 12% CO2 in order to eliminate variation in the feed C02
levels due to loss of CO 2 from the feed bottle. The amount of C02 in a particular liquid
stream, present mainly as dissolved C02 and bicarbonate, was determined by
measuring the partial pressure of C02 (Pc02) and the pH using a blood gas analyzer
(Ciba Corning Diagnostics, Medfield, MA). The partial pressure of CO 2 is related to the
dissolved C02 concentration through Henry's Law. The bicarbonate concentration can
then be determined by assuming the simplified equilibrium relationship,
CO2+H20 <> HCO +H+
which has an apparent equilibrium constant K'= C (Putnam and Roos 1991).
c0 2
Thus measuring the partial pressure of C02 and pH allows the total dissolved carbon
dioxide plus bicarbonate concentration to be calculated from
CA = CCO2 + CHCO3 C02 l (H
Based upon correlations in Schumpe (Schumpe, Quicker et al. 1982), the Henry's law
constant for our serum-free medium at 370C was estimated as Hco2 = 4.20 x 106
Pa*L/mol, which is very close to the value (4.19 x 106 Pa*L/mol) for cerebrospinal fluid
at 370C and pH = 7.20 (Severinghaus 1965). Because both the Henry's law and
equilibrium constants are functions of ionic strength, one would expect aqueous
solutions with similar Henry's constants to have similar equilibrium constants. Therefore,
we estimated the apparent equilibrium constant as pK' = -log(K') = 6.138, which is the
measured value for cerebrospinal fluid at 370C and pH = 7.20 (Severinghaus 1965).
3.3.3.7 Calculation of Metabolic Fluxes
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Metabolic fluxes were calculated by metabolite balancing using the central carbon
metabolism network shown in Figure 3-1. Serial reactions were lumped into single
reactions. In addition, metabolite requirements for biomass and product synthesis were
accounted for as described in Zupke and Stephanopoulos (Zupke and Stephanopoulos
1995) using the cell composition determined for CRL 1606 by Xie and Wang (Xie and
Wang 1994). The pentose phosphate pathway was analyzed by considering only the
biosynthetic demand for ribose carbon skeletons. The production of NADPH can not be
used to determine the pentose phosphate pathway recycle due to the uncertainty of
transhydrogenase activity in this cell line, as well as the fact that the malic enzyme may
use either NAD+ of NADP+ (Eigenbrodt, Fister et al. 1985). Therefore, reducing power
was lumped in an NAD(P)H pool. This may introduce some error in distinguishing C02
released from the pentose phosphate pathway and the TCA cycle.
A matrix of stoichiometric coefficients (A) was constructed using the reaction network
shown in Figure 3-1 and used to calculate the metabolic fluxes (x). The material balance
on the metabolites in the reaction network can be represented as
x = (A T  -A)- 1ATPT r (3-10)
and is explained more thoroughly in Zupke and Stephanopoulos (Zupke and
Stephanopoulos 1995)(1995) and Nyberg, et al. (Nyberg, Balcarcel et al. 1999).
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3.3.3.8 Estimation of ATP Production and ATP demand for Biosynthesis
Specific ATP production for the viable cells at a steady state was calculated using the
calculated metabolic fluxes and the associated stoichiometry for ATP, NADH, and
FADH 2 for each reaction included in the metabolic network (Table 3-1). The total ATP
produced is determined by summing the product of each flux with the stoichiometry of
each of the 33 reactions. A confirmation of the consistency of the network is that NADH
and FADH pools sum very nearly to zero. The net ATP produced is used for a variety of
cellular processes, including biomass synthesis. The portion of ATP produced from
glycolysis is determined from reactions 1 through 4. Any leftover NADH not spent to
make lactate is assumed to yield only 2 additional ATP since it is generated in the
cytosol (to be used for oxidative phosphorylation, it would be converted to FADH 2 by the
glycerol phosphate shuttle as it entered the mitochondrion, Stryer, p. 417). The amount
of ATP made from the TCA cycle is determined from the fluxes and stoichiometry of
reactions 6 through 24 and 31. As another internal check, the ATP produced by
oxidative phosphorylation of NADH and FADH 2 from TCA cycle reactions (6 through 24,
minus 31 (NADH to biomass)) should agree well with the ATP produced from the
reduction of oxygen in reactions 32 and 33.
Some of the ATP produced by the cells is used in the synthesis of biomass. The ATP
demand for biomass is calculated from the stoichiometric coefficients for synthesis of
cellular and product protein and synthesis of non-protein cellular components. The
coefficients are determined using biochemistry for the known cellular composition of this
cell line (Xie and Wang 1994). The rate of ATP demand for biosynthesis is simply the
sum of the coefficients times the growth rate. The ATP demand for other cellular
functions are not estimated here.
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Table 3-1. Stoichiometry for ATP, NADH, and FADH 2 for the central carbon
metabolic network.
Reaction ATP NADH FADH2
1 Glc 4 G6P -1
.E 2 G6P 4 2 GAP -1
3 GAP 4 Pyr +2 +1
4 Pyr - Lac -1
6 Pyr - AcCoA +C02 +1
7 Pyr + Glu + a-KG + Ala
8 OAA + AcCoA + a-KG + C02 +1
9 a-KG 4 SuCoA + CO 2  +1
10 SuCoA - Fum +1 (GTP) +1
11 Fum - OAA +1
12 OAA -) Pyr + C0 2
13 GIn 4 Glu
14 Glu + a-KG +1
15 GAP + Glu + Ser + a-KG +1 +2
16 GAP + Glu + Gly + a-KG +1 +2
17 Lys + 2 AcCoA + 2 C0 2  +5 +1
18 Ile - AcCoA + SuCoA -1 +3 +1
19 Leu 4 3 AcCoA -2 +2 +1
20 Glu 4 Pro -1 -2
21 Thr - SuCoA -1 +1
z 22 Val - SuCoA + C02 -1 +4 +1
o 23 OAA +GIn - Asn + a-KG
< 24 OAA + Glu + Asp + a-KG
31 NADH 4 BiomaSSNADH -1
32 0.5 02 + 3 ADP + NADH + +3 -1
3 ATP + NAD+
33 0.5 02 + 2 ADP + FADH2- +2 -1
1 12 ATP + FAD
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3.3.3.9 Cell Cycle Distribution
2.0 x 106 cells from a reactor sample were spun down and resuspended in 1.0 ml of
stain solution (10 ml: 0.3g PEG 6000, 0.5 ml propidium iodide (50 pg/ml in PBS), 0.5 ml
RNAase (180 U/ml in PBS), 0.1 Triton X (10% in PBA), 8.9 ml sodium citrate 4mM pH
7.8; final pH adjusted to 7.2), and incubated at 370C for 20 minutes. After incubation,
1.0 ml of salt solution (10 ml: 0.3g PEG 6000, 0.5 ml propidium iodide (50 pg/ml in
PBS), 0.1 Triton X (10% in PBA), 9.4 ml NaCl 0.4 M; final pH adjusted to 7.2) was
added, and the sample was stored in the dark at 40C for 24 to 48 hours. Flow cytometry
analysis was performed using a FACScan flow cytometer (Becton Dickinson, San Jose,
CA). 30,000 events per sample were measured for their fluorescence of 300nm uv-
light. The raw data were processed with ModFit Lt v.2 analysis software (Verity
Software House, Topsham, ME) to determine the cell cycle distributions. Sampling and
analysis was done in duplicate for every data set, with the exception of steady state A,
for which only one sample was analyzed.
Cell cycle data obtained from the above analysis are for the fraction of cells that were
measured to be in either GO- or G1-phase (one copy of DNA), G2/M-phase (two copies
of DNA), or S-phase (intermediate amount of DNA). The fractions (fG1, fs, and fG2/M) are
used to numerically calculate the progression time for each of the three phases (tG1, ts,
and tG2/M) using the following equations from Susuki and Ollis (Suzuki and Ollis 1989)
tc= ln(2)/ p =tG + t + G2IM (3-11)
X
tGIJ 2(-11c)dt
fGl 0 (3-12)
tGI +tS
f2('-"tcdt
s= tI (3-13)
tc /tcn(2)
IC
f2( -'GI 1C0 dt
fG2IM =GI+fstc /1n(2)
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I adopted the equations assuming that there does not exist an arrested, non-cycling
population of cells (which implies that the growth rate is a function of the total cycle
time, tc) and by lumping the equations for G2 and M phases together. The assumption
agrees with the observed cell cycle distributions for this hybridoma cell line.
3.3.3.10 Determination of Intracellular c-Myc Protein Concentration
c-Myc western blots were performed using cells taken from two additional continuous
culture experiments, conducted separately from the five other steady states. One of the
cultures was at a steady state with a dilution rate of 0.02 hr 1 and with 10 mg/L insulin
present in the feed (the regular amount of insulin). The other culture was at a steady
state with D = 0.03 hrW, yet with insulin levels in the reactor diluted out to below the
detectable limit of 1 mU/L (< 0.1 pg/ml insulin), following 15 residence times after
switching to an insulin-free feed (insulin concentration measured by ELISA kit (ALPCO
#10-1113-01, NH). Both cultures exhibited the similar physiologies as their counterpart
steady state from the initial data set.
Cell extracts for each culture were obtained from 1.25x1 07 cells and washed twice in
ice-cold PBS. The pellet was then resuspended in 0.5 ml lysis buffer (50 mM Tris-HCL
pH 8, 150 mM NaCI, 0.02% sodium azide, 0.1% SDS, 100 tg/ml PMSF, 1 pg/ml
aprotinin, 1% Nonidet P-40, and 0.5% sodium deoxycholate) and incubated at 40C for
30 minutes. Next cellular debris was pelleted out by centrifugation at 12000g for 10
minutes at 40C. Supernatant was stored at -800C.
The amount of total protein in the cell extracts was determined using the Lowry method
(Bio-Rad). 37 to 50 pg of protein from cell extracts in 20 ptl sample buffer (50 mM Tris-
HCL pH 6.8, 100 mM dithiothreitol, 2% SDS, 0.1% bromophenol blue, 10% glycerol)
were electrophoresed on a 10% SDS-polyacrylamide gel. Separated proteins were
transferred to a nitrocellulose membrane (0.45 prm pore size). The nitrocellulose
membrane was blocked overnight at 40C with 5% (w/v) nonfat dry milk in TBS (8.76 g/L
NaCl, 10 mM Tris-HCI pH 7.4) After rinsing with TBST (TBS plus 0.05% Tween 20), the
membrane was incubated for 1h at room temperature with rabbit polyclonal IgG anti-c-
Myc (Santa Cruz Biotechnologies), diluted 1:500 in 5% (w/v) nonfat dry milk in TBST.
Blots were again rinsed in TBST and further incubated for 1 h at room temperature with
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anti-rabbit IgG peroxidase linked antibody (Amersham), diluted 1:1000 in 5% (w/v)
nonfat dry mild in TBST. After a final wash in TBST followed by TBS, c-Myc bands were
visualized by the ECL system (Amersham). For positive control, an amino terminal
domain of c-Myc corresponding to amino acids 1-262 was used (Santa Cruz
Biotechnologies). The hybridoma bands were compared to bands for anchorage-
dependent CHO cell lysates, corresponding to time points following the stimulation of
the serum-arrested, synchronized CHO culture with insulin.
3.4 RESULTS
The physiology of hybridoma cells in glutamine-limited chemostat steady states was
determined in terms of total and viable cell densities, growth and death rates, extent of
apoptosis, cell cycle distribution, metabolic uptake and production rates, the net
intracellular fluxes into the pyruvate node, ATP production by central carbon
metabolism, ATP requirement for biomass and product synthesis, and production rate
for the MAb product. The figures below depict these quantities versus the dilution rate
(for densities, growth and death rates, and apoptosis) or versus culture growth rate (for
other quantities) for each of the four steady states, called A, B, C, and D for dilution
rates 0.04, 0.03, 0.02, and 0.01 hr-, respectively. When distinct from steady state A,
data for steady state E (D=0.04 hr 1) is also shown.
3.4.1 Cell Death
Steady state cell counts (Figure 3-2) reveal increasing total cell densities at the two
lowest dilution rates. The total cell density at D=0.03 hr 1 (steady state B) is slightly
suppressed, presumably the result of the glutamine limitation in the absence of a shift in
metabolism (see metabolism below). Viable cell densities were also greater at the two
lowest dilution rates, yet to a lesser degree than the total density due to cell death. The
viabilities for the measured steady states, determined by Trypan Blue exclusion, span a
range from 95% down to 40% at the slowest dilution rate. The cell density for steady
state E (a steady state at D = 0.04 hr 1, after returning from D = 0.01 hr') is
approximately twice that of the density at the first steady state at 0.04 hr-1 (A). This
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multiplicity of steady states is the result of sustained metabolic efficiency even upon re-
supplying ample nutrients (Follstad, Balcarcel et al. 1999).
The growth and death rates (Figure 3-3) depict a reduction in growth rate and an
increase in death rate as the dilution rate is decreased. Interestingly, the reduction in
dilution rate from 0.02 hr-1 to 0.01 hr-1 (C -> D) results in only a modest decrease in
growth rate, yet a dramatic increase in death rate. The cell death that occurs at lower
dilution rates is indeed the result of apoptosis, as measured by the acridine orange /
ethidium bromide assay (Figure 3-4).
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Figure 3-3. Steady state growth and death rates as a function of
dilution rate.
chemostat
Error bars represent 95%-confidence limits for the measurement of A, or the 95%-confidence
interval for data taken on two consecutive days (C and D) and three consecutive days (B).
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3.4.2 Metabolism
The metabolic uptake and production rates (Figure 3-5) reveal distinct differences in the
metabolism for the steady state cultures. Cells at steady state A and B have similar
metabolic rates for glucose and glutamine consumption. They also have high lactate to
glucose ratios (1.90 and 1.99, respectively) and relatively lower oxygen-to-glucose
ratios (0.76 and 0.94). Cells at steady state C and D however show a marked shift in
metabolic activity. Glucose and glutamine rates have dropped off severely. Lactate
production has also severely declined, yielding lactate-to-glucose ratios for C and D of
1.49 and 1.35. Oxygen consumption rate actually increased, resulting in oxygen-to-
glucose ratios of 2.17 and 2.94, respectively. Steady state E shows similar glucose
uptake compared to Steady State A, but lesser lactate production and glutamine
consumption and greater oxygen consumption.
The analysis of intracellular metabolite fluxes by Follstad, et. al. (Follstad, Balcarcel et
al. 1999) reveals that the net surplus of carbon at the pyruvate node coming from
glycolysis and TCA recycle (reactions 3 and 12 in the metabolic network) and leaving to
the TCA cycle (reaction 6) is higher for steady states A and B, yet lower for steady state
C and D (Figure 3-6). The shift in metabolism can also be visualized in the ratio of
carbon fluxes entering the pyruvate node (reactions 3 + 12) to the carbon flux going to
TCA cycle (reaction 6). This ratio decreases with growth rate, indicating that the cells
under glutamine limitation are utilizing more of the carbon at the pyruvate node for the
TCA cycle rather than for lactate production. Data for steady state E reveal the
sustained efficiency of carbon utilization as seen for steady states C and D, which is
dramatically different than that for steady state A.
The intracellular fluxes are used to calculate the ATP that is produced by glycolysis and
TCA cycle activity coupled with oxidative phosphorylation. The level of ATP generated
from glycolysis decreases with growth rate, while the level of ATP generated from TCA
activity increases (Figure 3-7a). Thus, the percent of total ATP generated from
glycolysis drops from 29% to 19% as the growth rate decreases and death rate
increases. The ATP requirement for biomass (Figure 3-7b) reveals that the majority of
the ATP is being utilized for other purposes (maintenance). Assuming the ATP
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production balances the requirement, it is evident that more ATP is needed for the other
requirements at the lower growth rates. ATP is generated to a greater degree from
glycolysis for steady state E (36%) versus steady state A (29%).
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Figure 3-5. Specific metabolism for steady state chemostat cultures.
Unattached data points correspond to steady state E.
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for steady state
The surplus is equal to the sum of reactions 3 and 12 minus 6 from the metabolic network. The
ration is equal to the quotient of reactions 3 and 12 over reaction 6. Data for metabolic fluxes
calculated by Follstad, et. al., (Follstad, Balcarcel et al. 1999).
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3.4.3 Cell Cycle
The measurement of cell cycle distribution (Figure 3-8a) for our hybridoma cell line
reveals that the culture growth rate does not correlate with the percentage of cells that
are within the cycle (S, G2, and M phases). In all cases, about 70-80% of the culture is
cycling. Furthermore, the trend in percent of cells in G1 is one that decreases from
about 30% for fast growth down to 20% for slower growth. When the cell cycle data is
plotted as progression times for each phase (where the total progression time for the
cycle is the doubling time), it is apparent that it is the increase in time for S-phase
progression that is the primary cause for increasing the total progression time.
77
Cell Cycle Progression Times
35
Dj
-30C Doubling Time
0 25 - +GIProgression ---
. + S P rogres s ion
20
5G2-M 
Progression
U)
10I ..
0
5
0
0 0.01 0.02 0.03 0.04
Growth Rate (hr-1)
Figure 3-8 a-b. Cell cycle distribution and cell cycle phase progression times for
steady state chemostat cultures.
Error bars for distributions represent 95%-confidence limits for the measurement of A, or the
95%-confidence interval for data taken on two consecutive days (C and D) and three
consecutive days (B). Errors for progression times are the propagated from the 95%
confidence limits for the growth rate and the distribution.
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3.4.4 Monoclonal Antibody Production
Monoclonal antibody production was measured and is shown as specific mass
production per viable cell per hour (Figure 3-9). The specific productivities span a
greater than 2-fold range. A maximum in productivity occurs at the intermediate growth
rate of 0.036 hr 1 (Dilution rate = 0.03 hr 1 for steady state B). Lower productivity for
steady state E compared to steady state A (33% lower) is presumed to be due primarily
to the differences in metabolism since cell death and cell cycle are very similar for both
steady states.
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Figure 3-9. Specific production of monoclonal antibody for steady state
chemostat cultures.
Errors bars for A and E are those propagated from the 95% confidence level for MAb
measurement, viable cell density, and dilution rate. Errors bars for B, C, and D are the 95%
confident intervals for the average value taken from multiple days.
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3.5 DISCUSSION
3.5.1 Emergence of Apoptotic Cell Death at Steady State
The nature of the equilibrium between growth and death that is achieved in a steady
state culture is not one that is easy to grasp. At the simplest level, the viable cell density
is the highest one allowable given the environmental and genetic constraints. Yet the
difficulty in understanding the steady state emergence of cell death lies in trying to
imagine which cell from a particular mitotic division will survive and which will die. For a
steady state with a viability of only 40% (such as for steady state D), only about one in
two (4 in 10) of the initially viable daughter cells from a successful division will survive.
One could try to argue that the parent cell, which was successful in viable proliferation,
conferred its advantages to both of its daughters, and that both of the daughters should
live, where as daughter cells from an inferior cell would both die. This very well may
occur occasionally, but eventually those daughters or their descendants must die,
otherwise we would observe only high viability steady state cultures as dead cells
washed out.
Thus, some sort of selection process occurs among all daughter cells to determine
which will live or die in such a steady state. This competition among the viable cells
ensues for 5 complete residence times (21 days), at the dilution rate of 0.01 hr', with
cells growing at 0.023 hr', for a total of about 17 generations. After an initial quick
decline in viability'as the dilution rate was decreased from 0.02 hr-, the cell density and
viability remained steady throughout the wait for a fluid dynamical steady state. At the
steady state, the viable cell density of the culture hovers around the residual nutritional
levels that remain after the growth of cells. Any burst in viable cell growth by an
advantaged subpopulation would be checked by the tightening of nutritional
requirements, which would stimulate more death. Thus, for the nutrient limited steady
state, the equilibrium viable cell density hovers around the residual nutrient levels.
The competition for nutrients that is hypothesized above would result in the survival of
the fittest daughter cells that exhibit the most robust physiology for the given
environmental situation. Without direct measurements and accepting the fact that the
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culture is at a steady state, the cells that are proliferating in a viable fashion cannot be
part of a subpopulation of the viable cells. Any such subpopulation would overtake the
culture and reach a new equilibrium. During the transient, this is what may have
happened actually, rather than assuming that all the viable cells adapted uniformly.
Possible microscale differences in metabolic potential or other cellular characteristic
may have paved the way for the viable culture of cells with a dramatically different
metabolic behavior. Yet once at steady state again, the population of viable cells must
be homogeneous and death must occur as a stochastic process based on nutrient
availability and possibly random fluctuations in intracellular events.
The data from this series of chemostats reveals that cell death emerges as a function of
nutritional environment. Furthermore, as will be discussed below, the impediment to
growth appears to be progression through the S-phase. The arrest of cells in S-phase
as the result of glutamine-limitation is understandable given that glutamine is a building
block for all five nucleotides (Xie and Wang 1994). Thus, the stochastic selection of
cells that live or die can be imagined to occur within the S-phase. As cells arrest in S-
phase waiting for available glutamine, they eventually die by apoptosis (presumably by
p53 activity) or just barely make it to the G2/M phase. Death of some cells in the S-
phase frees up glutamine for the others. The role of metabolism during the S-phase
arrest is unclear. As shown below, metabolism is shifted towards higher efficiency,
indicating an increase in demand for cellular ATP. Such a metabolic shift may or may
not be related to the S-phase arrest and/or the emergence of apoptotic cell death.
3.5.2 Shift in Metabolism
Shifts in metabolism and cell yield have been documented by several other researchers
in the past (Miller, Wilke et al. 1987; Miller, Wilke et al. 1989; Miller, Wilke et al. 1989;
Hiller, Aeschlimann et al. 1991; Hayter, Curling et al. 1993; Hiller, Clark et al. 1994;
Bonarius, Hatzimanikatis et al. 1996; Linz, Zeng et al. 1997; Vriezen and Dijken 1998),
including by myself and Nyberg et. al. for a suspension CHO cell line (Nyberg, Balcarcel
et al. 1999). In this particular study, the metabolic analysis reveals that the viable cells
respond to the nutrient limitation by shifting their metabolism from glycolysis toward
TCA cycle and oxidative phosphorylation, utilizing glucose carbon more efficiently and
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consuming more oxygen. Looking at the four steady states together, it appears that
there are two dominant profiles for metabolism. One, for fast growing cells of high
viability with plentiful nutrient supply, utilizes the majority of its glucose for ATP
production via glycolysis resulting in high lactate production. Another profile, that for
slower growing, lower viability cultures under glutamine limitation, utilizes noticeably
more glucose and more oxygen for ATP production via the TCA cycle, resulting in less
lactate formation. The fifth steady state culture (E) shows a mix between these two
profiles, with both high glucose consumption and high oxygen consumption.
Overall, the shift in metabolism most probably reflects a robust response for the
hybridoma cells as they become more and more constrained by the reduction of the
dilution rate. Though under severe nutrient limitation (which is probably triggering death
by impeding passage through the S-phase), it appears that the viable cells are capable
of shifting their metabolism to generate sufficient ATP for survival. The ATP production
that was calculated and plotted above assumes that the P/O ratio remains constant at a
value of 3. Under this assumption, the shift in metabolism is one that maintains
adequate ATP levels for the survival of some cells. Without the shift in metabolism, ATP
production would decrease as a function of growth rate. That the shift is one towards
better efficiency is evident in the physiology of the fifth steady state culture (E) that was
obtained after steady state D (D=0.01 hr-1) by increasing the dilution rate back up to
0.04 hr'. This fifth steady state, rather than flexibly reverting back to higher lactate
production and inefficiency, maintained the metabolic efficiency seen at the lower
dilution rates. The metabolic efficiency, coupled with a more favorable nutrient
environment, resulted in an equally high viability as seen for the first steady state at
0.04 hr 1 , yet one that had roughly twice the cell density. Thus, the shift in metabolism
following nutrient limitation and its effect on viable cell density for steady states at the
same dilution rate, implicate culture metabolism as a parameter which can dramatically
influence viable cell density and the extent of death in a culture. Brian Follstad has
followed up the findings in this work concerning culture metabolism in fed-batch cultures
and in regard to mitochondrial potential.
Yet, the higher ATP production at lower growth rates (or the lack of relationship
between ATP and growth rate) reveals that the cell is either spending more ATP for
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maintenance or possibly that the P/O ratio has decreased from 3 and the cell is not
actually making the amount ATP than I calculate assuming P/O = 3. In either case, the
metabolic shift can therefore also be hypothesized as being the result of accumulated
maintenance for cellular functions and/or the impediment of metabolic capacity. One
possible sink for maintenance ATP is the energy required to protect cells within an S-
phase arrest, or apoptosis may result from ATP shortages. Nonetheless, the cell with
higher maintenance requirements and/or reduced metabolic capacity would also
respond by shifting its metabolism and even increasing its metabolic capacity to provide
more ATP under the limiting conditions. Although this second possible explanation for
metabolic shifts is probably overshadowed by the effect of nutrient limitation, it is a
hypothesis that is necessary to describe the metabolic shifts and cell death observed for
fed-batch cultures in the absence of nutrient limitations.
Thus, for these chemostat steady states, the shift in metabolism in taken to be a robust
response to the increasing glutamine-limitation, and possibly as well as a metabolic
impediment. The relationship between apoptosis and metabolism is unclear. Evidence
that metabolism is not the primary cause for apoptosis is inferred from the doubling of
cell density that occurred when the dilution rate was increased again.
3.5.3 Defect in Cell Cycle Control
The trend observed in cell cycle distribution for these four steady states is quite contrary
to what is expected of a normal cell cycle function (Lodish, Baltimore et al. 1995) or
what has already been modeled or documented in other hybridoma cell lines (Suzuki
and Ollis 1989; Martens, Gooijer et al. 1993; Goswami 1998). As described in a cell
biology text, the cell cycle contains two checkpoints that prevent passage through the
cycle in the absence of necessary factors, such as nutrients and growth factors. The
data obtained for this hybridoma reveal that the first checkpoint (at the transition form
G1 to S) is not operating correctly. Instead of exhibiting reduced entry to the cell cycle
as the dilution rate is decreased and the nutritional environment becomes leaner, the
culture actually shows a moderate increase in entry to the cell cycle (G1 residence
drops from 30% to 20%). In terms of progression time through each cycle phase, the
cells maintain a constant residence time in G1 of approximately 5 hours. The result of
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sustained entry to the cell cycle is the accumulation of cells in the S-phase. S-phase
progression time doubles as the dilution rate is decreased. In fact, of all the measured
parameters, the S-phase progression time is the only one that matches the trend for the
emergence of apoptotic cell death. G2/M progression remains constant at around 2
hours. Thus, it appears that the cell cycle for the hybridomas is defective in controlling
entry to the cell cycle, and cells may be inferred to be dying within the S-phase. This
finding explains the previously described phenomenon of "abortive proliferation" that this
hybridoma is known to exhibit under suboptimal culture conditions (Chung, Sinskey et
al. 1998).
Further evidence for this cell cycle defect was obtained by measuring expression of c-
myc (a proto-oncogene involved in entry to the cell cycle) at different dilution rates and
with or without insulin. c-Myc protein was measured as a possible cause for defective
cell cycle control following the hypothesis made by Chung, et. al. for this cell line
(Chung, Sinskey et al. 1998). In contrast to an anchorage dependent CHO cell line
(Sanfeliu, Chung et al. 1999 in press), c-myc expression did not depend on the
presence of insulin and was not noticeably different at the two different dilution rates
investigated. Furthermore, c-Myc in the hybridoma was expressed well above that of the
anchorage CHO cell line in all cases. The relatively high levels of hybridoma c-Myc are
even more impressive given that the CHO cells were synchronized (c-Myc normally
shows peak expression in early G1), whereas the hybridoma cells were cycling, with
only about 30% of the cells in G1 as usual. Thus, c-Myc for the hybridoma is either
expressed constitutively throughout the cycle or is expressed at extremely high levels
during early G1. In either case, this measurement of increased c-Myc levels for our
hybridoma cell line supports the observed deregulation of cell cycle entry. c-Myc is
taken to be at least one of the possibly several factors which obviate the first checkpoint
in the cell cycle.
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1. Positive control
2-6. C-myc expression from anchorage-dependent CHO
cells stimulated with insulin following arrest by
serum withdrawal. Time points for the
synchronized culture at 0, 2, 4, 6, and 8 hours
following insulin addition. (load = 50 pg-protein)
7. C-myc for Hybridomas form an insulin(-) steady
state culture at D = 0.03 hr-1. (load = 50 pg-protein)
8. C-myc for Hybridomas form an insulin(+), steady
state culture at D = 0.02 hr 1 . (load = 38 pg-protein)
Figure 3-10. Western blot for c-Myc protein.
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In contrast to batch and fed-batch phenomena (Chapter 4), death in these chemostats
is not associated with increases in the progression times for all the phases of the cell
cycle (Chapter 4). Whereas cells in fed-batches are given an optimal nutrient supply,
chemostat cells are under glutamine-limitation. It is not unreasonable to believe that a
nutrient limitation in the chemostat results in a slowing of S-phase progression and may
possibly mask a potential arrest in G2/M. Conversely, fed-batch cultures would not
necessarily exhibit slower S-phase progression with adequate nutrients available, and
so an arrest in G2/M would be more evident. The critical difference between the
chemostat and fed-batch cell cycle phenomena is that the G1-phase progression time
remains constant for the chemostats, whereas the G1-phase progression time for fed-
batch increases. As will be discussed in Chapter 4, the increase of progression times for
all the phases during fed-batches points to another underlying phenomenon as the
cause for slower growth and cell death.
Overall, this defect in the cell cycle confers the ability for the hybridoma cells to grow
very fast, with doubling times as low as 14 hours. The following figure (Figure 3-11)
contrasts the "textbook" model for cell cycle control vs. one that better describes the
CRL 1606 hybridoma. As denoted in the figure, apoptotic cell death is known to be
reduced by the presence of additional protective environmental and genetic factors that
help the cells complete the cycle as they enter it constitutively. Another approach, which
is the subject of Chapter 4, is to slow down the entry to the cycle using an arresting
agent, such as rapamycin.
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Figure 3-11. Cell cycle diagram for "textbook" cell cycle and hybridoma cell
cycle.
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3.5.4 Specific Production of Monoclonal Antibody
The specific production of MAb does not appear to be a simple function of growth rate.
Previous studies have shown that hybridoma cultures which are growing slower may
exhibit higher specific production rates (Suzuki and Ollis 1989; Al-Rubeai and Emery
1990; Martens, Gooijer et al. 1993). This phenomenon is related to the nature of
production of antibodies and its better efficiency in the G1 phase of the cell cycle. Thus,
for cells that can arrest in G1 as the dilution rate is decreased, it is observed that there
is a higher specific MAb production rate. However, in my hybridoma cell line that does
not arrest in G1, there is no observed increase in specific production rate. In fact, the
reduction in specific productivity at dilution rates of 0.02 and 0.01 hr 1 could be due in
part to the reduction in percent of cells in G1 phase.
Another consideration for the observed trend in specific productivity is the emergence of
apoptosis. In addition to having fewer cells in G1 at the lower dilution rates, the viable
cells of a culture that is suffering from high levels of apoptosis could reasonably be
imagined not to be the most productive ones. The high death rates and the delay in S-
phase reveal that their metabolic shift, though helpful, cannot entirely compensate for
the shortage of glutamine.
In addition to cell cycle and cell death effects, it appears that metabolic differences
between the steady states may also play a role in specific productivity. The maximum
productivity observed for steady state B coincides with a metabolic state that has an
increased production of ATP from the TCA cycle in addition to sustained glycolysis and
lactate production. Perhaps the observed optimum in specific productivity for MAb's is
due to the balance of biosynthetic precursors and ATP production, which ultimately
depend on the metabolic state of the cells.
Evidence for the role of metabolism on specific productivity is found in the MAb
production rate for the multiple steady culture that was achieved at D = 0.04 hr 1 (E)
following the D=0.01 hr-1 steady state. The superior density steady state that was
observed upon returning to the initial dilution rate of 0.04 hr' had a specific production
rate that was nearly half that of the initial 0.04 hr 1 culture. Here, with growth rate and
cell cycle distribution the same in each case, and also with very little apoptosis in both
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cases, it clearly appears that MAb productivity is affected by the metabolism of the
hybridoma cell. A shift in metabolism away from glycolysis towards TCA cycle
apparently negatively impacts MAb production. Perhaps MAb precursors are derived
from glycolytic biosynthetic precursors, and hence MAb production is negatively
impacted upon a metabolic shift towards TCA cycle.
These observations shed some light on the observed variable nature of specific MAb
production seen between different batch experiments. Just as different inocula of the
same cell type have variable growth and death behavior, different inocula can also have
different specific MAb production rates. Interestingly, both the growth and MAb
production phenomena intersect with culture metabolism, which as presented in this
investigation, can be very different depending on their environment and cultivation
history.
3.6 CONCLUSIONS
Hybridomas were observed at a wide range of dilution rates, spanning a full range of
culture physiologies for fast growing cultures with high viability down to slow growing
ones with very low viability. It was observed that cell death correlates with the aberrant
and persistent entry of cells to the cell cycle. The culture growth rate is apparently not
being controlled by the first check point to the cell cycle, which would have resulted in
an arrest of cells in the G1 phase of the cycle. Rather, it is evident that the cells entered
the cycle and were delayed within the S-phase as a result of nutrient limitation at lower
dilution rates. Thus, the emergence of cell death for this hybridoma under suboptimal
conditions is exacerbated by the defect in cell cycle entry.
Under conditions of higher levels of apoptotic cell death, the viable population of cells
shows a shift in metabolism towards TCA activity and oxidative phosphorylation. The
shift is due to glutamine-limitation, and presumably implies that cellular energetics may
be compromised as a result of or in conjunction with the emergence of cell death. The
shift in metabolism is a response that enables cells to produce ATP more efficiently as
resources become scarcer at lower dilution rates. The enhanced metabolic efficiency is
demonstrated to yield higher viable cell densities following the lifting of nutritional
constraints.
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Specific productivity of monoclonal antibody is observed to be a complex function of cell
death, metabolic state, and cell cycle distribution. Cultures with increased cell death,
metabolism shifted towards TCA cycle, and a lower percent of cells in G1-phase exhibit
lesser specific productivities. Of two steady state cultures with similarly high viability and
comparable cell cycle distributions, the one with higher lactate production and lesser
TCA cycle activity exhibits the higher specific productivity. The highest specific
productivity is observed for the culture with an intermediate metabolic state, modest
apoptosis, and average Gi-phase residence.
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4 ENHANCEMENT OF CULTURE VIABILITY AND
PRODUCTIVITY USING THE CELL CYCLE
ARRESTING AGENT RAPAMYCIN
4.1 ABSTRACT
The cell cycle arresting agent rapamycin is used as a medium additive to inhibit cell
cycle entry of hybridoma cells. Though rapamycin's most notable effect is growth arrest
within the G1-phase of the cell cycle, in this study, rapamycin is used as an anti-
apoptosis factor for a cell line with defective control of cell cycle entry, a defect which
has been implicated in exacerbating apoptotic cell death.
Results demonstrate the 24-hour delay in the emergence of cell death for the hybridoma
cell line in the presence of rapamycin. Despite growth being inhibited mildly, the
extension of viable proliferation results in higher maximum viable cell densities and
greater integrated viable cell densities. Over the course of 6-day fed-batch experiments,
the positive effects of rapamycin on culture physiology result in a doubling of
monoclonal antibody titer, due to the increase in viable cell densities as well as an
increase in apparent specific productivity.
Rapamycin's mechanism for the above physiological changes in this hybridoma cell,
and in particular, it ability to postpone and minimize apoptotic cell death, remains an
open question. Among rapamycin's physiological effects is the arrestment of cells in the
G1-phase of the cell cycle. Such an effect is observed for this hybridoma cell line. The
typical 30% fraction of total cells found in G1 is increased to 40-45% with rapamycin
present. This corresponds to an increase of 30-50% in G1 residence time. It is possible
that additional time in G1 allows for more timely production of intracellular genetic
factors needed for cellular function and survival during DNA synthesis and mitosis. Yet,
preliminary data showing that rapamycin also affects metabolism indicates that a shift in
metabolism might also possibly play an important role in the enhanced survival of the
hybridomas.
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4.2 INTRODUCTION
The initial interest in identifying arresting agents for the hybridoma cell line lay in having
controls for the observations of cell cycle distribution that were to be obtained during
chemostat studies. Cell cycle progression was a possible physiological parameter that
was expected to be associated with the emergence of apoptotic cell death in this cell
line. It was my intention to use phase-specific cell cycle arresting agents to verify any
findings regarding cell cycle phenomena from chemostats in follow-up batch studies. My
initial hypothesis during the spring of 1997 was that cell death was associated with or
perhaps caused by an arrestment in a particular phase of the cell cycle. Thus, as a side
project and with the aid of an undergraduate student, Ryan Gilbert, I went forward
during the summer of 1997 to find and test various arresting agents that would trigger
apoptotic cell death by arresting the hybridoma cell line.
From the literature, Ryan and I chose four agents (alleged to arrest in a particular phase
for other cell lines) with which to begin our studies: (1) sodium butyrate (S-phase) (2)
olomoucine (G1 and/or G2/M), (3) n-butyl 5-chloro-2-pyrimidoxyacetate (G2/M-phase)
and (4) rapamycin (G1-phase) (Crosby and Bethold 1960; Gacek, K et al. 1979;
Benneche, Stande et al. 1993; Aagaard-Tellery and Jelinek 1994; Glab, Labidi et al.
1994; Joensuu and Mester 1994; Vesely, Havlicek et al. 1994; Misteli and Warren
1995). Batch experiments were performed at various concentration of each arresting
agent to see if any of the substances had any effect on cell growth, cell death, and cell
cycle distribution 'for our hybridoma cell line. By the end of the summer, we had
observed that sodium butyrate, olomoucine, and rapamycin all had G1-phase arresting
activity, whereas 5-butyl n-cholo-2-pyrimidoxyacetate did not have any observable
activity. The remarkable observation at that time was that the arrestment did not
necessarily result in more apoptotic cell death. Depending on the concentration of the
arresting agent, each of the three active agents actually delayed apoptosis, with
rapamycin showing the best overall effect.
The full impact of such a result would only come to be appreciated after the completion
of the chemostat study described in Chapter 3 (Fall 1997). From the chemostat
experiments I learned that the nature of the hybridoma cell obviates nutrient limitation
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as a means to regulate the passage of cells from the G1-phase of the cell cycle into the
S-phase. The apparent constitutive entry to the cell cycle confers the ability of the cells
to grow very quickly under optimal conditions, with doubling times as low as 14 hours.
Yet at the same time, the unbridled entry to the cell cycle could possibly be leading to
apoptotic cell death as a result of nutrient, growth factor, or genetic factor limitations.
Overall, I was forced to reverse my initial hypothesis concerning cell cycle arrestment
and apoptosis. For my hybridoma cell, it is actually a lack of arrest that can be
detrimental to the culture. Eventually (by the summer of 1998), the combination of
results from the chemostats and cell cycle arresting agents would serve as the basis for
a new hypothesis: slowing down entry to the cell cycle may lead to less apoptosis,
especially for suboptimal environmental conditions. During the summer of 1998, and
with the help of another undergraduate student, Jose Aleman, I investigated rapamycin
as a medium additive to enhance viability and show that an inhibition of entry to the cell
cycle can be beneficial. With rapamycin's positive effects confirmed and applied
successfully to a variety of batch and fed-batch cultures, and with the consent and
urging of my thesis committee, the rapamycin story was upgraded from the status of a
side-project to a primary focus of my thesis. During the fall of 1998 1 finally turned to
look deeper into the literature and to additional experiments to try to ascertain how
rapamycin was protecting the cells from apoptosis.
Two other works occurring in parallel at that time also supported the reversal of
hypothesis described above. First, Chung et. al. demonstrated that insulin and Bcl-2 act
as survival factors for the hybridoma cell line that they intuited, based on literature
reports, exhibited faulty regulation of cell cycle entry presumably due to c-myc over-
expression (Chung, Sinskey et al. 1998). Second, Sanfeliu et. al. demonstrated that c-
myc induction and expression by insulin in an anchorage-dependent CHO cell line leads
to cell death in the absence of survival factors, and furthermore that cell death is
minimized for cultures growing slower as the result of nutrient limitation (Sanfeliu and
Stephanopoulos 1999; Sanfeliu, Chung et al. 1999 in press). These fellow works
comforted me greatly as I re-formulated my hypothesis for the hybridoma cell cycle and
designed experiments with rapamycin. Both of the works point to the emergence of cell
death being the result of entry to the cell cycle in the absence of some other factors that
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are necessary for cell survival. Achieving faster growth with a deregulated c-myc (the
hybridoma cell) or by stimulating c-myc with insulin (Sanfeliu's CHO cell) is not as
simple as just forcing entry to the cell cycle. Depending on environmental and cellular
constraints, cells finding themselves "prematurely" in the S-phase may be limited in
other necessary components and thus die by apoptosis. As I fortuitously identified,
rapamycin acts as another survival factor, presumably through its inhibition of
progression into the S-phase.
The essence of this chapter is to demonstrate the positive effects that rapamycin (the
best of the four arresting agents tested) has on hybridoma cell culture. At the optimum
concentration, the mild arrest in GI-phase leads to only a mild reduction in growth rate,
but a dramatic reduction in death rate, allowing an additional day of viable proliferation
before viability begins to decline. The extension of viability results in higher viable cell
densities, greater integrated viable cell densities, and higher monoclonal antibody titers.
Thus, the use of rapamycin is shown to be a valuable tool to enhance culture
productivity. Furthermore, it can also help discern the relationship between the cell cycle
and metabolism and the underlying causes for apoptotic cell death.
4.3 MATERIALS AND METHODS
4.3.1 Cell Line and Culture Medium
The cell line used was a murine hybridoma (ATCC CRL-1606) which produces and
secretes an immunoglubulin IgG against human fibronectin. Each inoculum culture was
prepared from a frozen stock of CRL 1606 hybridomas (previously adapted to serum-
free medium) grown in T-flasks (Corning, Cambridge, MA.) and spinner flasks (Bellco,
Vineland, NJ) within a 37 0C humidified incubator (95% relative humidity) with 10% CO 2
atmosphere. The inocula were passaged daily for one to two weeks by subculturing the
culture down to 2.5e5 cell/ml (from the approximately 7.5e5 cell/ml reached after 24
hours).
The hybridomas were grown in glutamine-free IMDM basal medium (Specialty Media,
Inc., Lavallette, NJ), supplemented with 10 mg/L insulin (USB), 5 mg/L transferrin
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(USB), 2.44 ptL/L 2-aminoethanol, 3.5 pL/L 2-mercaptoethanol, 7.5 mg/L protease free
bovine serum albumin (Sigma Chemical Co.), and 1 U/mI penicillin - 1 pg/ml
streptomycin (Sigma). Glutamine was added at a concentration of 4.0 mM prior to an
experiment. No serum or hydrolysates were added.
During the reactor experiments, the medium was further supplemented with pluronic
F68 (Sigma #P-5556) and antifoam A (Sigma #A-5633). 10 ml of the 10% Pluronic F68
were added per liter of medium to yield a concentration of 0.1% w/v pluronic. Antifoam
A stock solution was prepared at a concentration of 0.1 w/v in water and sterilized by
autoclaving. The antifoam A stock was stored at room temperature. The stock bottle
was shaken vigorously prior to addition to emulsify the solution. 1.0 mL of stock was
added per liter of culture, yielding a concentration of 100 PPM antifoam. These
additives ensured that the sparging had negligible effect on culture density and viability,
as determined by separate trials at much higher sparging rates.
Experiments in which rapamycin (Sigma Chemical Co., St. Louis, Mo.) was added were
given the appropriate amount of a rapamycin stock solution. Rapamycin stock solutions
were made at either 325 plM or 1 mM by the addition of either 3.37 mL or 1.09 mL
industrial grade ethanol to 1.0 mg rapamycin. Stock solution was stored as aliquots of
100 and 250 tL at -70 0C for up to six months. Medium for rapamycin batch experiments
(other than the optimization batches) were given sufficient rapamycin stock solution to
yield a concentration of 100 nM for rapamycin. Fed-batch experiments, in which
rapamycin was re-fed daily starting on the second day of culture, were given sufficient
rapamycin stock solution to yield an equivalent concentration of 50 nM (not including
any residual rapamycin). Based on the culture behavior, the added rapamycin plus the
residual concentration yielded an estimated combined concentration between 50 and
100 nM throughout the experiment.
Initial medium for fed-batch experiments consisted of the IMDM medium described
above, with the regular amount of glucose and glutamine (25 mM and 4 mM).
Supplemental medium was a concentrated stock of nutrients and vitamins prepared
according to the stoichiometric feeding strategy developed by Xie and Wang (Xie and
Wang 1994; Xie and Wang 1994; Xie and Wang 1994; Xie and Wang 1996). Total
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concentration of nutrients in the supplemental medium was set to 600 mM.
Supplemental medium was stored frozen at -20 0C in 10-mL aliquots. During some fed-
batch experiments, cultures were fed additional insulin stock solution as well. In these
cases, volumes of the 2-g/L insulin stock sufficient to add an equivalent of 10-mg/L
insulin to a culture were added starting on the second day. The depletion or re-feeding
of insulin was shown not to impact the emergence of cell death.
4.3.2 T-Flask Batch and Fed-Batch Experiments
Batch and fed-batch experiments conducted in T-flasks were performed in either T-25
cm 2 flasks (volume = 10 mL), T-75 cm 2 flasks (22.5 mL), or T-175 cm2 flasks (50-60
mL) (Corning, Cambridge, MA.). Flasks were placed within a heated and humidified CO 2
incubator set at 37 0C, 95% relative humidity, and 10% CO 2. Cultures were sampled
daily for cell counts and cell cycle analysis by transferring momentarily to a sterile hood,
rocking back and forth to mix, and retrieving the desired volume with a disposable
plastic pipette.
Daily feeding of supplemental medium, insulin stock, and rapamycin stock during fed-
batches was accomplished within a sterile hood by removing approximately 10 mL of
culture to a sterile 15 mL centrifuge tube, adding milliliter amounts of supplemental
medium and microliter amounts of insulin and rapamycin stock, gently vortexing to mix,
and transferring the fortified partial culture back to the T-flask. This procedure was
adopted to facilitate the transfer of such small volumes for rapamycin and insulin in a
reproducible and sterile fashion. The amount of supplemental medium to provide was
determined using the material balance program created by Mollborn, et. al. (Mollborn
1996). Apparent growth and death rates and viable and total cell densities from each
fed-batch experiment were used as inputs.
4.3.3 Bioreactor Batch Experiments
Batch bioreactor cultures were cultured within a 3-liter water-jacketed Applikon reactor
(Foster City, CA) at a working volume of 1.5 liters. A New Brunswick Scientific (Edison,
NJ) ML 4100 controller was used to monitor the bioreactor temperature, monitor and
control the pH and dissolved oxygen, and control mixing of nitrogen, air, and oxygen for
98
the feed gas via a solenoid control assembly. A heated water jacket maintained the
temperature at 37 0C. The pH was controlled at 7.20 +/- .05 by addition of 320 mM HCl
and up to 10% C02 in the gas feed or a solution of 6.2 g/l NaOH and 0.4 g/l KOH as
needed. The dissolved oxygen concentration was maintained at 50% of air saturation by
a constant 75-150 mL/min (0.05-0.1 VVM) of sparging maintained with a Mass Flow
Controller. C02 concentration in the feed was adjusted manually with a rotameter set at
flows of 3.5 to 7.5 ml/min to minimize HCl addition. Agitation was set at 175 rpm.
Process data (T, pH, DO, control outputs) were logged through the ML-4100 controller
to a computer using the AFS software from New Brunswick Scientific (Edison, NJ).
The reactor experiments were inoculated with approximately 400 ml of inoculum culture
of a density of approximately 8 x 105 with high viability (> 95%) to give a starting density
of 2.0 x 10 cell/mI. The reactor was sampled daily for analysis and to recalibrate the pH
and DO probes using the sampling technique described in Chapter 3.
4.3.4 Analytical Methods
4.3.4.1 Cell Number and Viability
Cell number and viability were determined by cell counts using a hemacytometer with
trypan blue dye exclusion. One slide was counted daily for each T-flask culture, two
slides for the reactor cultures. Due to an overwhelming body of evidence showing that
the hybridomas die by apoptotic cell death during batches and fed-batches, it was taken
for granted that the dominant mode of death was apoptosis. An occasional check of
some of the experiments for the extent of apoptosis, performed as described in Chapter
3, confirmed that this was true.
4.3.4.2 Metabolite Concentrations
Supernatant samples taken from a flask or reactor were prepared, stored, and analyzed
as described in Chapter 3. Supernatants were analyzed for glucose, ammonia, and
lactate concentrations during some of the experiments.
4.3.4.3 Insulin Concentration
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Supernatant from cultures for insulin analysis was stored in the same manner as that for
the metabolite concentrations. The concentration of insulin in each sample was
determined using an insulin ELISA kit (ALPCO #10-1113-01, New Hampshire), per
manufacturer's instructions.
4.3.4.4 MAb Antibody Concentration
MAb antibody concentrations were determined by ELISA as described in Chapter 3.
4.3.4.5 Calculation of Growth and Death Rate and Specific Uptake and Production
Rates
The apparent culture growth and death rates (p and kd) were determined from cell
balances using total and viable cell densities (nT and nv) obtained by Trypan blue
counts:
dT= pin, = Pf~nr (4-1 )
dt
dn~
d= pnv - kdnV (4-2)dt
where fv is the fraction of viable cells. Between two time points, and taking the growth
rate, death rate, and viability as constants at their average values over the time interval,
these balances yield the following expressions for the average culture growth and death
rates over a specific time interval:
. + _ In(nT2 /nT) (4 3)f(t 2 -ti )
=- _ 1n(n 2/n,1) (4_4)d 1-+2 1+2 (t 2 - 4()
Integrated viable cell densities (IVCDs) were calculated by numerical integration using
the trapezoid rule:
IVCD1,j = Jnvdt ~ (nv + nv(i+) )(ti+1) - ti) + .... + - (nv- + n, )(t - 1(j)) (4-5)
tj 2 2
Specific metabolite production or uptake rates (or MAb production rate) were
determined by a species balance:
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d = -cn (4-6)
Using the IVCD, this balance yields the following expression for an average specific rate
over two time points:
q--+2 (C2 -C) (47)
IVCDI- 2
4.3.4.6 Estimation of ATP Production
With only glucose, lactate, and ammonia as measurements, total ATP production was
estimated with the help of the physiology observed in the chemostat experiments
discussed in Chapter 3. First, ATP from glycolysis was determined from the measured
glucose uptake rate and the observed glucose-to-lactate ratios. Second, ATP from TCA
cycle was taken to be the same as that for a chemostat culture that exhibited a similar
GUR and L/G ratio. Control cultures had similar GUR and L/G as chemostat steady
state A (D=0.04 hr), whereas rapamycin cultures had similar GUR and L/G as
chemostat steady state C (D=0.02 hr').
4.3.4.7 Cell Cycle Distribution
Cell cycle distributions and progression times were measured by the same method
described in Chapter 3. The determination of cycle distribution was performed once per
day per T-flask culture, in duplicate for reactor cultures. Cell cycle phase progression
times are calculated using the average growth rate for an interval and the average of
the cell cycle distribution fractions from the beginning and the end of the interval.
4.4 RESULTS
4.4.1 Effects of Rapamycin on Culture Cell Density and Viability
4.4.1.1 T-flask Batch Cultures
The first evidence of rapamycin's positive effect on hybridoma cell cultures was
obtained during four to five day batch experiments performed in T-flasks. The optimum
rapamycin concentration was determined from a series of four T-flask cultures given 0
nM, 50 nM, 100 nM, or 200 nM (data not shown). 50-100 nM provided the best effects in
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terms of viable cell density and IVCD, whereas 200 nM showed a detrimental inhibition
of growth and lesser reduction in death rate.
Cell density and viability plots are provided for the averages of batch cultures grown
with or without rapamycin. The plots are composed of three control cultures and four
rapamycin cultures, taken from the initial experiment, the optimization experiments, and
an additional confirmatory experiment. The cultures included in the rapamycin group are
those that were given the optimum concentration of 100 nM. The 95%-confidence error
bars shown are more representative of variations of inoculum state and experimental
outcome rather than experimental error. The error bars indicate the outcome one would
expect based on the three to four independent trials. Furthermore, the average trend
holds true for each individual experiment: a rapamycin culture always outperformed the
control regardless of other factors.
Plots of total and viable cell density and viability for the control and rapamycin
experiments show the reduction in growth rate and the extension of viability for the
rapamycin cultures (Figure 4-1 a,b). Control cultures grow viably for two days in batch.
The presence of rapamycin slows the growth of a culture, yet allows the culture to
outperform the control by proliferating viably up through the third day in a batch. Thus,
viable cell density and the IVCD are enhanced by the presence of rapamycin through its
effects on culture physiology.
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Figure 4-1 a,b. Comparison of T-flask hybridoma batch cultures with and without
rapamycin. a. total and viable cell density b. viability.
The control data is the average from three separate experiments. The rapamycin data is the
average of four separate experiments.
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4.4.1.2 Bioreactor Batch Cultures
To further test the enhancement of cultures using rapamycin, hybridoma cells were
cultivated in a 3-liter bioreactor. The aim of this test was to confirm the effect at a larger
scale, as well as to see if the better-controlled environment of a bioreactor would yield
further increases in cell density beyond those already seen in T-flasks. The figure for
the control and rapamycin reactor runs depicts a similar effect of rapamycin on the
outcome of the reactor experiments that was seen for the T-flask experiments (Figure 4-
2). Though the reactor cultures had higher viability and higher peak densities than the
T-flask cultures (possibly the result of the better environment), the control culture
nevertheless died after 2 days and the rapamycin culture died after 3 days. Thus, the
effect of rapamycin was maintained at the bioreactor scale. The emergence of cell
death which occurs with or without rapamycin must be attributed to other factors beyond
nutrient depletion, dissolved oxygen depletion, pH changes, or ammonia and lactate
accumulation (data measured but not shown).
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Figure 4-2 a,b. Comparison of bioreactor hybridoma batch cultures with and
without rapamycin. a. total and viable cell density b. viablity.
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4.4.1.3 T-flask Fed-Batch Cultures
The use of rapamycin was combined with the stoichiometric feeding strategy developed
by Xie and Wang that had already been successful in extending culture growth by
maintaining the optimal nutritional environment and minimizing the formation of the
undesired by-products lactate and ammonia (Xie 1997). Previously, the feeding strategy
was successful in maintaining a viable population of cells, although viability was
declining as the result of cell death. The aim of coupling nutritional control with
rapamycin addition was to see if even further improvements could be achieved for fed-
batch cultivation of the hybridomas and for increasing product titer.
The following figure (Figure 4-3 a,b) depicts the average outcomes for control and
rapamycin-fed fed-batches. The control data is the average of 5 fed-batch control
cultures, while the rapamycin data is that for 3 fed-batch rapamycin-fed cultures. Other
fed-batch experiments in which rapamycin was fed only initially (data not shown),
showed intermediate results, which prompted us to feed additional rapamycin on a daily
basis. The 95%-confidence error bars shown are more representative of variations of
inoculum state and experimental outcome rather than experimental error. The error bars
indicate the outcome one would expect based on the three or five independent trials. As
for the averages for T-flask batch experiments, the average trend holds true for each
individual experiment: a rapamycin culture always outperformed the control regardless
of other factors.
As for the T-flask -batches and reactor batches, the rapamycin cultures outperform the
controls in terms of maximum viable cell density and IVCD. Yet despite supplying
additional nutrients, death still emerges after day 2 for the controls and after day 3 for
rapamycin cultures. The presence of nutrients slows the decline in viability but does not
prevent the emergence of cell death. It was determined that lactate and ammonia levels
were not inhibitory for these cultures. Dissolved oxygen was estimated and measured
via blood gas analyzer to be sufficient. Though pH could be a cause for death in T-
flasks (it was measured to be 6.8 to 7.0 for some of the fed-batches), the reactor trials,
in which pH was controlled, point to something other than pH as acting as a possible
trigger of apoptosis.
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Figure 4-3 a,b. Comparison of T-flask hybridoma fed-batch cultures with or
without rapamycin.
The control data is the average from five separate experiments. The rapamycin data is the
average of three separate experiments.
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4.4.1.4 Summary of the Effect of Rapamycin on Cell Density
Overall, in terms of maximizing viable cell densities and IVCD's, the use of rapamycin is
very effective despite slightly inhibiting culture growth. The table below compares the
achieved IVCD's for the various types of experiments, where the error ranges
correspond to 95% confidence intervals for the observed cultures (Table 4-1). Two
IVCD's are of interest. The first is the IVCD corresponding to period during which the
culture has high viability (> 90%). For controls this is a two-day period, for rapamycin, a
3-day period. From this measure, it appears that rapamycin allows cells to grow viably
to a higher density before death emerges. The second IVCD is calculated over the total
process time, 4 days for batches and 6 days for fed-batches. It is clear that rapamycin
enhances viable cell density and yields IVCD's that are 20-30% greater overall.
Table 4-1. Comparison of culture cell density enhancement by rapamycin.
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IVCD I high viability IVCD | total
(107 cell-hr/ml) (107 cell-hr/ml)
Control 2.9 ±0.8 7.0± 1.9
T-flask BATCHES
Rapamycin 4.5 ± 0.6 8.2 ± 0.7
Control 4.4 ± 20% 7.0 20%
Reactor BATCHES
Rapamycin 7.2 ± 20% 10.0 20%
Control 3.0 ± 0.3 15.0 ± 0.8
FED-BATCHES
Rapamycin 5.4 ± 0.8 18.0 ± 0.5
4.4.2 Effect of Rapamycin on Growth Rate and Death Rate
Data from the fed-batch cultures is used to calculate the apparent growth and death
rates for control and rapamycin cultures (Figure 4-4 a,b). The rates are calculated over
daily periods using the equation described above. The error bars are the 95%
confidence intervals for the average of rates calculated for each experiment in a given
set. Though the observed ranges are large, their average holds true for the observed
changes in growth and death witnessed within any of the runs. Rapamycin inhibits the
growth rate 10-25% during the first two days, when both control and rapamycin cultures
have high viability. Afterward, rapamycin cultures grow slightly faster than the controls,
though at lower rates than at the beginning. Finally, at the end when death has fully
emerged, control cultures show faster growth rates again. Overall, in both cases, the
initially fast growth of the first two days is observed to slow down on the third and
following days.
More dramatic than the differences in growth rate is the suppression of death rate for
rapamycin cultures. Both cultures exhibit little death initially (< 0.004 hr-1) during the
first two days, but then death within the control culture emerges sharply between the 2 nd
and 3 rd days, while the rapamycin culture shows no increase in death yet. Even as the
death rate for rapamycin begins to increase between days 3 and 4, it does so much
more gradually. This delay and reduction is death rate is the dominant positive effect of
rapamycin on the hybridoma cells. It appears that the growth rates for the control and
rapamycin cultures follow the similar paths (at first fast, then slow), but it is the lack of
death in the rapamycin culture that allows it to outperform the control.
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Figure 4-4 a,b. Growth and death rates during hybridoma fed-batches with and
without rapamycin.
The control data is the average from five separate experiments. The rapamycin data is the
average of three separate experiments.
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4.4.3 Effect of Rapamycin on Cell Cycle Distribution and Cell Cycle
Progression
As described in the literature, and the reason I adopted it as a good candidate for an
arresting agent for our studies, rapamycin is shown to increase the percentage of cells
in the G1-phase of the cell cycle. Below is data for the cell cycle distribution for fed-
batch cultures with or with out rapamycin (Figure 4-5 a,b,c) (rapamycin cultures were
given 100-nM rapamycin initially and 50 nM daily beginning on day 2). Cell cycle data
was not acquired during the first day of the rap-fed cultures, although other data
confirms arrestment is already visible. Over the four day period on which we can
compare, it is evident that the percent of cells in G1 for the control remains
approximately at 30% (the same fraction seen during the chemostats), but that the
percent of cells in G1 for rapamycin ranges from 37-48%. At day two, when both
cultures are proliferating viably, G1 for rapamycin cultures is roughly 30% greater (28%
vs. 37%), which agrees adequately with the observed reduction in growth rate. In terms
of the other phase of the cell cycle, rapamycin appears to minimize the increase of cells
in the G2/M phase of the cell cycle and also maintains a lesser fraction of cells in the S-
phase. Overall, in terms of cell cycle distribution, rapamycin cultures have a lesser
percentage of cells within the cycle (S plus G2/M) as compared to the control.
Interestingly, for both control and rapamycin cultures, the fraction of cells within the Gi-
phase remains steady despite the observed slowing of culture growth and the
emergence of cel death. The analysis for the progression time for each of the phases of
the cell cycle between the first and second days and the second and third days during
the fed-batches reveals that progression times for all phases are increasing as death
emerges (Figure 4-6 a,b), and regardless of the presence of rapamycin. The total
cycling time (the doubling time for growth) is calculated from the growth rate during an
interval. As I discussed for the chemostat data, the application of an accepted cell cycle
model (Suzuki and Ollis 1989) must be done with the assumption that cells do not arrest
in late G1 phase, since otherwise would require that a higher percentage of the culture
be in G1, which is in direct contradiction to the measured distributions. Thus, I allow the
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total cycle time to vary with growth rate as I set the fraction of arrested cells (fA) equal to
zero in the following equation:
tc =(1- fA) -ln(2)/p (4-8)
If I were to calculate fA based on a constant tc for fast growing cells, a decrease of 50%
in growth rate would yield a fraction of arrested cells of 50%. But in reality I never
measure G1 (which would be the sum of arrested cells plus those cycling) to be greater
than 45%, regardless of growth rate. Thus, with the fraction arrested set to zero, the
total cycling time increases for decreases in growth rate. After calculating the total
cycling time, I calculate the progression times for each phase based on the measured
distribution. The result is that fed-batch cultures appear to progress more slowly
throughout all the phases of the cell cycle. The relative progression times are two to
three times longer for G1 and G2/M, where as progression through S-phase is 1.5 to 2
times longer.
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Figure 4-5 a,b,c. Cell cycle distribution during hybridoma fed-batches with and
without rapamycin.
The control data is the average from five separate experiments. The rapamycin data is the
average of three separate experiments. No data was obtained for the first day of rapamycin
fed-batches.
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Figure 4-6 a,b,c. Cell cycle progression times during hybridoma fed-batches with
and without rapamycin.
The control data is calculated from the growth rate and cell cycle distribution for the average of
five separate experiments. The rapamycin data is similarly calculated from three separate
experiments.
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4.4.4 Enhancement of Monoclonal Antibody Production
In support of the primary goal for research in the field of therapeutic protein production,
a principle effect of rapamycin on the hybridomas is to increase monoclonal antibody
titers. The effect is the result of two complementary phenomena. The first is the
increase in viable cell density that results from rapamycin's reduction of culture death
rate. With increases of total IVCD's about 20-30%, we can expect proportional
increases in product titers as well. The second, fortuitous phenomenon is that higher
hybridoma production of MAb's is associated with the G1 phase of the cell cycle. Thus,
an increase in the apparent specific productivity is also observed. Combining the two
effects, it is shown that monoclonal antibody titers can be doubled by the presence of
rapamycin (Figure 4-7 a). For my serum-free, 6-day fed-batch process, the use of
rapamycin increases the titer from 0.25 g/L to 0.55 g/L (120% greater). Data shown is
for two controls and three rapamycin experiments conducted simultaneously from a
single inoculum. Data for other fed-batches shows typical variation in specific
productivity and titer, yet the effect of rapamycin to yield greater titers and increased
specific productivity over the control cultures is conserved for all experiments.
The specific productivity (Figure 4-7 b) observed during control fed-batches is within the
same range as those measured for the chemostats, specifically being similar to that of
steady state A (D=0.04 hr 1). The specific productivity during rapamycin fed-batches is
slightly greater than the maximum observed for the chemostats at steady state B
(D=0.03 hr 1). Such an increase in specific productivity is plausible for the slower
growing rapamycin culture with a greater fraction of cells in G1, with a possibly shifted
metabolism, and in the absence of nutrient limitation. The increase in specific
productivity is believed not to be the result of increased passive release of antibodies
from stationary phase cells. Measurements of intracellular MAb concentration for both
control and rapamycin cells indicates that the amount of MAb's inside the cells is
insignificant and can not account for increases in titer (data not shown).
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Figure 4-7 a,b. Monoclonal antibody titers and specific productivity during fed-
batches with and without rapamycin.
Errors for titer data are within 10%. Specific productivity for the control is the average
calculated from two experiments. Specific productivity for rapamycin is that from three
experiments.
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4.5 DISCUSSION
4.5.1 Mechanism of Rapamycin
The effect of rapamycin on culture physiology is an active area of research. To date
there is substantial literature that supports the arrestment of cells in G1 by the presence
of rapamycin (Terada, Franklin et al. 1993; Aagaard-Tellery and Jelinek 1994; Hung,
Jamison et al. 1996; Wadsworth and Siekierka 1996; Metcalfe, Canman et al. 1997;
Hashemolhosseini, Nagamine et al. 1998; Peterson, Desai et al. 1999; Sabatini 1999).
The arrestment phenomena, however, is a downstream event which follows somewhat
after the interaction of rapamycin with the protein signaling FRAP pathway. As shown in
the diagram below, which is a consolidation of knowledge taken from several sources,
the FRAP pathway is one which controls the translation of proteins and the activity of
ribosomal proteins (Figure 4-8).
Rapamycin diffuses into cells and binds to the protein FKBP12, a complex that then
interacts with the protein FRAP. This interaction draws FRAP away from its role as an
active kinase for p 7 0 S6k and 4E-BP1. A shift in p70S6k phosphorylation in turn causes
shifts in several other downstream protein phosphorlyations, such as for S6 (a
ribosomal protein). A shift in 4E-BP1 phosphorylation impacts the availability of
translation initiation factors. There are a number of papers describing how rapamycin
affects proteins associated with cell cycle control. However, the connection between the
FRAP pathway and its ultimate downstream targets remains unclear. In yeast cells,
rapamycin causes the upregulation of survival genes and starvation genes, and the
down regulation of glucose and amino acid transport genes (Schreiber 1999). The effect
of rapamycin on mRNA translation appears to have a global impact on cellular
physiology. Some of the impacts, such as on cell cycle progression, are well
characterized; others, such as on metabolism and apoptosis, are still being elucidated.
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Figure 4-8. Interaction of rapamycin with the FRAP signaling pathway
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4.5.2 Cell Cycle Arrest
One well-established phenomenon downstream of the FRAP pathway and rapamycin's
primary effect is the arrestment of cells in the G1 phase of the cell cycle. Measurement
of cell cycle distributions for my hybridoma confirms that the arresting agent inhibits
entry to the cell cycle, even with defective c-myc regulation. A recent literature report
confirms rapamycin's direct action on cell cycle control (Hashemolhosseini, Nagamine
et al. 1998). It claims that rapamycin destabilizes cyclin D1 mRNA (cyclin D1 is
associated with the latter part of the G1 phase of the cell cycle) and also accelerates the
degradation of cyclin D1. Both these effects lead to an extension of residence in the G1-
phase by inhibiting the accumulation of cyclin D1, and hence the cyclin D1-cdk complex
needed to activate additional cellular processes. Rapamycin's ability to inhibit cell cycle
entry in my hybridoma cell line agrees with the findings regarding cyclin D1. Rapamycin
can successfully inhibit cell cycle entry despite the c-myc deregulation because c-myc
expression precedes that of cyclin D1.
The effect of rapamycin on delaying passage through the G1-phase of the cell cycle
agrees with the extent of reduction of the apparent growth rate for the hybridoma cells.
For example, looking at the data for fed-batches on their second day (shown above), a
control culture exhibits a growth rate equal to 0.0475 hr' and spends approximately 3.1
hr (the G1-phase progression time) of its 14.6 hr doubling time in G1. The rapamycin
culture, on the other hand, exhibits a growth rate of 0.0425 hr1 and spends 4.8 hr in G1.
Holding progression times for S-phase and G2/M as being equal (by calculation, S is an
hour longer and G2/M an hour shorter for rapamycin, differences which cancel here),
the increase in the G1-phase residence time from 3.1 hr to 4.8 hr should increase the
overall doubling time from 14.6 to 16.3 hr. Indeed, 16.3 hr corresponds exactly to the
growth rate of 0.0425 hr'. Thus, it is reasonable that rapamycin's effect on cell cycle
progression is the cause for the observed reduction in growth rate for rapamycin
cultures, at least when comparing fast growing, high viability cultures.
It is interesting that both the control and rapamycin fed-batch cultures exhibit the same
symptoms of growth arrest and increases in progression times for all phases of the cell
cycle. The increase in G1 progression for both cultures is in fact greater than the 1.7-
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hour increase for the rapamycin culture during viable proliferation. The cause for this
phenomenon in fed-batches is unknown. Yet, in the following chapter, the same
phenomenon will be observed upon the removal of insulin from steady state
chemostats, depending on the environment and metabolic state of the cells. Thus, in
these cultures, it appears that the trend for fed-batches is one of decreasing metabolic
capacity as time passes. The metabolic challenge may be reflected in the uniform
extension of progression through the cell cycle and the emergence of cell death.
4.5.3 Rapamycin Delays Apoptotic Cell Death
The major finding in this work is that another one of rapamycin's effects is the reduction
of apoptotic cell death for hybridoma cultures. I believe this to be a novel finding
because literature regarding rapamycin does not mention such an anti-apoptotic effect
for rapamycin. Yet attributing the delay of apoptosis solely on cell cycle phenomenon
(rapamycin's well-known effect) may not be entirely justified. There is preliminary
evidence (see next section) to show that metabolism is also affected, being shifted
towards more efficient consumption of glucose. From the chemostat work and
subsequent fed-batches performed by Brian Follstad, an increase in metabolic
efficiency can be associated with increases in viable cell density and sustained viability
during fed-batches. Thus, a complete explanation for the effect of rapamycin must
address both cell cycle and metabolism as playing a role in reducing apoptosis. As for
other survival factors such as insulin and Bcl-2, metabolism, cell cycle, and apoptosis
are intimately related and affected by changes in one another. The certainty here is that
rapamycin's effect on cell physiology has a protective effect against apoptotic cell death
during batch cultivation.
The evidence presented here is insufficient to determine how the altering of a cell's
protein profile by inhibiting FRAP signaling leads to reducing cell death. With FRAP
inhibition leading to changes in mRNA translation and ribosome function, it could be
changes in one or many proteins that could be responsible for suppressing apoptosis.
Changes to cell cycle control proteins have been reported, and help explain the delay in
G1. Even still, a mere delay cannot fully explain the reduction in cell death. If it is the
delay that really helps the cells, I believe other changes beyond those for cell cycle
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control proteins must occur during the delay that serve to protect the cells later in the
cycle. This is the essence for my hypothesis for the relationship between cell cycle entry
and apoptosis: by aiming to slow down entry to the cell cycle, I implicitly agreed that
extended time in G1 confers better survivability for cycling cells. The delay in
progression may allow for (more complete) production of additional protein factors that
enhance survival. If so, the identification and control of such protein factors would be an
ideal goal for genetic manipulation.
In trying to understand rapamycin's anti-death activity, it may be beneficial to consider
the similar, though less dramatic, effects that sodium butyrate and olomoucine also had
on G1-arrest and reduction of apoptosis for this hybridoma cell line during preliminary
experiments. Sodium butyrate inhibits histone deacetylation, leading to cycle arrest in
G1 and G2 (Hung, Jamison et al. 1996). Olomoucine also leads to G1 and G2 arrests
through its inhibition of CDK activity (Hung, Jamison et al. 1996). That these substances
exclusively effect cell cycle related phenomena and yet also influence the emergence of
cell death, could further support the effect of delayed cell cycle progression on reducing
apoptosis. At the same time, such evidence (given that sodium butyrate and olomoucine
are not as effective for preventing cell death) could also be used to support a hypothesis
that rapamycin may act on other cellular functions (such as metabolism) to minimize cell
death.
4.5.4 Metabolism of Rapamycin Cultures
While there is very good evidence for the relationship between cell cycle progression
and apoptosis, it is nonetheless important to consider other observed differences in
culture physiology. Culture metabolism is also known to change in conjunction with the
emergence of cell death (Chapter 3). During rapamycin experiments, differences in
metabolism were visibly observable in the differences in the color of conditioned culture
medium of control and rapamycin flasks. The rapamycin culture medium looked
noticeable redder in color versus the control culture medium that was more orange-
yellow (culture medium contains phenol red as a pH indicator). The significance of this
observation is that the metabolism of rapamycin cultures (at least in terms of producing
lactic acid and ammonia, which affect the pH) is apparently different from the controls
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since they both were reaching similar total cell densities though producing different
quantities of acids and bases. This observation is supported by lactate and ammonia
measurements for some of the rapamycin experiments. Furthermore, the measurement
of glucose consumption indicates that central carbon metabolism may be shifted as
well. Cultures with rapamycin present have lesser specific uptake rates for glucose than
that measured for control T-flasks and reactor cultures. Furthermore, the measured
Lactate/Glucose ratios for rapamycin cultures are lower than their control counterparts,
the exception being the rapamycin culture with the smallest sGUR. (Figure 4-9a)
Lesser glucose uptake rates and lesser production of lactate point to a metabolism that
is more efficiently shuttling glucose carbon to the TCA cycle. This shift in metabolism of
glucose and production of lactate is similar to those shifts in metabolism that have
already been observed as being associated with enhanced viability of cell cultures.
Based on early chemostat data with CHO cells, we saw how glucose limited cultures
metabolize more carbon through the TCA cycle, hence operating more "efficiently"
(Nyberg, Balcarcel et al. 1999). Brian Follstad and I also observed a "more efficient"
metabolism in glutamine-limited hybridoma chemostats (Chapter 3, (Follstad, Balcarcel
et al. 1999)) Cultures with a metabolism relying more on TCA cycle than glycolysis help
explain the multiple steady states with higher viable cell densities that were observed at
same dilution rates. Dr. Anna Sanfeliu observed that her CHO cells grew slower under
glutamine-limited conditions (they produce glutamine from glutamate using Glutamine
Synthetase), yet they exhibited more robust behavior under sub-optimal conditions
(Sanfeliu and Stephanopoulos 1999). Finally, I have now shown that the hybridoma
cells grow more robustly when their growth rate is somewhat inhibited by rapamycin. A
personal communication with Dr. Sabatini of the Whitehead Institute provides additional
support for rapamycin's effect on metabolism (Sabatini 1999). During our discussion
Sabatini mentioned that rapamycin effects are drastically reduced when a cell line is
transfected with an ecotrophic receptor, which is used to make a cell line infectable to
retroviral vectors. He said he believed that rapamycin was causing the cells to mimic
amino acid limitation behavior, and that the ecotrophic receptor, which is actually a
leucine transporter, might be alleviating the "amino acid limitation" imposed by
rapamycin. His observations are in line with my own observations regarding the kind of
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shift in metabolism that occurs in my hybridoma cultures in the presence of rapamycin,
as well as those of Schreiber (Peterson, Desai et al. 1999; Schreiber 1999).
Thus, already knowing that metabolic phenomena are also associated with cell death
(from Chapter 3 and Chapter 5), I cannot discount the possible connection between
rapamycin's effects on metabolism and cell death. The possible enhancement of
metabolic capacity may explain why rapamycin cultures outlive the control cultures
during fed-batches where both exhibit growth inhibition and uniform cycle arrest.
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4.5.5 Beyond Hybridomas
The beneficial effects of rapamycin are strongly associated with controlling cell cycle
entry. Understandably, this is an especially important effect for the hybridoma cell line
that exhibits defective cell cycle entry. Possible applications of rapamycin for other cell
lines, such as Chinese Hamster Ovary cell lines, which retain proper cell cycle control,
are not futile, however. The growth stimulation of these cell lines by growth factors
within serum or by insulin essentially stimulate cells to enter the cell cycle, even under
conditions that could be sub-optimal. It already being demonstrated that such entry in
and of itself is not sufficient for viable proliferation, it may be possible for rapamycin to
provide a beneficial inhibition of cell cycle entry for cell lines which are being externally
signaled to enter the cell cycle. Preliminary evidence with CHO cells within the
Stephanopoulos group indicates rapamycin's possible anti-apoptosis effect, though it is
harder to observe due to the greater degree of growth arrest that occurs.
4.6 CONCLUSIONS
The cell cycle arresting agent rapamycin is observed to have beneficial effects on
hybridoma culture. At the optimum concentration of 50-100 nM, rapamycin mildly
inhibits cell cycle entry resulting in a mild reduction in growth rate. In addition to
changes in growth rate, cell cycle distribution, and metabolism, rapamycin also
postpones the emergence of apoptotic cell death for one day, and reduces its extent
thereafter. As a result, hybridoma cells grow with higher viability over the course of
batch and fed-batch cultures, reaching higher peak viable cell densities and achieving
greater integrated viable cell densities. Such improvements in cell density result in the
doubling of monoclonal antibody product titer. The increase in productivity results from
the higher IVCD's, as well as the greater apparent specific productivity for hybridoma
cultures with a higher percent of cells in the G1-phase of the cell cycle.
Rapamycin's effect on culture physiology is partially understood in the context of its
inhibition of the FRAP protein signaling pathway and the regulation of mRNA translation
and ribosome function. Such effects are known to be associated with altering cell cycle
control proteins, such as cyclins and cdk's. The link between rapamycin and the anti-
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apoptosis effect observed in this work remains unclear. The complexity of the
connection is due to the changes in growth rate, cell cycle distribution, and metabolism
that occur simultaneously with apoptotic cell death.
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5 THE PROTECTIVE EFFECT OF INSULIN ON THE
VIABILITY OF HYBRIDOMA CELL CULTURES
5.1 ABSTRACT
Accumulated experience with the growth of the hybridoma cell line in serum free media
with and without insulin points to the presence of other, as of yet undetermined,
environmental factors which play a role in the proliferation and apoptosis of the
hybridoma cells. Insulin, the only growth factor added to our serum-free medium, plays
a dual role as a growth factor and also as protective factor against cell death.
Nevertheless, it is found that cells can sometimes grow viably without insulin, albeit at a
reduced growth rate, as long as the cells are passaged daily and the cell density
remains low. At higher cell densities and with less frequent passaging, insulin is
necessary to extend viable proliferation.
In the course of a long term study of the role of insulin for steady state hybridoma
growth, we observed that cells were able to survive for many residence times despite
complete insulin withdrawal in three of five insulin-free chemostat cultures. Two steady
state cultures, one at a high (D=0.04 hr 1) and another at a low (D=0.02 hr 1) dilution
rate, each exhibited metabolic changes, cell cycle arrest, and apoptotic cell death within
10 residence times (10-20 days) after removing insulin from the feed medium. However,
sustained cell growth was observed in three chemostat cultures run at an intermediate
dilution rate (D=0.03 hr-) for an additional 10 to 30 residence times beyond insulin
withdrawal. The physiology of these cultures, in terms of cell density, growth and death
rates, and metabolism, remained the same despite the absence of insulin.
These differing responses to the withdrawal of insulin were further investigated in batch
experiments using (1) cells obtained from an insulin-free chemostat culture and (2)
chemostat-conditioned medium from an insulin-free chemostat; each collected at the
end of an insulin-free chemostat culture that survived without insulin. We observed that
the chemostat cells grew significantly slower and began dying after 24 hours when
cultivated in batches without insulin, hence reproducing the previously seen behavior of
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stock cells. Yet, at the same time, we observed how batch cultures (of both chemostat
cells and fresh stock cells) proliferated relatively faster and with high viability for two full
days despite the lack of insulin when they were inoculated using 30% of chemostat-
conditioned medium. Thus, it appears that the seemingly anomalous behavior of
hybridoma cells in insulin-free chemostats is the result of differences in their
environment rather than changes in the nature of the cells. The environment that allows
for the proliferation of cells in the absence of insulin is observed to possess unknown
factors that stimulate growth and lack unknown factors that stimulate death.
5.2 INTRODUCTION
In order to improve cell culture processes, be it by designing better a medium, choosing
targets for genetic manipulation, or creating new cell lines, we need to understand the
factors which affect the ability of cells to proliferate viably. One highly investigated and
employed factor is insulin. Insulin has a positive effect on viable proliferation, through its
known stimulation of the map kinase cascade and its various endpoints.
The adaptation of the hybridoma cell line to serum-free medium demonstrated the
positive effects that insulin has on hybridoma growth rate and death rate. Chung, et. al.
showed that insulin allowed the viable proliferation of the hybridoma following serum
withdrawal (Chung, Sinskey et al. 1998). Cells given insulin grew faster and lived
longer, with high viability up through two days. It is well known that insulin acts in a
variety ways through signal transduction pathways to support metabolism and cell cycle
function. From the chemostat experiments of Chapter 3, however, I know that insulin
does not play a role in entry to the cell cycle: the c-Myc overexpression essentially
short-circuits the effect of insulin in this regard. Nonetheless, insulin remains a
necessary media component. It has a positive effect on cell physiology that allows
cultures to proliferate faster and for longer times with high viability. Thus, in addition to
being a "growth factor", insulin serves as a survival factor that protect cells from
apoptotic cell death. The primary goal of this work is to better understand how insulin
protects cells from apoptotic cell death.
128
While insulin has been shown to be very beneficial for growth of cultures, it has also at
the same time, been implicated in stimulating cell death under suboptimal culture
conditions. Sanfeliu, et. al., showed how serum-arrested CHO cells could be stimulated
by insulin to grow viably for a few days, but that such stimulation by insulin eventually
led to apoptotic cell death (Sanfeliu, Chung et al. 1999 in press). This behavior
contrasted the behavior of cells grown with serum, which grew viably and then arrested
viably once again when a limitation arose. Thus, though insulin is a very effective and
necessary factor for promoting proliferation, by itself it cannot completely protect cells
against cell death, and may even exacerbate cell death by "over-stimulating" entry to
the cell cycle. Taking both Chung's and Sanfeliu's findings together, it appears that c-
Myc stimulation and cell cycle entry is the real culprit for cell death, and that insulin
confers some protection for cycling cells.
Understanding the key role insulin has in cell culture engineering technology, it was
quite shocking to learn that insulin degrades very rapidly in batches, fed-batches, and
chemostats. Work by Goswami verified that insulin was dramatically degraded during
fed-batches of CHO cells (Goswami 1998). This was alarming in light of the reduction in
glucose uptake and the cell cycle arrest in G1 (physiological parameters associated with
insulin stimulation) that were observed to occur along with the emergence of cell death
and insulin depletion. The degradation of insulin was attributed to proteases that are
present in conditioned medium from CHO cell cultures. Goswami found that glycocholic
acid, an amino peptidase inhibitor that prevents degradation from the N-terminus, was
successful in minimizing the degradation of insulin in cell-free conditioned medium. The
high degradation rate of insulin in cultures is also observed for hybridoma cells grown in
batches, fed-batches, and steady state chemostats. From insulin measurements taken
in chemostat cultures, the insulin degradation rate is observed to be a complex function
of cell density, dilution rate, and insulin feed concentration (it is not simple first order
decay). Despite the observed 50-fold reduction in insulin concentration from the feed
medium to the reactor medium (100,000 mU/L down to approx. 2000 mU/L), the
residual insulin concentration is apparently sufficient to maintain the steady states.
I investigated the use of glycocholic acid in conjunction with insulin feeding to maintain
higher residual insulin concentrations during fed-batches of hybridoma cells. Though the
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insulin feeding strategies were successful in keeping insulin levels higher than that of
the control, the presence of additional insulin is shown not to influence the emergence
of cell death. Thus, insulin is necessary to reach higher viable cell densities, but it is not
sufficient to prevent the emergence of cell death.
To better understand insulin's role in protecting cells against apoptotic cell death, I
investigated the effect of insulin withdrawal from hybridoma steady states containing
insulin (100,OOOmU/L = 10 mg/L) by switching to an insulin-free feed. The physiology of
the cultures was measured daily for at least 10 to 15 residence times (15 to 30 days), as
insulin washed out exponentially. Initially, the goal of such experiments was to
document the changes in metabolism, intracellular fluxes, and cell cycle distribution that
occurred along with the emergence of cell death that was expected. While two
experiments provided cultures which exhibited changes in metabolic and cell cycle
distribution that were associated with apoptotic cell death, three of the experiments did
not exhibit any observable physiological changes at all, even for many residence times
beyond complete depletion of insulin. Thus, the goal shifted from studying the
physiological changes associated with cell death due to insulin depletion, to probing the
apparent lack of need for insulin altogether that was exhibited by the majority of the
experiments.
Toward this new objective, I re-visited the role of insulin during batch cultivation. A
series of batch experiments were performed to compare the insulin-dependent behavior
of fresh stock celIs and cells taken from the insulin-free reactors. Both types of cells
behaved similarly, being able to grow viably without insulin when passaged daily and
kept at low cell density, and needing insulin to proliferate viably to higher cell density
during 2 days in batches. The major finding came from growing either type of cells in
medium containing either 30% regular conditioned medium (from the inoculum) or 30%
conditioned medium from the insulin-free reactors. Cells placed in the former and
without insulin could only grow viably for 24 hours (normal behavior), but the cells grown
with the chemostat-conditioned medium and without insulin grew viably for 48 hours,
slower in growth than the insulin(+) case, but with high viability. Altogether, the evidence
presented herein will show that the emergence of cell death for the hybridomas is
dependent on the as of yet undetermined factors present in conditioned medium. Insulin
130
protects cells against cell death in more highly conditioned environments, but insulin is
not necessary for survival when the environment is not as conditioned.
5.3 MATERIALS AND METHODS
5.3.1 Cell Line and Culture Medium
The cell line used was a murine hybridoma (ATCC CRL-1 606), described in Chapter 3,
and maintained in a similar manner. Inocula were passaged daily by subculturing the
approximately 7.5e5 cell/ml cultures down to 2.5e5 cell/ml. The hybridomas were grown
in glutamine-free IMDM basal medium, as described in Chapter 3. For some fed-
batches, glycocholic acid was added to cultures at a concentration of 2.0 mM to
minimize insulin degradation. Glycocholic acid (Sigma, #G7132) stock was prepared in
MilliQ water at a concentration of 150 mg/mL and stored at 40C.
5.3.2 T-Flask Batch and Fed-Batch Experiments
Batch and fed-batch experiments were conducted in the same manner as described in
Chapter 4. Daily feeding of supplemental medium and insulin stock during fed-batches
was accomplished as described in Chapter 4.
5.3.3 Bioreactor Operation
Five separate insulin-withdrawal experiments from steady state chemostat cultures
were obtained using 2-liter and 3-liter Applikon reactors (Foster City, CA), at working
volumes of 1.2 and 1.5 liters. The chemostats were run in the same manner described
in Chapter 3, scaling liquid and gas flows accordingly for the different working volumes.
Agitation for the 3-liter reactor was set at 175 rpm. Each experiment was inoculated at a
density of 2e5 to 3e5 cell/ml from an inoculum culture at a density of approximately 8e5
cell/mi with high viability.
Insulin withdrawal was performed holding the dilution rate fixed. Experiments were
performed at the following dilution rates (and in the given order): 0.04 hr 1, 0.02 hr',
0.03 hr 1, and two simultaneously at 0.03 hr'. The first and the last 0.03 hr-1
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experiments were eventually shifted to dilution rates of 0.02 hr-1 and 0.04 hr-1, but only
after insulin was fully depleted. The last three runs were inoculated with 2.0-mM
glutamine in the batch reactor, without any detrimental effects, to facilitate startup and
the reaching of a first steady state. The last two runs were also immediately started with
lower insulin concentration in the feed medium (5100 and 510 mU/L respectively) to
expedite the insulin washout, and, furthermore, insulin was reduced stepwise, rather
than all at once.
5.3.4 Analytical Methods
5.3.4.1 Cell Number, Viability, and Apoptosis
Cell number and viability were determined by cell counts using a hemacytometer with
trypan blue dye exclusion. One to two slides were counted for batch and fed-batch
cultures. Three slides were counted for bioreactor cultures.
For bioreactor cultures, the extent of apoptosis was determined by the acridine orange /
ethidium bromide (AO/EB) assay using a hemacytometer (Mercille and Massie 1994).
Apoptosis cell counts consisted of counting 200 cells for 6 separate hemacytometer
chambers, for a total of 1200 cells. Such cell counts were used to calculate the
observed percentage of cells that were viable, apoptotic (early and late), or necrotic.
The cell death in batches and fed-batches was presumed to be due to apoptosis given
the overwhelming evidence and experience that apoptosis is the dominant mode of
death under the ,conditions studied. This assumption was periodically verified by an
AO/EB count.
5.3.4.2 Metabolite Concentrations
Samples for metabolite concentration analysis were taken and stored as discussed in
Chapter 3. Full metabolite analysis was performed for the first three insulin-withdrawal
experiments. Analysis of samples from batch, fed-batch, and the last two insulin-
withdrawal experiments consisted of glucose (Sigma protocol 16-UV), lactate (Sigma
protocol 826-UV), and ammonia (Sigma protocol 171-UV) assays, as needed.
5.3.4.3 Calculation of Specific Uptake and Production Rates
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The steady state metabolic production or uptake rates were determined for bioreactor
experiments as described in Chapter 3:
Metabolic production or uptake rates for batches, fed-batches, and dynamic chemostats
were determined as described in Chapter 4.
5.3.4.4 Oxygen Uptake Rate
During bioreactor experiments, the oxygen uptake rate (OUR) was obtained as
described in Chapter 3.
5.3.4.5 Cell Cycle Distribution
Cell cycle distribution was determined by the method described in Chapter 3. Single
measurements were performed for batch and fed-batch experiments, whereas
bioreactor measurements were performed in duplicate.
5.4 RESULTS
5.4.1 Insulin Degradation
Accepting the presence of insulin as a necessary prerequisite for extending viable
proliferation in the hybridoma cell line, I investigated daily feeding of insulin as well as
the addition of glycocholic acid, a protease inhibitor, to help combat the near complete
degradation of insulin observed during batch and fed-batch experiments. Goswami
determined glycocholic acid (10 mM) to be the protease inhibitor that best minimized
insulin degradation in highly conditioned, cell-free medium samples at 37 0C for 10 hours
(Goswami 1998). To make use of this finding for my batches and fed-batches, I needed
to determine if glycocholic acid minimized insulin degradation for hybridoma-conditioned
medium and at what concentration glycocholic acid could be used without being toxic to
a growing hybridoma culture.
Both these questions were answered in a series of five hybridoma batches given 0 mM
(control), 0.3 mM, 1.0 mM, 3.0 mM, or 10.0 mM glycocholic acid [hereafter abbreviated
as GA]. Starting with 100,000-mU/L insulin, it is evident that glycocholic acid minimized
degradation over the 40 hours observed (Figure 5-1). The protection against insulin
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degradation appears to linear with respect to the log concentration of glycocholic acid.
The culture without any GA showed about 75% degradation, whereas the culture with
10.0-mM GA showed only 23%. In terms of toxicity however, it appears that the culture
with 10.0 mM was severely inhibited by the presence of GA at that concentration: cells
did not grow and were even found to be fewer in number than had been inoculated.
Cells at lower concentrations of GA faired better, exhibiting normal growth with high
viability. Thus, the optimum level of GA for hybridoma cultures was determined to be 2.0
mM, where cell growth was not apparently impacted and insulin degradation was
reduced to 40% vs. 75% for the control over a forty-hour period.
134
Glycocholic Toxicity Test - 40 hr
2.OE+06
1.5E+06
1.OE+06
5.OE+05U
O.OE+OQ
mTotal Cells
Viable Cells -
-+-Insulin Level
Control 0.3 mM 1 mM 3 mM 10 mM
Sample
Figure 5-1.
degradation.
Effect of glycocholic acid on hybridoma proliferation and insulin
135
9E+4
8E+4
7E+4
6E+4
5E+4
4E+4 3
C
3E+4 2
2E+4
1E+4
OE+O
The impact of insulin feeding and glycocholic addition on the emergence of cell death
was investigated in a series of three fed-batch hybridoma cultivations. All three
experiments were begun with the full amount of insulin (100,000 mU/L). The control did
not receive any more insulin or any GA. The second culture was re-fed another full
amount of insulin daily beginning on the second day. The third culture was also re-fed
insulin in the same manner as the second culture, but was also given a one time shot of
2.0 mM GA at the beginning.
In terms of cell densities, the three cultures behave nearly identically for the first two
days, each growing quickly and with high viability (Figure 5-2 a). The plot of insulin
concentration shows that the amount of insulin left after 48 hours (before any insulin is
re-fed) is roughly 18,000-19,000 mU/L for the control and the "insulin-fed" culture, and
about 28,000 mU/L for the culture with GA (Figure 5-2 b). Yet after the second day, and
despite feeding insulin to the "insulin" and "GA" cultures, death emerges within all the
cultures, although at varying degrees. On the third day, insulin concentration is 3000
mU/L for the control, and greater than 20,000 for both the "Insulin" and the "GA"
cultures. Thus, it appears that the higher insulin levels between day two and three do
not prevent the emergence of cell death for the hybridoma cells. The control and the
"insulin" culture behave very similarly, and ironically, due to normal variation or for
unknown reasons, the "GA" culture expresses the most death. Furthermore, as is
evident in the chemostat experiments, insulin levels of the order of 2000 are sufficient
for steady state growth. Thus, the emergence of cell death in these experiments must
be attributed to other factors besides insulin concentration. Insulin is necessary for
viable proliferation up through approx. 50 hours (see following sections), yet its
presence does not protect the culture from death beyond 50 hours.
136
Comparison of
+ Control - Total
+ Control - Viable
+ Insulin - Total
-0- Insulin - Viable
Glyc Aci
Glyc Aci
Insulin Strategies
2.5E+06
2.OE+06
1.5E+06
1.OE+06
5.OE+05
0.OE+00
1 2 3 4
Time (days)
E
75
Insulin Concentration
Control
insulin
Glyc + Ins
50000
40000
30000
20000
10000
0
43210
Time (day)
Figure 5-2 ab. Effect of insulin concentration on the emergence of cell death.
Note: values for insulin concentration for "Insulin" and "Glyc + Ins" on day three were above
detection limit - they are greater than 20,000 mU/L on that day.
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5.4.2 Withdrawal of Insulin from Steady State Chemostat Cultures
To investigate the role that insulin plays as a growth factor and a protective factor, I
measured the physiology of continuous hybridoma cultures after switching to an insulin-
free feed medium. A total of five such experiments were conducted, at dilution rates of
0.04 hr 1, 0.02 hr 1 , and 0.03 hr- in triplicate. The physiology of each culture was
measured in terms of cell density, degree of apoptosis, cell cycle distribution, and in
some cases, metabolism for glucose and glutamine, production of lactate, and uptake of
oxygen.
Two of the five steady states cultures were unable to continue proliferating upon
removal of insulin (Figure 5-3 a b). The high dilution culture (performed first) exhibited
cell cycle arrest, apoptotic cell death, and a shift in metabolism within 10 residence
times (10 days) of removing insulin from the feed. The low dilution rate culture
(performed second) likewise exhibited its dependence on insulin within 10-15 residence
times (20-30 days) after removing insulin from the feed. The next culture, however, run
at D=0.03 hr 1 (#1), survived unchanged for 20 residence times. An additional two insulin
withdrawal experiments were conducted at D=0.03 hr 1, this time starting out with lower
insulin feed concentrations and lowering insulin in steps. Both such experiments
reproduced the previous behavior seen for D=0.03 hr', this time surviving for greater
than 20 residence times without insulin. The dilution rate for the experiment at D=0.03
hr 1 (#3) was eventually increased to D=0.04 hr 1 without detriment to the culture.
Plots of viable, apoptotic, and necrotic cells determined from the acridine
orange/ethidium bromide assay show that the two cultures that exhibited physiological
changes died by apoptosis (Figure 5-4 a b c). The emergence of apoptosis coincides
with the decline of viable cell density, which begins at day 9 for D=0.04 and day 21 for
D=0.02. The three experiments that survived insulin withdrawal do not show any
changes with respect to apoptosis. Experiment D=0.03 #3 showed lesser apoptosis
when its dilution rate was increased to 0.04, a normal response.
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Figure 5-3 a,b. Viable cell density and residual insulin concentration
withdrawal of insulin from steady state hybridoma chemostats.
during the
Insulin feed concentration was switched from 100,000 mU/L to zero in one step for D=0.04,
D=0.02, and D=0.03 #1 at day 0. Insulin feed for D=0.03 #2 was started at the lower level of
5100 mU/L, and was reduced 2100, then 42, and finally zero. Insulin feed concentration for
D=0.03 #3 was initially 510 mU/L and was reduced to 51 and then zero.
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Figure 5-4 abc. Viable, apoptotic, and necrotic cell populations during
Figure 5-4 a,b,c. Viable, apoptotic, and necrotic cell populations during
withdrawal of insulin from steady state hybridoma chemostats.
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The dominant change in cell cycle distribution that is associated with the growth arrest
and apoptosis seen in experiments at D=0.04 and D=0.02 is an arrest in the G2/M-
phase of the cell cycle (Figure 5-5 a b c). The beginning of arrest coincides with
apoptosis and occurs at insulin levels of 10 mU/L for D=0.04 and 2-3 mU/L for D=0.02.
Both of these cultures also exhibit mild arrestment in the Gi-phase. The other
experiments show no such changes in cell cycle distribution.
In terms of cell cycle progression times (Figure 5-6 a b), both of the experiments that
failed to maintain their steady state show increases in the progression times for G1 and
G2/M. These increases in cell cycle progression upon insulin withdrawal are
reminiscent to those seen during fed-batch cultures (Chapter 4). Compared to the
relative changes in the other progression times, the S-phase does not appear to be as
affected, only increasing 50% for the experiment at D=0.04 and actually decreasing for
the experiment at D=0.02. Changes in progression times for the experiment at D=0.04
start close to the same time that cell density begins to fall and death emerges. However,
for the experiment of D=0.02, it is evident that the increases in G1 and G2/M
progression times begin much earlier. Progression times for G1 and G2/M are initially
4.3 and 4.8 at for the insulin(+) steady state (day zero) (data not shown), but steadily
increase to 6.6 and 5.7 by day 18 (shown below), three days prior to culture arrest and
cell death. Then they increase further thereafter.
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Figure 5-5 a,b,c. Cell cycle distributions among G1, S, and G2/M during the
withdrawal of insulin from steady state hybridoma chemostats.
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Figure 5-6 a,b. Cell cycle progression times during the withdrawal of insulin from
steady state hybridoma chemostats.
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Changes in metabolism only occur for the two cultures that eventually died without
insulin. Both cultures show increases in glucose uptake and lactate production as
insulin washes away (Figure 5-7 a b c). These shifts appear to coincide with the other
physiological changes. Changes in glutamine uptake and oxygen uptake also occur, yet
apparently beginning up to 5-10 days prior to the changes in cell density, apoptosis, and
cell cycle distribution (which begin to occur at day 9 for D=0.04 and day 21 for D=0.02)
(Figure 5-8 a b). Inferences about the role of insulin in metabolism are to be made with
caution. Not only are the cells dying (which has been seen to be associated with an
increase in TCA cycle activity) but the viable cell number is also declining, and hence
the residual nutritional supply is increasing and therefore relaxing the nutrient limitation.
Still, the trends observed for metabolism are reasonable. For D=0.04, we see a slight
increase in glutamine and oxygen consumption prior to cell death, which may perhaps
reflect cells' response to the loss of metabolic support from insulin (i.e. less efficiency
without insulin). For D=0.02 I observe the reverse trend - glutamine and oxygen
consumption drop slightly prior to cell death. Here, for cells already in a much more
constrained environment (and hence presumably already depending on more oxidative
phosphorylation), the loss of insulin perhaps limits the cells' ability to consume
glutamine and oxygen for energy. For both experiments, glutamine uptake and oxygen
consumption appear to increase once death begins and nutrients become more
available as the result of declining cell density. Distinct from the two chemostats that
could not survive, metabolism for D=0.03 #1 remains steady, as did the rest of its
physiology. Metabolism was not measured for D=0.03 #2 and D=0.03 #3.
Thus, continuous cultures at dilution rates of 0.04 hr-1 and 0.02 hr-1 were unable to
maintain their steady states due to metabolic changes and cell cycle arrest. The enigma
surrounding the insulin-free chemostat cultures is that those grown at an intermediate
dilution rate (D=0.03 hr-1) were able to survive for many residence times beyond the
point at which insulin was completely washed away.
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Note: The final data points of each series are less reliable due to the transient nature of the
culture and the decreasing viable cell number.
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of insulin from steady state hybridoma chemostats.
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Figure 5-8 a,b. Glutamine uptake and oxygen consumption during the withdrawal
of insulin from steady state hybridoma chemostats.
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5.4.3 Insulin(-) Chemostat Cells
To further investigate the ability of cells to grow viably in the absence of insulin, cells
frozen from the end of chemostat experiments D=0.03 #2 and D=0.03 #3 were
defrosted and passaged daily in 100% fresh insulin(-) medium and 100% fresh
insulin(+) medium. The goal of such experiments was to see if the cells were
permanently adapted to an insulin-free medium. For simplicity, results are only
presented for chemostat cells from D=0.03 #2 - chemostat cells from D=0.03 #3
behaved similarly during all the experiments. As controls, a fresh stock of cells were
also defrosted and passaged daily in the same insulin(-) and insulin(+) media.
As shown below, both the chemostat cells and the fresh stock cells could be defrosted
and passaged to high viability regardless of the presence of insulin (Figure 5-9 a b).
Insulin(+) cultures grew faster than the insulin(-) ones, but both types of culture reached
greater than 90% viability after several days.
Having essentially obtained healthy insulin-free inocula, the chemostat cells and the
fresh stock cells were seeded into insulin-free batches and allowed to grow for 48 hours
(Figure 5-10). Each culture was seeded at 2.0e5 viable cells/ml using roughly 30% of its
own conditioned medium (lightly conditioned for 24 hours at an average viable cell
density of 4-5e5 cell/ml). Again both cultures performed well despite the absence of
insulin. The chemostat cells and the stock cells without insulin grew more slowly than
the insulin(+) control, yet they maintained high viability for 48 hours. Such viable growth
of the stock cells was thus far an apparent contradiction to the earlier work that showed
cells dying within 48 hours (Chung, Sinskey et al. 1998).
The contradiction was resolved when I repeated the batch experiments, this time using
more highly conditioned medium for the inoculation of the flasks. The more highly
conditioned medium used was that from the insulin-positive control of the previous
experiment, which had supported cell densities up to 1.4 x 106 cell/ml (it was
conditioned for 48 hours by an average of 8e5 cell/ml). Each new experiment was
seeded into 30% of more highly conditioned medium and either 70% insulin(-) fresh
medium or insulin(+) fresh medium. It was now that I observed that the chemostat cells
still required insulin for viable proliferation up through 50 hours in batches (Figure 5-11 a
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b). Moreover, the same behavior was observed for the stock cells seeded under similar
conditions. Stock and chemostat cells grew at quite different rates, but their
dependence on insulin was shared.
Overall, the dependence on insulin for viable proliferation was apparent only in an
environment that contained more highly conditioned medium. These batch experiments
demonstrate that it was the chemostat environment that was dictating the behavior of
the cells, and not any permanent changes in gene expression or protein control
networks of the cells themselves.
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Figure 5-9 a,b. Passaging of Insulin(-) Chemostat cells and fresh stock cells in
insulin(-) and insulin(+) medium.
149
Figure 5-10.
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Figure 5-11 a,b. Insulin(+/-) batch cultures of insulin(-)-chemostat cells and fresh
stock cells
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5.4.4 Insulin(-) Chemostat-Conditioned Medium
I next investigated the effect of chemostat-conditioned medium that was stored as cell-
free supernatant from the end of the D=0.03 #2 experiment. This special conditioned
medium was used to seed a batch of fresh stock cells. Fresh stock cells, which were
cultivated in insulin(+) medium, were seeded into insulin(-) medium, using either 300/9 of
regular conditioned medium (from the inoculum) or 30% of chemostat-conditioned
medium. Cells were also seeded into insulin(+) medium with regular conditioned
medium for the control. The cells with regular conditioned medium grew slower and died
earlier than the insulin positive control (Figure 5-12 a b). Interestingly, the stock cells
with chemostat-conditioned medium, though growing a little slower than the control,
proliferated with high viability for two days, and then even outperformed the control on
the last day in terms of viable cell density.
To see if the robustness of the cells grown in the special chemostat-conditioned
medium was due to the absence or presence of unidentified conditioned medium
factors, stock cells were also grown with or without regular conditioned medium.
Cultures containing insulin grew quickly and viably for 48 hours regardless of the type or
the absence of conditioned medium (data not shown). Growth and death for cultures
without insulin did depend on the conditioned medium used (Figure 5-13 a b). Cells
seeded into insulin-free medium consisting of 30% regular conditioned medium faired
the worst, while cells seeded into insulin-free medium consisting of 30% chemostat
conditioned medium faired the best. Cells seed into 100% fresh medium grew the
slowest yet with an intermediate viability.
These experiments indicate that the chemostat-conditioned medium (which is insulin-
free) contains, at the very least, one unknown factor that supports growth, and possibly
lacks another unknown factor that stimulates death. The unknown growth factor may be
an autocrine factor. Indeed interleukin-6 can enhance viability of Sp2/0 hybridoma cells
(Chung, Zabel et al. 1997), as well as the hybridoma of this study (data not shown). The
factor that seemingly leads to more cell death in the experiment with regular conditioned
medium is hypothetical, yet the proposed accumulation of such a death factor, as will be
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discussed in Chapter 6, may be used to describe the extent of conditioning of the
culture medium that apparently affects the emergence of apoptosis.
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Figure 5-12 a,b. Cell density and viability for fresh stock cells in insulin(+ or -)
medium, with either regular or chemostat-conditioned medium.
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5.5 DISCUSSION
The growth of hybridoma cells in the absence of insulin reveals the presence or
absence of positive and negative factors that affect proliferation and the emergence of
cell death. The last figure above (Figure 5-13 a b) reveals that the chemostat-
conditioned medium contains a positive factor that is not present in regular conditioned
medium nor is supplied by 100% fresh medium. Even at 30% of its concentration in a
chemostat (30% chemostat-conditioned medium is mixed with 70% fresh medium for
the batches), the unknown positive factor allows for faster growth with high viability for
48 hours compared to the other insulin-free batches. However, the factor does not allow
for growth as fast as that seen in fresh insulin(+) medium, with or without regular
conditioned medium (Figure 5-12 a b, 100% fresh insulin(+) not shown). Perhaps this is
because the factor has been diluted three-fold. Yet another explanation is that the factor
is only replacing some of insulin's various effects on cellular physiology. This would be
feasible since it has been hypothesized that insulin acts both dependently and
independently of insulin-receptor tyrosine kinase activity. The independent signaling
involves G-proteins and intracellular receptors, which are proposed to interact with
metabolic enzymes in mitochondria (Term Project for Molecular / Cell Bioengineering
submitted by Brian Follstad) (Follstad 1997).
5.5.1 Dependence on insulin for cell cycle progression is either not
unique or not necessary
One of insulin's important effects is that of its activation of cell cycle related genes
through signal transduction via the MAP kinase cascade. Though in this hybridoma it
has been shown that c-myc expression (one of the endpoints of the MAP kinase
cascade) is independent of nutrients and insulin, MAP kinase activity should still be
required for other genetic factors. Phosphorylation of the MAP protein (the acronym
refers to mitotic activating protein and microtubule associated protein) is necessary to
allow the reorganization of microtubules during mitosis. In the unphosphorylated state,
MAP binds microtubles to provide structural support, and upon phosphorylation, MAP's
affinity for microtubles is reduced, and microtubules are destabilized and able to
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reorganize (Lodish, Baltimore et al. 1995). Thus, in the absence of insulin stimulation, it
is possible that the mitotic spindle (which is comprised of microtubles) would not be able
to form (as readily) and the cells may arrest in G2-M. Given that cells can proliferate
without insulin stimulation, implies that the MAP kinase cascade is either constitutively
activated for the hybridoma (which would agree with the c-myc deregulation as well) or
that the unknown factor in conditioned medium can replace insulin's stimulation of the
map kinase cascade. Thus, by one mechanism or another, it appears that the removal
of insulin does not absolutely lead to cell cycle inhibition. Insulin's effect through signal
transduction pathways is not unique or may even be moot for this cell line.
5.5.2 Insulin provides support for metabolism
Ruling out insulin's role as a growth factor for cell cycle progression, I thus attribute the
protective role of insulin against growth arrest (exhibited as increases in both G1 and
G2/M or all phases of the cell cycle) and against apoptosis to its other well-known
effects on cellular metabolism. Though the exact mechanism of regulation is debatable,
the presence of insulin can lead to significant increases in the activity of metabolic
enzymes, such as that for pyruvate dehydrogenase (Gottschalk 1990). Furthermore,
insulin is reported to enhance mitochondrial Kreb's cycle activity (which "is the energy
source for the anabolic activity of the cell") by 30% (Bessman and Mohan 1997). As
opposed to the stimulation of the genetic factors that are absolutely necessary for
progression through the cell cycle, I view a metabolic enhancement of 30% by insulin as
an additional resource that a cell can harness when cellular energetics so require.
The results presented in this chapter can be cast in a framework that assumes that it is
primarily the metabolic capacity of a culture that is dictating its dependence on insulin
as a survival factor. Essentially, insulin may provide protection against apoptosis by
enhancing metabolic capacity. As for the fed-batch cultures in Chapter 4, it appears that
cultures shift their metabolism and exhibit uniform increases in cell cycle progression
under conditions of increasing environmental stress. The metabolic shift indicates an
increase in maintenance and slower progression through the cell cycle implies some
sort of limitation. The presence of insulin allows cultures to grow viably for an additional
25 hours despite the progressively harsher environment. In this framework, insulin may
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forestall apoptosis by giving the cells more metabolic potential with which to respond to
the limitations. In this sense, the requirement of insulin then depends on both the
metabolic state of the cells and the nature of the environment.
5.5.3 Insulin protects cells against detrimental environmental factors
The relationship between environmental factors and insulin protection is demonstrated
by the ability to passage cells without insulin as long as the medium is changed
frequently (daily) and the cell density is maintained low. Cultivation past 25 hours
requires the presence of insulin. The influence of environmental factors on insulin
requirement is also highlighted by the differences between chemostat-conditioned
medium and regular conditioned medium. For unknown reasons, not all conditioned
media are of the same nature. It is unclear why regular conditioned medium from cells
passaged with insulin contains different types or amounts of factors than chemostat-
conditioned medium obtained from an insulin-free chemostat. Presumably, just as for
the production of the product MAb, the variation in production of such factors may
depend on culture physiology as well.
The survival or death of cells in insulin-free chemostats is then an indication of both the
metabolic state of the culture and the degree of conditioning of the chemostat medium.
At the lowest dilution rate of 0.02 hr 1, the culture is the most limited on glutamine and
has the greatest dependence on TCA cycle and oxidative phosphorylation, as indicated
by its glucose, glutamine, lactate, and oxygen metabolic rates. Furthermore, in terms of
conditioned medium, the lowest dilution rate culture should have the highest
accumulation of factors (assuming constant production). Thus, this culture appears to
be doubly taxed in its metabolic needs to survive in the presence of more severe
nutrient limitation and possibly harsher environment. Thus, it is reasonable that the
removal of insulin could be detrimental. Indeed, well before the culture density begins to
fall and death emerges, the cycle progression in G1 and G2/M have become extended.
Eventually, the removal of metabolic potential causes severe enough of a limitation that
cell growth is comprised and death emerges.
If the culture at the highest dilution rate (D=0.04 hr 1) had survived without insulin, I
could simply state that the increase in nutrient supply (and hence less of a metabolic
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shift) and the decrease in factor accumulation (less environmental stress) associated
with faster dilution rates of 0.03 and 0.04 would be sufficient to allow the survival of
insulin-free cultures. But that was not the case. Three different experiments survived at
0.03, but the initial experiment at 0.04 did not. Essentially, the lack of survival at D=0.04
is evidence that either the metabolic state of the cells was suboptimal or that the
environment was conditioned to a greater degree than that of the 0.03 experiments. Yet
the metabolic state is observed to be "normal" for the insulin(+) steady state (meaning
that it was not shifted towards TCA cycle) and only changes once death begins. Thus, I
am left with trying to rationalize why the environment would be less optimal at D=0.04
hr than that at D=0.03 hr-1 in terms of negative conditioned medium factors. My
hypothesis for such a difference in environment for the 0.04 and 0.03 experiments is
presented in Chapter 6.
The evidence presented in this chapter reveals something of the nature of the as of yet
undetermined cause for apoptosis during batches and fed-batches. Insulin's effect on
cell physiology is one that allows cells to grow faster and more viably despite increased
levels of negative conditioned medium factors. Insulin's role as a protective factor is to
support the normal metabolic and cell cycle function of cells. Yet with the ability of cells
to grow viably even in the absence of insulin, insulin's role for metabolism seems to be
the dominant effect in protecting cells against apoptosis which results from increasing
environmental stresses.
5.6 CONCLUSIONS
The role of insulin in hybridoma cell culture was investigated in terms of its ability to
protect cells against apoptotic cell death in serum-free medium. Because of its known
positive effects, the severe insulin degradation observed in batch, fed-batch, and
continuous cultures is minimized through the use of insulin feeding and the protease
inhibitor glycocholic acid. Yet despite successfully maintaining higher insulin
concentrations through the first three days of batch culture, the higher levels of insulin
do not extend viable proliferation beyond two days in batches.
159
Insulin-free chemostats were achievable with insulin-dependent hybridoma cells at an
intermediate dilution rate of 0.03 hr 1, yet not at dilution rates of 0.04 or 0.02 hr'. Such
survival at the intermediate dilution rate is shown to be related to the nature of the
conditioned medium environment rather than the nature of the cells. Cells taken from
the insulin-free chemostat still exhibited insulin-dependence in batch experiments.
Moreover, conditioned medium from the insulin-free chemostat was able to support
viable proliferation of fresh stock cells for 50 hours (just as long as the insulin(+) case).
The ability of insulin to extend viable proliferation is attributed to its role in supporting
metabolism. Apoptotic cell death in fed-batches with insulin (Chapter 4) and apoptotic
cell death upon removal of insulin (this chapter) exhibit the same symptoms of growth
arrest and metabolic changes. With the growth arrest not occurring as the result of cell
cycle impediment in any particular phase (all phases are delayed), it is an impediment in
cellular metabolism that is taken to be the cause for growth inhibition and the
emergence of cell death. In this framework, insulin serves as a protective factor through
its stimulation of additional metabolic capacity. As cultures exhibit a shift in metabolism
to one of higher maintenance, insulin may confer a culture the ability to more robustly
meet the increase in energy demand. The protection of insulin is observed to be linked
to the extent of conditioning of the culture environment. The additional metabolic
capacity provided by the presence of insulin is necessary for longer survival in more
highly conditioned environments, which are presumably the principle cause for the
increase in maintenance energy.
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6 DISCUSSION AND IMPLICATIONS OF
EXPERIMENTAL FINDINGS
6.1 REDUCTION OF APOPTOSIS IN FED-BATCH CULTURE
The investigation of hybridoma physiology in continuous culture provided useful
evidence for the relationship between metabolism, cell cycle progression, and
apoptosis. Such evidence can and has been applied to the improvement of fed-batch
cultures with the aim of maximizing the production of therapeutic proteins. Yet, the
chemostat evidence is not directly applicable to fed-batch cultures due to the
differences in nutritional environments. In the chemostats, the cells are limited on
glutamine and cell death emerges at lower dilution rates primarily due to the nutrient
limitation (though other factors may play a role as well, as is discussed later). In fed-
batches, no nutrient limitation (or any other known limitation for that matter) is present
by design. In terms of growth factors, residual insulin levels in chemostats of greater
than - 1000 mU/L (1% of that in fresh medium) are apparently sufficiently high despite
degradation. Though insulin levels in fed-batches can become fully depleted, as
demonstrated in Chapter 5, the depletion of insulin to levels lower than those found in
the chemostats follows the emergence of cell death. Thus, in terms of known medium
factors which we can control and measure, the major difference between chemostat
experiments and the fed-batch experiments is nutrient levels. All the other process
variables, such as temperature, pH, and osmolarity, can be monitored and controlled at
optimal setpoints. Hence, the question remains as to why cell death emerges in fed-
batch cultures. The emergence of death at lower dilution rates in the chemostats is
expected for a continuous cell line, but the explanation for the emergence of cell death
in a well designed fed-batch still eludes us. The investigation of the protective roles of
rapamycin and insulin in my work show that survival in fed-batch environments depends
on how the cells respond (in terms of shifts in metabolism and changes in cell cycle
progression) to environmental limitations, whatever they may be. Interestingly, as I
hypothesize in this chapter, the very same environment to which the cells must adapt
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may also be conditioned in different ways or at different rates depending on the cellular
physiology.
6.1.1 Metabolism and Apoptosis
Despite differences in nutrient levels, the physiology of cells in chemostats is still
ultimately very useful because of the similarity between the physiology of cells at
different dilution rates and cells at different time points in a fed-batch. Culture
physiology in a fed-batch during the first two days before death emerges is comparable
to the physiology of cells in a chemostat culture at a high dilution rate. Both are fast
growing and exhibit high viability. They also both produce more lactate and consume
less oxygen. Culture physiology for the fed-batch on later days after death emerges is
comparable to the physiology of cells in a chemostat culture at lower dilution rates. Both
are slower growing and exhibit lower viabilities. Also, both tend to produce less lactate
and consume more oxygen. Thus, even though the cause for cell death is apparently
different for each system, the physiology associated with cell death is remarkably
similar. In both cases, cell death is associated with a growth arrest and a shift in
metabolism towards TCA cycle and oxidative phosphorylation.
The observed shift in metabolism, towards better efficiency for glucose metabolism and
higher maintenance, as the result of nutrient limitation or other causes, implicates the
compromising of cellular energy production as cells die by apoptosis. In response to
known or unknown causes for cell death and in the presence of sufficient nutrients and
growth factors, the cells appear to respond robustly by shifting their metabolism in a
direction to supply additional energy. Even though cell death emerges, the extent of cell
death is less than I imagine would occur if the cells did not shift their metabolism at all.
Hence, a shift towards efficiency should be taken as a positive, anti-apoptotic response.
Indeed, the viable cells from the chemostat at the lowest dilution rate exhibited the
ability to reach twice the viable cell density when returned to the better environment at a
higher dilution rate. This multiplicity of steady states dramatically emphasizes the
influence of metabolism and cellular energetics on viable cell density and apoptotic cell
death. Brian Follstad is pursuing this finding concerning the metabolic effects on
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apoptosis. He has linked higher metabolic efficiency and mitochondrial potential with a
higher culture viable cell density.
6.1.2 Cell Cycle and Apoptosis
The cell cycle phenomenon observed in the chemostats points to the inhibition of S-
phase progression as the cause for the increase in doubling time. Both G1 and G2/M
progression times appear to remain fairly unchanged, while progression time through
the S-phase increases from 10 to 20 hours as dilution rate is decreased. It is reasonable
that glutamine limitation (or any nutrient limitation in general) may delay S-phase
progression as the result of a shortage of synthetic precursors for DNA. The apoptosis
that results from within the S-phase of a proliferating culture could be due to p53 activity
or another DNA checkpoint. The emergence of apoptosis in my particular hybridoma
cell line is particularly severe since entry to the cell cycle is deregulated. Similarly, for
the anchorage CHO cell line, the stimulation of cell cycle entry by growth factors can
also lead to cell death under sub-optimal conditions. The dramatic improvement in
culture performance by employing a rationally designed medium rests for the most part
on the minimization of cell death due to delays in S-phase progression by nutrient
limitation.
In the absence of nutrient limitation, cells in a fed-batch culture still exhibit growth arrest
and cell death. Cell cycle analysis reveals that arrestment occurs uniformly for each
phase of the cycle as growth declines and apoptosis emerges. The elongation of the
G1-phase is particularly interesting because it sharply contrasts the behavior seen in
the chemostats, as well as the finding that cell cycle entry is defective in the hybridoma.
As opposed to the chemostat phenomenon, there is something different about the fed-
batch cultivation that leads to a delay in G1. The delay of G1-progession, as well as the
delay of the other phases, implicates another phenomenon as the cause for growth
arrest and cell death.
From the insulin-withdrawal chemostat at D=0.04 hr 1 (that could not maintain an insulin-
free steady state and did exhibit apoptosis), it appears that growth arrest and apoptosis
also are associated with the uniform elongation of the cell cycle. Thus, to explain the
death in fed-batches, one could propose that cell death emerges as the result of insulin
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depletion. However, as was shown in Chapter 5, the insulin levels when death emerges
in fed-batches were sufficiently high and did not effect the emergence of cell death.
Thus, the similarity in cell cycle phenomenon for the insulin-free chemostat at D=0.04
hr' and fed-batches that apparently contain sufficient insulin also implies that there may
be another underlying phenomenon causing growth arrest and cell death which the two
culture systems share in common. Furthermore, insulin cannot be uniquely required for
proliferation since the hybridomas have been observed to grow without insulin
altogether.
The phenomenon at the intersection of cell death due to insulin depletion in chemostats
and cell death occurring in fed-batches may very well be metabolism. The role of insulin
for metabolic function, rather than cell cycle function, could explain the duality of culture
responses when it is removed from steady state chemostats. Depending on the culture
physiology and the environment for a particular steady state, insulin may or may not be
required for additional metabolic capacity. In this context, the removal of insulin is
thought to limit metabolic capacity, which in turn can lead to slower cell cycle
progression, growth arrest, and cell death. That fed-batch cultures exhibit similar cell
cycle phenomenon is thus additional evidence, though indirect, that it is possibly the
obstruction of metabolic function that is leading to growth arrest, uniform cell cycle
arrest, and apoptosis.
The ability of this cell line to proliferate viably in the absence of insulin points to the
presence of other factors (autocrine, interleukins) in insulin-free conditioned culture
medium. Though insulin stimulation of c-myc via the MAP kinase cascade is not
required for this hybridoma cell line, insulin should presumably still be required for MAP
(microtubule associated protein) phosphorylation and microtubule reorganization. Viable
proliferation in the absence of insulin indicates that insulin' effect as a growth factor is
not unique - the hybridomas can somehow still perform cell cycle division. Thus, once
again, the arrest of cells in fed-batches is probably the result of other factors beyond the
direct expected effect of depletion of growth factors.
The evidence for and discussion of the role of cell cycle in apoptotic cell death for this
hybridoma cell thus further implicate the role that metabolism has on the emergence of
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apoptosis. Obviously, proper cellular function is key for viable proliferation. Here it is
plausible that unhindered progression through all phases of the cell cycle depends on a
robust metabolism.
The mounting evidence for metabolic impediment as the underlying phenomenon for
cell death raises questions as to the role of rapamycin in delaying apoptosis. As shown
in Chapter 5, rapamycin's primary effect on the cell cycle is to extend G1-phase
progression. However, it also leads to a lesser degree of uniform cell cycle arrestment
as compared to the controls. It is not exactly clear why longer G1-phase residence
results in lesser inhibition for transition through S-phase and G2/M-phase. As I believed
in my initial hypothesis regarding the role for arresting agents, it may be that a delay in
G1 allows for the more complete production of intracellular factors that support cell
cycle function and viability. Yet, the possible link between a uniform cell cycle
arrestment and metabolism support a newer hypothesis that rapamycin's positive
effects on viability could be due to its effects on metabolism.
As shown in the Chapter 5 discussion, metabolism data do show that rapamycin
cultures appear to have the more efficient metabolic profile. The mechanism behind the
metabolic effect of rapamycin could be direct or indirect. As described for yeast cells by
Schreiber (Schreiber 1999), rapamycin causes many up-regulations and down-
regulations in related cell cycle and metabolism genes. Perhaps, these genetic changes
are homologous in mammalian cells and thus rapamycin can have a direct impact on
metabolism. Or, barring the existence of such a direct connection, perhaps cell cycle
progression itself can influence metabolism. Though it is clear that metabolism can vary
despite a constant cell cycle distribution (chemostat data), it is also well established that
metabolism is a function of growth rate. It is possible that a shift in metabolism may
simply follow a shift in cell cycle distribution towards slower growth. However, it is
intriguing that such a shift be similar to that of a nutrient-limited or fed-batch culture that
is undergoing cell death. Evidence for rapamycin addition causing a starvation
response, as if there were an amino acid limitation, makes the shift in metabolism
appear to be more complex than just a growth rate related downshift.
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The differences in cell cycle progression and cell death for chemostats with and without
insulin, and fed-batches with or without rapamycin are depicted below. Here the delay in
progression of cells through G1 is seen to be related to the absence of insulin
(chemostat D=0.04 and DO.02) or the arrestment of cell growth during fed-batches. The
rapamycin culture shows the slowest progression throughout, but the same increasing
trend as the control nonetheless. The insulin-free chemostat culture at D=0.02 hr-1
appears already delayed within G1 even prior to cell death, as was discussed in
Chapter 5. Overall, in terms of the relationship between cell death and cell cycle arrest,
it appears that the arrest during fed-batch cultures and insulin-free chemostats is
associated with greater cell death than is observed when the arrest occurs in the
presence of rapamycin. Cell death for the insulin(+)-series of chemostats is associated
with arrest in S-phase rather than G1.
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6.2 MONOCLONAL ANTIBODY PRODUCTION
The monoclonal antibody titer of 0.55 g/L from my six-day rapamycin fed-batch cultures
is a significant improvement over the non-rapamycin counterpart titer of 0.25 g/L.
Relating back to the state of the art objective fed-batch described in Chapter 2, the use
of rapamycin is observed to put the production of MAbs for a serum-free fed-batch
process on par with the serum-based ones. On a ten-day basis (the length of time
theoretically sufficient for the production of 10.0 g/L in a death-free fed-batch), the
rapamycin-fed fed-batch is estimated to yield 0.95 g/L, thus outperforming the
previously mentioned records for MAb production in fed-batches.
The apparent specific monoclonal antibody production for this hybridoma is observed to
vary over quite a broad range. Data from chemostat steady states span about a 2.5-fold
range in apparent specific productivity, from 0.9 to 2.3 x 10-9 mg/cell/hr. Apparent
specific productivity in the control and rapamycin fed-batches spans a similarly large
range, from 1.4 to 3.2 x 10-9 mg/cell/hr. Such variance is attributed to differences in the
extent of nutrient limitation, changes in G1 residence, and shifts in metabolism. The
observed constant productivity in previous work is still plausible nonetheless. During
extended fed-batches with significant apoptosis occurring, the metabolism of the viable
cells would be expected to be pinned at the most efficient / highest maintenance state
and the cell cycle distribution would be fairly constant as arrestment would be occurring
uniformly in each phase.
From the two multiple steady states at 0.04 hr-1 discussed in Chapter 3, it is not clear
whether a metabolic shift or a change in cell cycle progression is responsible for the
40% lower specific productivity for the second steady state (E). G1 progression time
(MAb production is believed to be highest in G1) for the first steady state at D=0.04 (A)
was 3.9 hr, whereas it was 3.1 hr for the second steady state at D=0.04 (E), a decrease
of about 20%. Though the decrease in G1 residence would be expected to detract from
apparent specific productivity, specific productivity is observed to depend on more than
just G1 progression time (Figure 6-2). The scatter in data is attributed to differences in
culture viability and metabolism. Also shown is the observed progression of decreasing
168
specific productivity observed during the withdrawal of insulin from a steady state at
D=0.02 hW-. Even before cell death emerges for that insulin withdrawal experiment (Day
21), specific productivity has decreased significantly while G1 progression time
increased.
The value 0.9 x 10~9 mg/cell/hr observed for specific productivity for the steady states D
and E (D has viability = 40%, E is the multiple steady state at D=0.04 hr-1 that exhibits a
shifted metabolism) is comparable to the value of 0.85 x 10-9 mg/cell/hr quoted for this
cell line during extended fed-batches (Xie 1997). This is reasonable since the cells in
the fed-batch environment are controlled at lower nutrient levels, levels that can shift
metabolism toward the more efficient state, and are exhibiting higher death rates.
Furthermore, the higher value quoted by Glacken of 1.2 x 10-9 (data from Xie, (Xie
1997)) is also reasonable since that number is calculated from the early portion of the
culture run where metabolism may not be fully shifted and cell death was not as severe.
Thus, in addition to providing consistent data with previous investigators, I believe my
observations add additional insight as to the underlying causes that can influence
specific productivity.
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Figure 6-2. Specific production of monoclonal antibody for chemostat and fed-
batch experiments versus progression time through the G1-phase of the cell
cycle.
Chemostat data A, B, C, D, and E are from a single series of steady states at dilution rates of
0.04, 0.03, 0.02, 0.01, and 0.04 hr-1, respectively. Chemostat data F and G and from the
insulin(+) steady state prior to insulin withdrawal at dilution rates of 0.04 and 0.03 hr-1,
respectively. The insulin withdrawal series data is for a chemostat at D = 0.02 hr 1. Fed-batch
data for rapamycin and control cultures is that measured between days 2 and 3. 95%
confidence limits are approximately 10-15% of productivity values and approximately 1 hour
for G1 progression times.
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Thus, the dependence of apparent specific productivity on growth rate, cell cycle
progression, metabolism, and nutrient supply, and cell death (all of which are
interrelated themselves) can explain the variable productivity from this hybridoma cell
line. In this context, the significant enhancement of apparent specific productivity by
rapamycin cannot be attributed solely to the increase in residence in the G1-phase of
the cell cycle. The interrelation of the cellular phenomena should be considered in the
explanation of variance in specific productivity. For rapamycin-fed fed-batches, the
dramatic increase in apparent specific productivity up to 3.2 x 10-9 mg/cell/ml is
attributed to the combined effects of the elongated G1 progression, the shift towards a
more efficient metabolism, and the minimization of cell death. An increase in G1
residence of 50% cannot alone explain the tripling in specific productivity. The beauty of
rapamycin treatment is that higher productivity can be achieved without having to
"stress" the cells by reducing nutrient levels or by waiting for the stationary phase and
cell death. With rapamycin, the robustness of the cells can be measured in terms of the
decrease in death rate as well as the significant improvement of specific productivity.
6.3 CONDITIONED MEDIUM FACTOR PRODUCTION AND
ACCUMULATION
Despite all the evidence relating metabolism, cell cycle, and cell death phenomenon,
the mechanism that drives shifts in metabolism and cell cycle progression in conjunction
with the emergence of cell death remains a mystery. As has been raised throughout this
thesis, it appears that deteriorating cellular energetics may be the cause for the shift in
metabolic efficiency and the uniform delay in cell cycle progression. If this is indeed the
case, the question then remains as to what is the cause for the deterioration of cellular
energetics. It is within this framework that I hypothesize the existence of a conditioned
medium factor that stimulates cell death. The existence of such a factor has been
previously proposed and modeled in a similar way that I do below (Lee, Yap et al. 1995;
Zeng, Deckwer et al. 1998). For my analysis, I add the physiological impact that the
hypothesized factor has on cultures in terms of metabolism and cell cycle, and I also
allow for variation in its production. I claim that the factor acts as a "poison" to the
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production of energy for proper cell function. The result of such poisoning of metabolic
potential would trigger apoptosis by indirectly impeding cellular functions, including cell
cycle progression.
This hypothesis for cell death stems from my accumulated experience with the
cultivation of hybridomas under a variety of conditions: under nutrient limitation, in the
presence or absence of insulin, in the presence or absence of rapamycin, and in
batches, fed-batches, and chemostats. Following the description of my model for the
conditioning of culture medium, I present applications of the model, which in fact
comprise the phenomenon on which the model was based. Though the exact nature of
the conditioned medium factor is unknown, I believe this model is useful for explaining
some of the phenomena relating cell death that I have experienced over that last
several years. In its infancy, in the form of intuition, I applied the model and its
assumptions to design the proper batch experiments that demonstrate the role of
conditioned medium with and without insulin.
6.3.1 Proposed Model for "Conditioned Medium Hypothesis"
The proposed model is based on the survival or death of hybridoma cells in the absence
of insulin. For this analysis, viable proliferation in the absence of insulin serves as an
indication that deleterious conditioned medium factors have not accumulated to a level
that would stimulate cell death. Sustained viable proliferation in the absence of insulin
therefore is taken to imply that cellular metabolic function is intact, and thus, in this
framework, that it is not being poisoned by high levels of conditioned medium factors.
The presence of insulin supports a more robust metabolic function that allows cells to
proliferate in the presence of higher levels of conditioned medium factors.
The production of conditioned medium factors is related to the integrated viable cell
density of a culture and either the dilution rate or frequency of passaging. Factor
production is assumed to be the result of viable cell proliferation and metabolism, as
opposed to release of contents from dead cells. In this framework, the concept of
production of conditioned medium factors can be expressed and manipulated similarly
as other cellular rates, such as production of MAb. Furthermore, the production and
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accumulation of the factors are taken to be the same, hence neglecting degradation or
loss of factor activity.
A balance around a steady state chemostat for a quantity, F, the unknown factor that
causes death, yields an equation for the production of "death factors" per cell as a
function of the dilution rate, the level of factors F, and the number of viable cells in the
reactor. The balance for conditioned medium factors in a chemostat is:
dF
dt =nqF -DF
where F is the concentration of factors (unit/ml), nv is the viable cell density (cell/ml), qF
is the specific production of F (unit/cell/hr), and D is the dilution rate (hr 1 ). From such a
balance at steady state, the specific production of factors for a chemostat is determined
as:
DF
qF=
nV
For batch and fed-batch cultures, the governing equation for accumulation of
conditioned medium factors is given by:
t2
F - = nV(t) -qF (t)dt = IVCD I* qF
tI
To make use of the above equations, I must choose a relative reference point for the
level of F below which viable proliferation is sustainable without insulin. This is akin to a
toxicity level similar to those previously determined for ammonia and lactate, but in
relation to the presence of insulin. In making this choice of reference, I am preliminarily
assuming that the level of factor which stimulates cell death in insulin(-) medium is the
same for all hybridoma cultures without insulin. I likewise make the same assumption
for the insulin(+) F-level that I determine below. For now, such assumptions are
sufficient to proceed and make sense of my own data.
Thus, I arbitrarily assign a value of 1.0 unit/ml for a F-level below which cells do not
need insulin for viable proliferation and above which they do need insulin or else they
die. From batches without insulin, cells can proliferate for about 25 hours at low density.
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The corresponding IVCD up to the point of cell death is approximately 8.4 cell-hr/mI (an
average of 3.5e5 cell/ml * 24 hr). Using the equation for accumulation of factors in
batch, I can determine both the initial factor level for a typical experiment (which is
inoculated using about 1/3 of inoculum conditioned medium) and the specific rate of
factor production. Using an initial guess of 0.5 for F1, I determine an initial value for qF =
0.63e-7. With this qF I then calculate F1 for an inoculum that is passaged daily. Using
the new F1, I recalculate a new qF. Iteration yields F1 = 0.42 and qF = 0.69e-7
unit/cell/hr. Taking this qF, I calculate the F-level associated with the emergence of cell
death for an insulin(+)-positive batch to be 2.82 unit/ml (48 hour culture at higher
average density plus the initial 0.42 from inoculation). The following table summarizes
the model for insulin(+/-) batch cultures.
Analysis for Conditioned Medium Hypothesis in Batches
IVCD (cell-hr/ml) Specific Threshold F-level
Viability > 90% Production of F for cell death
(unit/cell/hr) (unit/ml)
Insulin(-) 0.84 x 107 0.69 x 10-7 1.0
Insulin(+) 3.5 x 107  0.69 x 10-7 2.8
The F-level associated with death in insulin(-) batches is used to analyze the survival or
death of insulin-free chemostats. Using the equation for chemostats above, the dilution
rate and the cell density of a steady state is used to calculate the minimum specific
production rate of F in the cases that resulted in death and the maximum specific
production rate of F for cases that resulted in survival. For instance, the culture at
D=0.04 hr 1 did not survive, and hence is taken to have an F-level greater than or equal
to 1.0, and hence a qF that is at least 0.8e-7. The three scenarios for different dilution
rates are summarized in the following table.
Analysis for Conditioned Medium Hypothesis from Chemostats
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Dilution Rate Viable Cell Survival? F at Steady Specific
(hr-1) Density State Production of F
(cell/ml) (unit/ml) (unit/cell/hr)
D = 0.04 5 x 10 5  No > 1.0 >0.80 x 10-7
D = 0.03 5-7 x 105  Yes 1.0 <0.50 x 10-7
D = 0.02 6 x 10 5  No > 1.0 >0.33 x 10-7
The calculated qF's at each dilution rate demonstrate that the production rate for the
factor cannot be constant within the context of this framework. The survival of the
chemostat culture at D=0.03 is associated with a lesser production of conditioned
medium factors relative to the cells in the chemostat at D=0.04. This drop in production
is taken to be sufficient to allow for an F-level which is smaller at D=0.03 than at
D=0.04. A further reduction in production rate for the chemostat at D=0.02 is possible,
though the beneficial effect is not sufficient to outweigh the slower dilution and hence
higher accumulation of conditioned medium factors.
The necessary variation of the production rate of conditioned medium factors to explain
the insulin-free chemostat behavior is not unreasonable. Similar trends with growth rate
exist for several metabolic rates, such as glucose and glutamine uptake and lactate and
ammonia production. Variation of MAb production likewise can vary several-fold
depending on culture physiology. If accumulation of death factors is truly a cause for cell
death, then their dependence on culture growth rate, metabolism, and/or cell cycle
distribution agrees with the coinciding link of such phenomena to the emergence of
apoptotic cell death. With higher conditioning levels hypothesized to lead to metabolic
impediment and cell cycle arrest, the robustness of cells that are growing slower (due to
nutrient control or rapamycin) may, perhaps, be due to their lesser production of
conditioned medium factors that stimulate apoptosis. Thus, as will be evident in the
applications, I will use knowledge of culture metabolism and growth rate in specifying a
high or low production rate for conditioned medium factors. Cultures under nutrient
limitation (though perhaps of lower viability due to S-phase limitation) are assumed to
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produce less factors. Likewise, cultures in the presence of rapamycin are also assumed
to produce less factors as the result of their decreased growth rate and the preliminary
evidence supporting their shift to more efficient metabolism.
6.3.2 Applications of the "Conditioned Medium Hypothesis"
6.3.2.1 Batch and Fed-batch Cultures
The analysis of many of my batch cultures, with and without insulin, is consistent with
the F-levels I used in developing my model. Insulin-free cultures started with regular
conditioned medium last only about 25 hours before the viability begins to decline. The
F-levels for such insulin-free batches range from 0.5 to 1.0 depending on the type or
absence of conditioned medium, whereas the F-levels prior to cell death for insulin(+)
experiments range from 2.4 to 3.4. For insulin-free batches, the type of conditioned
medium used is accounted for in the initial factor concentration at inoculation. The lower
F-levels for special or no conditioned medium correlate well with lower death rates. Yet
for the case of 100% fresh medium without insulin, death emerges at the lowest level of
F. Positive factors in conditioned medium do play a role in supporting viability as well.
6.3.2.2 Re-fed Suspension Cell Cultures
During the investigation of the physiology of hybridomas grown within 3-mm polymer
capsules, masters student Bettina Knorr developed a new protocol for her suspension
cell culture control. For the encapsulated cells, eighty to ninety percent of the spent
medium is exchanged for fresh medium on a daily (or 8 hour) basis. This exchange of
medium is simple since the cells are encapsulated within the polymer beads. For a
production process, such medium exchange is economically feasible since the product
MAb is retained within the beads, whose polymer shell has a MW cutoff of around 10
kDa, which still allows nutrients and insulin to pass through. To achieve a better
comparison between her encapsulated cells and the suspension cells, she decided to
exchange 80-90% of the suspension conditioned medium on a daily (or 8 hour) basis as
well, as opposed to fed-batch cultivation. She achieved this so-called "Re-fed
Suspension" culture by spinning down the entire culture and resuspending it in 80%
fresh, 20% conditioned medium.
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The performance of the cells in the re-fed suspension culture is quite astonishing. As
shown below, the re-fed culture dramatically outperformed control fed batches (my own
data as a polynomial fit of 5 cultures) (Figure 6-3). The re-fed viable cell density reached
7.0 x 106 cells/ml and maintained high viability (as measured by acridine orange and
ethidium bromide, a harsher assay for viability than trypan blue) for around 100 hours.
The average fed-batch control only reaches about 1.5-2.0 x 106 cells/ml and lasts for
only 50 hours with high viability. It appears that the exchange of most of the conditioned
medium every eight hours by centrifugation and resuspension allows the cells to reach
a viable cell density approximately four times that of a fed-batch. The re-fed density is a
record for serum-free hybridomas.
The lactate and ammonia concentrations were shown to be high at the end of an 8 hour
interval, but not above the established toxicity thresholds. The cause for the emergence
of apoptosis for the re-fed cultures can be explained in terms of the conditioned medium
hypothesis. The integrated viable cell densities at which death emerges is
approximately 4.0 x 107 cell-hr/ml (- 5e6 cell/ml for 8 hours) for the re-fed culture, and
3.5 x 107 cell-hr/ml (over 50 hours) for the fed-batch culture. Multiplying each IVCD by
qF = 0.69 x 10-7 yields F = 2.8 and F = 2.4, respectively. Thus, in calculating similar
levels of conditioning, the model helps me express the idea that the cells of the re-fed
system reach higher densities as the result of removing conditioned medium rather than
by some other cellular phenomenon. They both die at the similar F-levels. In addition to
supplying fresh nutrients and insulin, the removal of conditioned medium factors allows
the culture to proliferate viably to much higher densities.
This hypothesis was further applied to the improvement of culture performance within
the polymer beads. Similar to the fed-batch performance, death emerged at around 50
hours for beads with the standard pore size. Yet viable cell density reached a density
ten times that with standard beads when the pore size was made larger by the addition
of PEG 3400 to the polymer shell solution during preparation. The increase in pore size
would allow better transport for nutrients and insulin, though their transport was verified
to be sufficient with the smaller pores. A possible explanation for the culture's
improvement with the larger pore beads is the enhanced removal of conditioned
medium factors that cause cell death.
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Figure 6-3. Cell density and viability of re-fed vs fed-batch hybridoma cultures.
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6.3.2.3 Rapamycin-fed Fed-batch Cultures
Interestingly, cultures with rapamycin are observed to reach higher IVCD's than the
control cultures before death emerges. A rap culture can persist for up to 80 hours
before succumbing to cell death, reaching an IVCD of about 6.0 x 107 cell-hr/ml. This
near doubling of the IVCD at which death emerges relative to control cultures signifies
that (1) rapamycin cells are more resistant to whatever is causing the death or (2) that
rap cultures, with their altered metabolism, are conditioning their environment at a
slower rate or (3) a combination of both effects.
The conditioned medium model can be used to interpret rapamycin's effects on cell
death in either of the above cases. For the first case, we assume the same qF as for
control cells, namely 0.69 x 10-7, and calculate the F at which death emerges to be 4.14.
The higher F-value at which death emerges in the presence of rapamycin is analogous
to the higher F-value at which death emerges in the presence of insulin. It is possible,
like for insulin, that rapamycin leads to robustness by supporting cellular function. For
the second case, we fix F at which death emerges constant at 2.8 for insulin(+) cultures,
and calculate the associated qF to be 0.40e-7. Just as I explain the survival of cells in
insulin-free chemostats as depending on the reduction of qF, the extension of viability for
rapamycin cells could be due to the reduction of qF as well. Either case is feasible to
explain the reduction of death that rapamycin cultures exhibit. The rapamycin effect to
alter a cells protein profile could render cells more resistant to apoptosis. Conversely,
rapamycin's effects on cell cycle and metabolism could reduce the production rate of
conditioned medium death factors.
6.3.2.4 Chemostat Phenomena
The Conditioned Medium Hypothesis can be used to explain the severe increase in
apoptosis observed for the case of the lowest dilution rate chemostat. The associated F-
levels for each of the steady states are 1.2, 1.3, 3.6, and 6.2 for steady states A, B, C,
and D, respectively, where a constant qF =0.69e-7 is assumed. For C and D, the F-level
is greater than the threshold for death established for insulin(+)-batches. Allowing for
the fact that qF may be reduced for these growth arrested, metabolically shifted cultures,
steady state D is still sufficiently high that even a halving of the production rate would
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still result in a deleterious environment. Thus, the dramatic increase in cell death for the
steady state at the slowest dilution rate may be due to the combined effects of nutrient
depletion (causing S-phase related apoptosis) and the presence of high levels of
conditioned medium factors.
The existence of a multiple steady state at 0.04 hr-1 can also be considered from the
effect of conditioned medium factors for each steady state. Assuming similar specific
productivity for qF for each state, the first one had an F-level of 1.2, whereas the second
steady state, with nearly double the viable cell density, has an F-level of 2.3. Here it
appears that the second steady state is robust despite (or perhaps as the result of) the
higher F-level. However, if we assume that qF is decreased for the second steady state,
as a result of its efficient metabolism, the F-level could be similar to the first. Thus, with
the occurrence of multiple steady states being linked to metabolic phenomenon, the
differences in F-levels or F-production may one day be useful for better understanding
the multiplicity in cell density and specific productivity. Indeed, even though the dilution
rate is the same, the different metabolism has effects on residual nutrient levels. Effects
would also be expected in the extent of conditioning of the culture medium.
With regard to insulin-free chemostat experiments, I could use the conditioned medium
model to re-design experiments at D=0.03 hr 1 such that death should emerge. From the
conditioned medium hypothesis, I can intuit that cell death will occur for cultures at
D=0.03 hr' if the steady state viable cell density was higher. The higher viable cell
density could be obtained by increasing the glutamine feed concentration from 0.08 to
1.2 or 1.6 mM. Cell Death would be expected to occur for two complementary reasons:
(1) higher residual glutamine would allow for higher cell densities and hence higher
levels of the hypothesized death factors as calculated from the equation, and (2) a less
substantial shift in metabolism that would result in a higher specific production rate for
death factors than observed with a low glutamine feed medium. The proof of such an
experimental design is in the works by several Stephanopoulos co-workers, as they
study the role of insulin on cellular protein profiles (as measured by 2-D gels).
A final application of the model is in the explanation of the difficulty I experienced in
chemostat startup with the hybridoma cell line. For the first two attempts at starting up
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the chemostat, the cells were unable to reach a steady state due to severe growth
arrest and the emergence of cell death. The initial protocol (just like the one I used with
CHO cells) involved inoculating the reactor, letting cells grow in batch for two days, and
then starting the dilution rate at the desired setpoint. Yet, despite healthy batch growth
during the first two days, the hybridoma cells were unable to adapt smoothly to
glutamine-limited growth. Part of the problem is now understood in terms of the
defective cell cycle entry that I discovered for this cell line. As the glutamine
concentration approaches the low residual level, the cell cycle entry is not reigned in by
proper cell cycle control, resulting in even greater amounts of cell death within the S-
phase. A second important aspect during startup may be the level of conditioned
medium factors that are estimated to be present at the end of the two-day batch. Using
a constant value of 0.69 x 10-7 U/cell/hr for qF, I calculate the net accumulation of factors
during startup (Figure 6-4). As evident for the unsuccessful startup scenario below, the
F-level for the unsuccessful protocol reaches and slightly surpasses the threshold for
death for cells with insulin (F=2.8). Thus, in addition to improper entry to the cell cycle, it
is possible that the severity of the death response is also due to high levels of death
factors.
My solution to the problem at that time, based on simple intuition, was to start the
dilution rate earlier (at 24 hours) and appropriately adjust the dilution in order to keep
the cell density below 1.0e6 cell/ml. In the adjustment of the dilution rate, the growth
rate of the culture was calculated and used in conjunction with the current density to set
the appropriate dilution rate to stabilize the density below 1.0e6 cell/ml (I called this
procedure "chasing the growth rate"). Thus, a successful start up consisted of my
setting the dilution rate at 0.025-0.035 hr-1 on the first day, then increasing it to 0.04-
0.05 hr-1 on the second day, and then gradually lowering it over several days to the
final setpoint of 0.02-0.04 hr-1. For obvious reasons, keeping the culture at lower
densities from the beginning helped when the glutamine-limitation was reached.
Furthermore, as I plot below for the successful startup case, the avoidance of higher
levels of conditioned medium by keeping cell density down may have also been
beneficial. Startup may also have been improved by the use of conditioned medium
from an inoculum that was passaged daily (Finitiai = 0.42 for the successful startup)
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versus an inoculum that was passaged every other day (Finital = 0.89 for the
unsuccessful startup).
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Figure 6-4. Hypothesized death factor levels during successful and unsuccessful
chemostat startup.
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6.3.2.5 Anchorage-dependent CHO Cultures
Anchorage-dependent cells lines are typically cultivated in 6-well plates (1-3 mL).
Because the cells are attached, the culture medium is often replaced with fresh medium
on a daily basis in order to replace nutrients and growth factors. Whether the medium is
changed daily or not at all can have dramatic effects on the observed phenomena. From
the point of view of the conditioned medium hypothesis, the experiment in which the
medium is frequently replaced is more likely to be studying the effect of cellular
phenomenon, whereas the true batch experiment provides an additional environmental
effect, which in terms of cell death, may completely over-shadow the cellular
phenomenon.
The model for medium conditioning may be helpful in the design such 6-well plate
experiments. If the goal is to study the effect of conditioned medium factors, the medium
should not be replaced. Feeding of additional nutrients and growth factors can be
performed if necessary, as well as pH and osmolarity control. If the effects of
conditioned medium factors are to be minimized, culture medium should be replaced
frequently. The model can be used to estimate the necessary time interval between
medium replacement, based on the viable cell density and an assumed specific
production rate for conditioned medium factors, qF. From my model for hybridomas,
cultures containing insulin can proliferate up to a conditioned medium factor
concentration of F = 2.8 units. If for growing cells we take qF = 0.69e-7 unit/cell/hr, the
medium replacement interval will be equal to F/(qF*nv). For an average of 1.0e6 cells/ml,
the medium should be exchanged every 40 hours, and daily replacement would be
adequate. For twice the density, however, medium exchange would need to occur
within 20 hours, and hence daily feeding may not be capable of eliminating ill effects of
conditioning.
Such effects of medium replacement are apparent in the works of Anna Sanfeliu. Below
are cell density and viability profiles for anchorage CHO cells, switched from 5% serum
to 1 % serum, with or without insulin, on day 5 (Figure 6-5 a b). The first set of plots is for
the case where medium is not exchanged at all; the second set of plots is the
corresponding experiment during which she did exchange medium daily. A comparison
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of the experiments reveals that insulin has a deleterious effect that is much more severe
in the presence of conditioned medium factors. (Note: for the first set of experiments,
measured levels of nutrients and waste metabolites verify that sufficient nutrients
remain, and that lactate and ammonia, though quite high, are not past their toxic
thresholds). A second observation is that cell densities are suppressed in the presence
of conditioned medium factors. Both these observations are similar to the ones I have
made for hybridomas. Conditioned medium factors may arrest cells uniformly
throughout the cell cycle, leading to slower growth and cell death. For CHO cells, the
presence of insulin has been shown to stimulate entry to the cell cycle. Thus, in the
presence of conditioned medium factors that inhibit cell cycle progression, the increase
in insulin's negative effect on CHO viability may be due to the arrestment that occurs
within the cell cycle due to these factors. In the absence of conditioned medium factors,
lesser inhibition through the cell cycle results in lesser cell death. Finally, as discussed
above, it is interesting that the plateau in cell growth for the daily-fed cultures and the
emergence of cell death in the insulin-experiment occurs at a density around 2e6
cell/ml. Though perhaps this density is that of confluence, another explanation is that
daily replacement of the medium was too long an interval to avoid effects from
conditioned medium factors.
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Figure 6-5 a,b. Effect of insulin and conditioned medium on anchorage-
dependent gamma-CHO cells.
Data from Sanfeliu et. al. (Sanfeliu, Chung et al. 1999 in press)
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6.4 OPPORTUNITIES FOR FURTHER IMPROVEMENT OF
FED-BATCH CULTURES
6.4.1 Reduce Apoptosis by Supporting Cellular Function
6.4.1.1 Membrane Integrity and Energy Potentials
Part of the improvement of fed-batch cultures for the production of therapeutic proteins
described within this thesis stems from the reduction of apoptotic cell death through the
support of metabolism. It was shown that cells can shift their metabolism to
accommodate a limitation in a key nutrient (Chapter 3) and that metabolic robustness
depends on insulin stimulation (Chapter 5). Furthermore, there is sufficient evidence to
hypothesize that the conditioning of culture medium impedes metabolic function. Thus,
in the presence of insulin and in the absence of nutrient limitation and high levels of
conditioned medium factors, a shift in metabolism towards efficiency is associated with
better culture performance. In the chemostat experiments, a higher viable cell density
steady state (the multiple steady state for D=0.04 hr-1) is achieved for a hybridoma
culture upon lifting the nutrient limitation by increasing the dilution rate back up to
D=0.04 hr-1 from 0.01 hr-1. Similarly, cells of a culture that are grown on a leaner
medium exhibit extended viable proliferation during fed-batches (Brian Follstad's
Thesis). Brian Follstad has linked differences in metabolic behavior to shifts in central
carbon metabolism towards oxidative phosphorylation for cells with greater
mitochondrial activity and potentials. Hence, the importance of metabolic function for
culture robustness stems from the reduction in cell death that is observed for cultures
exhibiting more efficient metabolism. Additional research to further protect metabolic
function during fed-batches is warranted. The degradation of cellular membranes by
environmental factors, and the resulting decrease in ion potentials, could very well be
the principle cause for metabolic impediment. Brian Follstad's experiments with
mitochondrion decoupling agents demonstrate that loss of mitochondrial potential
results in apoptosis via the release of apoptosis inducing mitochondrial factors such as
cytochrome C and reactive oxygen species.
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The "strengthening" of the mitochondrial membrane is a possible explanation for the
benefits of BcI-2 overexpression. BcI-2 is an anti-apoptotic protein that is found
predominantly in mitochondrial membranes. It has been shown that part of its protective
role is associated with decreasing the release of cytochrome C from the inner
mitochondrial space. In light of the role that mitochondrial potential has in enhancing
culture performance, it is not unreasonable to suggest that genetic factor like Bcl-2 is
actually a "pro-mitochondrial" protein first and foremost, rather than anti-apoptotic
protein. The relationship between BcI-2's role in reducing apoptosis and its presence
within mitochondrial membranes agrees very well with the evidence for metabolic
function and apoptosis presented in this thesis and that of Brian Follstad.
6.4.1.2 Robustness within Cell Cycle
For the hybridoma cell line, the support of proper cell cycle progression initially takes
the form of addressing the defective cycle entry that leads to cell death under
suboptimal conditions. Observation of defective cell cycle control in chemostats, and the
measurement of high levels of c-Myc, led to the use of cell cycle arresting agent
rapamycin to mildly slow the progression of cells through the G1-phase. This was
remarkably successful in delaying the emergence of apoptosis and minimizing it
thereafter. As is discussed earlier, possible explanations for the anti-apoptotic effect
include allowing cells to complete production of intracellular factors, minimizing cell
death due to S-phase arrestment, shifting metabolism towards efficiency, reducing the
production of detrimental conditioned medium factors, and/or affecting the regulation of
any of a number of other intracellular proteins.
There are ample opportunities for additional research into the role of cell cycle
progression and apoptosis. To dissect the current handful of explanations for
rapamycin's effect, other means for arrestment should be investigated. For example, it
may be of interest to see if the knockout and reintroduction of c-myc on an inducible
promoter would yield a hybridoma that is much less prone to apoptosis. Another
interesting pursuit would be to investigate the induction of apoptosis within the S-phase
and G2/M-phases. Cell' biology contains much information about checkpoint-mediated
arrests, and the ensuing apoptosis that can occur if the checkpoint is not passed.
188
Perhaps, given that delays are bound to occur within the cell cycle due to nutrient or
conditioned medium factor limitation, it would be useful to learn how to fortify cells
against apoptosis when such delays occur. The arrestment is probably best left intact to
prevent serious genetic problems, but a delay in apoptosis upon checkpoint arrest may
grant cultures another level of robustness against suboptimal conditions.
Interestingly, the protein Bcl-2 protein has also been implicated in delaying progression
of cells from the G1-phase into the S-phase. Knowledge herein pertaining to the
interaction between metabolic function and cell cycle progression may imply that Bcl-2's
effects on cell cycle could be due to its primary support of metabolism. In the absence
of Bcl-2 (and for cell lines showing normal cell cycle entry regulation), lesser metabolic
capacity under suboptimal conditions may perhaps compromise the control of cell cycle
entry, which depends on phosphorylation events requiring energy.
6.4.1.3 Three-Prong Strategy
In the direct pursuit of high-density fed-batch cultures that yield record-high therapeutic
protein titers, I believe that a combination of pro-cellular function / anti-apoptotic
strategies could achieve the best fed-batch performance to date, even in serum-free
medium. The three strategies that have each been proven to enhance culture viability
are Bcl-2 overexpression (Joydeep Goswami and others), adaptation of inocula to
metabolic efficiency and increased mitochondrial potential (Brian Follstad), and medium
supplementation with rapamycin (myself). Since each strategy may be unique in its
mechanism to reduce apoptosis, I would expect some synergy among the effects.
Hence, a conservative estimate of the possible process improvement would be that the
effects combine to delay the emergence of apoptosis up through 96 hours (4 days), one
more day beyond rapamycin alone. Similar to my analysis of previous fed-batch
performances in Chapter 2, I estimate that the expected titer for such a 10-day fed-
batch process would be 1.3 g/L, up 0.35 g/L from the expected 0.95 g/L for a serum-free
rapamycin-fed fed-batch.
6.4.2 Search for Conditioned Medium Death Factors
6.4.2.1 The Presumed Nature of the Death Factor
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The observed effects of conditioned medium on insulin-free batches point to both
positive and negative factors that influence proliferation and apoptosis. Being that
insulin supplementation appears to provide sufficient stimulation, that even over-rides
the effects of other positive factors such as 11-6 (data not shown), the determination of
the negative factors and the prevention of their negative effects is a promising
hypothetical direction to pursue for the improvement of fed-batch processes.
As discussed in earlier sections, I am hypothesizing that the conditioning of culture
medium negatively affects cellular metabolism. Under this hypothesis, the effects of
both insulin and rapamycin on metabolism lead to protection against the accumulating
conditioned medium factors. Furthermore, as calculated for insulin-free chemostats, the
cellular metabolism may play a role in the rate that medium is conditioned. Cultures
under sufficient glutamine-limitation and cultures in the presence of rapamycin may
survive longer as a result of the shift in their metabolism, that in turn possibly reduces
the rate of contamination of the culture environment.
Relying on the findings in this thesis, as well as those from Brian Follstad, concerning
the effect of metabolism on apoptosis, I imagine that the conditioned medium factors
impede metabolic function by interfering with the integrity of cellular membranes (such
as in the mitochondria) and the energy potentials that they maintain.
6.4.2.2 Preliminary Findings
The hypothesis of other unknown factors that stimulate cell death stems from the partial
success of rapamycin in delaying apoptosis. If rapamycin's effect were purely of a
cellular nature, I would have to hypothesize why that nature succumbs to cell death
eventually anyway. It seems more plausible to imagine that rapamycin protects cells
against the conditioning of the medium, in the same fashion that we imagine how insulin
protects cells.
The differences in metabolism between rapamycin and control batches and fed-batches
were first observed in the difference in the color of T-flask cultures. With phenol red as a
pH indicator, it was evident that the rap culture pH at day 2 was around 7.1 (red color
still), whereas the control culture at day 2 was around 6.8-7.0 (more orange). This
observation raised the question of whether the difference in pH was simply the result of
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differences in cell proliferation (rap - 0.8-1.2e6 cell/ml vs. control - 1.0-1.5e6 cell/ml) or
if it were also an indication of differences in cellular metabolism. As shown in Chapter 4,
measurements of metabolites indicate that rapamycin culture metabolism appears to
produce less lactate. Knowing that cell death occurring in the absence of excessive
lactate accumulation or suboptimal pH, the difference in T-flask lactate and pH was
taken to be evidence that other unknown factors that affect cell death could also be
different. In this sense, it was rapamycin's effect on the conditioning of medium that
could possibly explain its anti-apoptotic effect.
At the same time I was trying to hypothesize why rapamycin cultures still were being
compromised by cell death, phenomena from the polymer-encapsulated hybridoma
cultures provided possible evidence of negative factors that may accumulate within the
beads. The increase in pore size, discussed earlier, allowed the cells to reach densities
10 times greater. Knowledge of the estimated pore sizes for standard polymer beads
and those with peg 3400 provide a rough indication of the size of the hypothesized
death factor. Cells in standard polymer beads had pores large enough to allow insulin (5
kDa) to pass through, but small enough to keep the MAb product (150 kDa) within the
beads. The larger pore size had an estimated cutoff of roughly 150 kDa up to 2000 kDa,
yet still retained a significant amount of MAb's within the beads. Thus it seems plausible
that a "death factor" could be a compound about 10 to 100 kDa in size. However,
transport across a pore also depends on the shape and charge of the compound, hence
the compound could be outside of this range nevertheless.
The search for the unknown cause of apoptotic cell death in hybridoma cultures began
by screening two well known environmental protein death factors, FAS ligand (FAS-L)
and Tumor Necrosis Factor Alpha (TNF-x). These substances have been shown to
directly trigger apoptosis in susceptible cell lines. However, neither of these substances
triggered cell death during 22 hours of incubation, as would have been expected in FAS
or TNF-a sensitive cell lines.
To determine if death activity could be contained within conditioned medium, I ran batch
cultures in the presence of concentrated fractions of highly conditioned medium. The
fractions were obtained from the conditioned medium of a viable culture grown up to 1.8
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x 106 cell/ml during 48 hours of culture (F = 2.6) for this conditioned medium). This
highly conditioned medium was concentrated by ultrafiltration using filters with
molecular weight cutoffs of 10k, 50k, and 100k. 15 ml of the conditioned medium was
placed in each type of ultrafiltration device, and spun down at room temperature for one
hour, at which time the retentate volumes were about 1-2 ml (7.5x-15x concentrates).
The retentate was then spiked into 18 hr old, high viability, 5.0 ml cultures. Assuming
the death factor was retained by the ultrafilters and completely transmitted, the recipient
culture would have received more than twice as much death factor as that present just
before death typically emerges in batch experiments (the F-level of the conditioned
medium would have risen from 0.8 to 6.1-7.2). Such a dose of death factors should
have killed the culture immediately. However, no such cell death was observed and all
the recipient cultures grew normally with high viability until 45 hours, after which they
began to die similar to the control. Taken at face value, this experiment tells me that the
death factor is not necessarily a very large molecule. Perhaps it is around 5k MW, yet of
shape and charge that a change in the pore size of the polymer beads was still
influential in its transport. Indeed, an autoinhibitor for murine hybridomas was isolated
previously - by hollow fiber filtration it is estimated to be around 3000 Da (Lee, Yap et
al. 1995) but remained unidentified.
6.4.2.3 Possible Candidates for Future Investigation
So the question remains as to what compound or quality of the conditioned medium the
death factor may be. From experience I can rule out pH, temperature, lactate
accumulation, ammonia accumulation, and dissolved oxygen limitation. Possible culture
parameters that I have not measured myself include dissolved C02 levels, osmolarity,
ionic strength (salt balance) of the medium, and reducing power of the medium. It is
known that these factors can be detrimental to cultures, though cells can typically grow
within wide ranges of each such factor. The emergence of death during batches and
chemostats (where pH, DO, are controlled, and where fresh medium maintains C02
levels and osmolarity and reducing power within healthful levels) detracts from these
being good candidates to pursue. Based on my preliminary observations, my best
guess for the nature of the death factor at the moment is that it may be a low-level
metabolite associated with excessive and/or inefficient glycolytic metabolism. Such a
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metabolic (methyl glyoxal) has been reported for CHO cells and is linked to catabolism
of amino acids and glucose (Chaplen, Fahl et al. 1996; Chaplen, Fahl et al. 1998). This
type of factor fits my preliminary findings in terms of size. It also satisfies my hypothesis
that metabolic profile of a culture can influence production of the unknown factor.
A good opportunity for identifying a death factor lies in the comparison of rapamycin-
conditioned and regular conditioned medium. To prove that the rap conditioned medium
is actually the key to understanding how rap cultures have delayed apoptosis in batch
cultures, one would need to demonstrate that 50hr-rapamycin-conditioned medium
(Rap-CM) can support viable proliferation, whereas 50hr-control-conditioned medium
(C-CM) cannot. This could be shown by exchanging the conditioned medium of two
parallel cultures, one grown with and one grown without rapamycin, at approx. 50 hrs of
culture, when both cultures still have high viabilities. According to the conditioned
medium hypothesis, I would predict that the rap-cells will die when placed in C-CM,
while the control cells will actually live in the Rap-CM. Several variations of such
experiments could be run to vary the effects of culture age (24-hr cells versus 48-hr
cells) and the strength of the conditioned medium (40 versus 50 versus 60-hr CM) if
necessary. It would also be wise to measure and compare pH, osmolarity, pCO 2 , and
any other possible measurable parameters, for clues concerning the emergence of cell
death.
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7 CONCLUSION
7.1 BRIEF SUMMARY
The study of hybridoma culture physiology in terms of metabolism, cell cycle
progression, and apoptosis has in the end provided a better phenomenological
description of the changes in some essential cellular functions that are associated with
the emergence of apoptosis. The emergence of death was examined in response to
several distinct environmental factors: under nutrient limitation, following insulin
withdrawal, with rapamycin supplementation, and in the presence or absence of
different types of conditioned medium. In all cases it appears that cellular metabolism
shifts towards greater efficiency and (assuming a constant P/O ratio) greater energy
production. As the result of deregulation of cell cycle entry, the cell cycle is delayed in
the S-phase for nutrient limitation and in all the phases for insulin depletion and
accumulation of higher levels of conditioned medium factors.
These characterizations for metabolic and cell cycle changes associated with apoptosis
have yielded fruitful insights and strategies for the improvement of fed-batch cell culture.
I have successfully applied rapamycin supplementation to minimize the negative effects
of the faulty control for cell cycle entry. For reasons unknown, a delay within the G1-
phase of the cell cycle serves to postpone the emergence of apoptosis. Brian Follstad
has identified that metabolically robust cells are ones that survive longer during fed-
batches or yield multiple steady states of higher cell density in continuous culture. He
has linked such metabolic robustness to increased mitochondrial activity and potential.
The prominence of metabolic phenomena in the emergence of apoptotic cell death
leads me to believe that insulin's protective role for hybridomas is based on its support
for metabolism. Likewise, even though it is better known as a G1-phase arresting agent,
rapamycin's protective role may also be linked with a metabolic shift supported by
preliminary evidence. Lastly, the effect of conditioned medium on hybridoma cultures is
made evident in survival or death in the absence of insulin. Survival factors such as
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insulin and rapamycin (as well as possibly BcI-2) appear to offer protection only in the
midst of high levels of conditioning.
In terms of further enhancing fed-batch technology, there remains plenty of room for
improvement of culture performance in regard to extending viable proliferation and
maximizing productivity. Such advances will come from the understanding and
exploitation of the cells own resources for survival. The basis on which we choose
further environmental and genetic modifications to cellular behavior will depend on
continued advances in our understanding of the cellular constraints (such as those that
have been observed herein for metabolism and cell cycle progression) that determine
whether a cell lives or dies by apoptosis.
7.2 LIST OF OVERALL FINDINGS
The following list serves to itemize my findings in this thesis concerning the effects of
rapamycin and insulin on the cell cycle and apoptosis of hybridoma cells. Due to its
prominence in the discussion, such a list must also include findings regarding
metabolism to be complete, and so I also include some overlapping findings from Brian
Follstad. In the following statements I also try to be clear about stating what has been
determined as fact and for which there is proof, and what I have hypothesized and
therefore is open to interpretation and future investigation.
1. Glutamine-limitation by the reduction of dilution rate in continuous culture
steady states is associated with increases in apoptotic cell death of
hybridomas.
1a. Cell cycle progression through the S-phase is delayed from 10 hours up to 20
hours, while progression through other phases remains relatively constant. The
increase in S-phase progression correlates with the emergence of apoptotic cell
death. The shortage of precursors for DNA synthesis may be the cause for the
delay of progression. Cell cycle regulation for DNA synthesis (perhaps by p53)
may be the trigger for apoptotic cell death.
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1 b. The emergence of cell death within the S-phase is very likely exacerbated by the
lack of regulation of cell cycle entry, that is due at least in part by the measured
high expression levels of c-Myc. Inappropriate entry to the cell cycle under sub-
optimal conditions (such as nutrient limitation) may lead to higher levels of
apoptotic cell death than would otherwise occur. This has been indirectly
demonstrated by inhibiting cell cycle entry with rapamycin, though the
mechanism for rapamycin's anti-apoptotic effect is unclear.
1c. Metabolism for steady states at lower dilution rates shifts towards greater
efficiency for the consumption of metabolites yet higher consumption of oxygen.
The shift in metabolism is deemed a robust response since the efficient
metabolic state is shown to yield a multiple steady culture of higher viable cell
density upon returning to a fast dilution rate and is associated with enhanced
viability for fed-batches inoculated with cells of greater metabolic efficiency.
2. Cell death in fed-batch cultures occurs by apoptosis and is associated
with the inhibition of growth rate.
2a. When apoptosis emerges, cell cycle progression is delayed for all phases of the
cell cycle. It is therefore presumed not to be the primary cause for growth
inhibition.
2b. Metabolism is observed to shift towards increased efficiency, as if to meet
increased .energy requirements. This increase in energy demand is taken to be
reflective of an increase in maintenance energy required as the culture medium
becomes more conditioned. Thus, as culture progress in fed-batch, energy
supply may be a limiting factor and may be the cause for growth inhibition,
delays in cell cycle, and apoptosis.
3. Rapamycin postpones the emergence of apoptotic cell death in
insulin(+)-hybridoma cultures.
3a. Rapamycin, a known G1-phase arresting agent, delays the progression of
hybridoma cells through G1 by 2 hours during optimal conditions early in a batch
or fed-batch.
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3b. Rapamycin postpones the emergence of cell death from 48 to 72 hours after the
start of a fed-batch. This anti-apoptotic effect of rapamycin has not been
previously described. This phenomenon is explained by the known effect of
rapamycin on the control of mRNA translation and ribosome function, and hence
the overall protein profile of the cells. Proteins reported to be affected by
rapamycin include some related to the regulation of cell cycle entry. Preliminary
evidence regarding a shift in metabolism may reflect changes in proteins related
to metabolic function as well.
3c. The optimum concentration for the hybridomas of this study was determined to
be 50-100 nM. For extended cultures, the poor stability of rapamycin is managed
by feeding 50 nM daily (starting at day 2), in addition to the 100 nM added
initially. Loss of rapamycin activity is observed in a decreased fraction of cells in
G1 and higher cell death. 200-nM rapamycin is observed to be suboptimal due to
the increased suppression of growth rate, and hence lower cell density, without
the benefit of the decreased death rate.
4. Indirect evidence demonstrates that insulin acts as a protective factor for
serum-free hybridomas through its effect on metabolism rather than cell
cycle.
4a. Insulin's protective role is demonstrated by its support in extending viable
proliferation from 25 to 50 hours in batch cultures. High viability of batches
passaged daily and the survival of three of five insulin-free chemostats
implicate insulin as protecting against environmental factors found in
conditioned medium.
4b. The presence of insulin for cell cycle progression is not absolutely required.
Cell cycle progression in the absence of insulin implies that either other
autocrine factors are present to stimulate signal transduction or that such
circuits are even more deregulated beyond that observed for c-myc
expression. The positive effect of insulin-free chemostat conditioned medium
on proliferation makes the explanation of autocrine factors more plausible.
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Furthermore, cell cycle phenomena associated with cell death are similar
with and without insulin and are not associated with an arrest in any
particular phase of the cell cycle
4c. Metabolic support by insulin is implicated by the requirement for insulin in
environments that are more conditioned. With cell death in fed-batches
possibly being due to energy limitation (a limitation possibly arising as the
result of increased conditioning of culture medium), insulin is thought to
confer additional metabolic capacity for the cells as they are observed to shift
their metabolism toward TCA cycle as they die.
5. Unknown conditioned medium factors are hypothesized to play a role in
the emergence of apoptosis.
5a. Insulin-free experiments revealed that the environment plays a key role in the
survival of cultures in insulin-free environments. Cells surviving without insulin at
steady state in a chemostat still required insulin for viable proliferation past 24
hours in batches. Furthermore, the insulin-free chemostat-conditioned medium
was able to support viable proliferation for up to 48 hours for both insulin-free
chemostat cells and a fresh stock of cells.
5b. The production and accumulation of conditioned medium factors that stimulate
apoptosis is modeled. Calculations for insulin(-), insulin(+), and insulin(+)-
rapamycin. experiments reveal consistent thresholds for each case. Moreover,
insulin-free chemostats point to the production of such factors as being variable,
perhaps depending on metabolism and cell cycle.
5c. Within this framework, the hypothesized conditioned medium factor that
stimulates cell death is attributed to be one of the unknown causes for cell death
in fed-batch cultures. If indeed a principle cause for apoptosis, accumulation of
the factor could be imagined to result in a metabolic impediment, which insulin
and rapamycin allow cells to combat more effectively.
6. Monoclonal antibody production is observed to be a function of
metabolism, cell cycle progression, and cell death.
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6a. An optimum in specific productivity for MAb production of 2.3e-9 mg/cell/hr is
observed at an intermediate dilution rate of 0.03 hr 1 in steady state chemostats.
Such an optimum is believed to reflect differences in metabolism rather than cell
cycle progression. A lower productivity from the multiple steady state may
support this belief.
6a. The combined effects of rapamycin on cell cycle distribution and metabolism
lead to an increase in the apparent specific productivity of MAb's from 1.5e-9 up
to 3.2e-9 mg/cell/hr. This physiological change is the dominant effect for the
achievement of higher MAb titer.
6b. For the 6-day fed-batches performed, rapamycin addition resulted in an increase
of titer from 0.25 to 0.55 g/L. On a ten-day basis for comparison of fed-batch
titers, a fed-batch process with rapamycin is expected to yield a record titer of
0.95 g/L for a serum-free process, which is competitive to previous processes
with this cell line, where 2.4 g/L was obtained from a three week fed-batch using
serum.
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